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1. Common abbreviations 
  
AAALAC  Association for Assessment and Accreditation for Laboratory Animal Care 
AMP   Antimicrobial Peptide 
AO Arbeitsgemeinschaft für Osteosynthesefragen / Association for the Study of 
Internal Fixation 
APC   Antigen Presenting Cell 
BA   Blood Agar 
BMP   Bone Morphogenetic Protein 
CFU   Colony Forming Unit 
CoNS   Coagulase-Negative Staphylococci 
DC   Dendritic Cell 
DNA   Deoxyribonucleic Acid 
DRI   Device-Related Infection 
ECM   Extracellular Matrix 
FRI   Fracture-Related Infection 
G-CSF   Granulocyte Colony-Stimulating Factor 
GE   Giemsa/Eosin 
H(1/2/3/4)R  Histamine 1/2/3/4 Receptor 
HIF   Hypoxia Inducible Factor 
HSC   Hematopoietic Stem Cell 
IFN-γ   Interferon gamma 
Ig   Immunoglobulin 
IL   Interleukin 
KC   Keratinocyte Chemoattractant 
KO   Knock-out 
LOD   Limit of Detection 
LTA   Lipoteichoic Acid 
M-CSF  Macrophage Colony-Stimulating Factor 
MCP-1  Monocyte Chemotactic Protein 1 
MDSC   Myeloid-Derived Suppressor Cell 
MMP   Matrix Metalloproteinase 
MPO   Myeloperoxidase 
MSC   Mesenchymal Stem Cell 
ODRI   Orthopaedic Device-Related Infection 
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PBS   Phosphate Buffered Saline 
PCR   Polymerase Chain Reaction 
PDG   Peptidoglycan 
PJI   Peri-prosthetic Joint Infection 
PMA   Phorbol 12-myristate 13-acetate 
(P)MMA  (Poly)methylmetacrylate 
PMN   Polymorphonuclear cells 
PRR   Pattern-Recognition Receptor 
PSM   Phenol Soluble Modulin 
RAPD   Random Amplification of Polymorphic DNA 
RNA   Ribonucleic Acid 
SD   Standard Deviation 
SE   Scanning Electron 
SEM   Standard Error of the Mean 
SPF   Specific Pathogen Free 
TGF   Transforming Growth Factor 
Th   T helper cell 
TLR   Toll-Like Receptor 
TNF-α   Tumour Necrosis Factor alpha 
Treg   T regulatory cell 
TSA   Tryptone Soy Agar 
TSB   Tryptone Soy Broth 
UV   Ultraviolet 
WT   Wild-type 
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2. Summary 
 
The subject matter of the present thesis is fracture-related infections (FRI), which represent one of 
the most common and challenging complications in orthopaedic trauma surgery. These infections 
delay fracture healing, can result in permanent loss of function or even amputation of the affected 
limb, and are associated with significant socio-economic costs. The leading etiologic agents for 
such infections are Staphylococcus aureus and S. epidermidis, which account for 50-75% of cases. 
S. epidermidis is responsible of 20-30% of these infections, increasing to 50% in late developing 
infections. Despite the clear clinical importance, the study of S. epidermidis has lagged behind that 
of S. aureus, with comparatively fewer experimental studies described in the literature. 
 
In the first part of the thesis, a new S. epidermidis fracture-related infection (FRI) model was 
established and characterized. The model was established using the MouseFix
TM
 system, a 
standardized internal fixator system for mice. After successfully establishing this infection model, a 
follow-up study was performed in order to investigate the role of fracture stability in the 
development and progression of FRI. The working hypothesis at the start of this thesis was that 
unstable fractures result in a higher infection incidence. The MouseFix
TM
 system is available with 
two types of implants that provide either mechanically stable or unstable fracture fixation and so, it 
served as an ideal system with which to test this hypothesis. This work was performed with both 
S. epidermidis and S. aureus and in two mouse strains (C57BL/6 and BALB/c). The study showed 
that C57BL/6 mice with rigid implants (stable fixation) cleared S. epidermidis infection at a higher 
rate compared to mice with flexible implants, thus providing evidence that stability can have an 
influence on infection progression. This finding, however, was not repeated for BALB/c mice, for 
which no differences were observed. The fact that the stability effect was dependent on the mouse 
strain used, highlights the role of host factors on infection progression. This then prompted the 
deeper investigation of immune responses in the model. We observed that instability was often 
associated with a higher tissue inflammation (e.g. higher mRNA levels of interleukin (IL)-33 or IL-
6), and the combination of instability plus infection with S. epidermidis significantly increased such 
markers. Due to the fact that infection with S. aureus resulted in rapid and extensive osteolysis, we 
were unable to maintain stability in these animals, so the hypothesis could not be reliably tested in 
this model for S. aureus. We were able, however, to compare the immune responses to 
S. epidermidis and S. aureus infection, with significantly higher secretion of pro-inflammatory 
cytokines (IL-6 or tumour necrosis factor (TNF)-α) and increased cell recruitment in the popliteal 
lymph node and spleen of mice infected with S. aureus. 
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In subsequent studies, we used our model of S. epidermidis FRI to test different hypotheses arising 
from these initial observations. The first such study involved investigating the role of IL-17A on 
FRI. We initially found that IL-17A mRNA expression and protein secretion from local cells was 
increased in experimental mice after inoculation with S. epidermidis. A follow-up study was then 
performed in IL-17A knock-out (KO) mice in an attempt to further elucidate the role of this 
cytokine in the development and progression of infection. Consistent with our first observations, we 
observed that IL-17A KO mice showed a reduced ability to clear infection, although differences did 
not reach statistical significance. In summary, these findings suggest an important role for IL-17A 
in FRI, although additional compensatory mechanisms may exist that play a similar role in KO 
mice. In our initial studies, we also found that histamine 2 receptor (H2R) mRNA expression was 
elevated in S. epidermidis inoculated mice and so we used H2R KO mice in an attempt to elucidate 
the role of this receptor in the development and progression of infection. Although differences were 
observed in cytokine and antibody production levels, these did not translate into different bacterial 
clearance rates suggesting that H2R is not involved in the infection response in our model. Finally, 
we aimed to evaluate the impact of previous existing immunity to S. epidermidis in our model. 
Experimental animals (e.g. specific-pathogen free (SPF) mice) do not have any pre-existing 
immunity to S. epidermidis, which contrasts with the human situation where a specific humoral 
immunity to S. epidermidis is observed. After subcutaneous inoculation of non-viable whole 
S. epidermidis cells, we demonstrated that specific adaptive immunity was present, however, this 
did not influence the infection rate, bacterial burden, or immune responses in our model compared 
to saline-treated controls. 
 
In conclusion, a S. epidermidis fracture-related infection mouse model was successfully established 
and characterized, representing one of the first models available in the literature. We provide 
evidence that stability is beneficial for bacterial clearance, supporting those clinical beliefs that 
stability should be maintained during FRI treatment. Immune responses associated to S. epidermidis 
and S. aureus infections were studied in this model, which depicted S. aureus as an agent of 
elevated inflammatory mediators and rapid osteolysis, whilst S. epidermidis was revealed to display 
signs of a sub-acute infection with few elevated markers of inflammation. This closely reflects 
clinical observations of patients with infection caused by these microorganisms. In addition, we 
used this model to understand the roles of IL-17A, H2R and pre-existing immunity in the infection 
progression, with some immune markers showing significant differences, but ultimately none of 
these single factors was found to be solely responsible for the development of FRI in this model. 
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3. Zusammenfassung 
 
Das Thema der vorliegenden Doktorarbeit sind Fraktur-bezogene Infektionen, welche eine der 
häufigsten und herausforderndsten Komplikationen in der Trauma Chirurgie darstellen. Diese 
Infektionen verzögern die Knochenbruchheilung, was zu einem permanenten funktionalen Verlust 
oder sogar zur Amputation des betroffenen Körperglieds führen kann und mit signifikanten 
sozioökonomischen Kosten verbunden sind. Führende Krankheitserreger solcher Infektionen sind 
Staphylococcus aureus und S. epidermidis, welche für 50-75% dieser Infektionen verantwortlich 
sind. Alleine S. Epidermidis verursacht 20-30% dieser Infektionen und sogar 50% der 
Spätinfektionen. Studien an S. epidermidis hinken trotz hoher Prävalenz und klinischen Bedeutung 
hinter jenen von S. aureus her. Zudem sind in der Literatur nur wenige etablierte Tiermodelle 
beschrieben.  
 
In der vorliegenden Doktorarbeit wurde ein neues S. epidermidis Fraktur-bezogenes 
Infektionsmodell etabliert und charakterisiert. Für das Tiermodell wurde das "MouseFix
TM
"-System 
verwendet, ein standarisiertes internes Fixateur-System für Mäuse. Es stehen zwei verschiedene 
Implantate zur Verfügung, welche unterschiedliche mechanische Eigenschaften (stabil und unstabil) 
haben. Nachdem mit diesem Infektionsmodell eine fortschreitende subklinische Infektion 
nachgewiesen und etabliert werden könnte, wurde anschliessend eine Studie durchgeführt, um den 
Einfluss der Frakturstabilität auf die Entwicklung und Fortschreitung der Infektion zu untersuchen. 
Diese Arbeit wurde mit S. epidermidis und S. aureus in Mäusen der Stämme C57BL/6 und BALB/c 
durchgeführt. Die Studie zeigte, dass C57BL/6 Mäuse mit "rigid" Implantaten (stabile Fixierung) 
eine S. epidermidis Infektion besser eliminierten als Mäuse mit "flexible" Implantaten. Dies lieferte 
den Beweis, dass die Stabilität einen Einfluss auf die Infektion hat. Die Tatsache, dass der 
Stabilitätseffekt vom verwendeten Mausstamm abhängig war, weist darauf hin, dass der Wirt einen 
Einfluss auf die Infektionsentwicklung hat. In beiden Stämmen, wurde eine höhere Entzündung 
(z.B. höhere mRNA-Level von Interleukin (IL)-33 oder IL-6) bei Instabilität nachgewiesen. Die 
Infektion mit S. Aureus führte in beiden Systemen ("rigid" und "flexible") zu einer schnellen und 
extensiven Osteolyse. Daher war ein Vergleichen der Fraktur Stabilität nicht möglich. Jedoch waren 
wir in der Lage, die Immunantwort von S. epidermidis und S. aureus zu vergleichen. Einige der 
untersuchten Immunparameter zeigten signifikante Unterschiede, wie zum Beispiel erhöhte 
Sekretion der proinflammatorischen Zytokine (IL-6 oder Tumor Nekrosis Faktor(TNF)-α) oder 
erhöhte Zell Rekrutierung in dem Kniekehlenganglion und in der Milz. Ebenfalls waren ersichtlich 
signifikante Unterschiede bei Gewichtsverlust und Osteolyse. 
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In darauffolgenden Studien wurden verschiedene Hypothesen mit unserem Tiermodell untersucht. 
Eine davon analysierte den Einfluss von IL-17A auf Infektionen. Wir hatten festgestellt, dass in den 
Mäusen nach einer Inokulation mit S. epidermidis, IL-17A mRNA und Protein Spiegel erhöht 
waren. Mit IL-17A knock-out (KO) Mäusen wurde daraufhin der Einfluss von Zytokinen auf die 
Entwicklung einer Infektion untersucht. Es konnte gezeigt werden, dass IL-17A KO Mäuse eine 
Infektion weniger gut eliminierten, jedoch war der Unterschied nicht signifikant. Dies deutet jedoch 
darauf hin, dass ein kompensatorischer Mechanismus existieren muss. Ebenfalls haben wir in 
unseren anfänglichen Studien festgestellt, dass die mRNA-Expression des Histamin 2 Rezeptors 
(H2R) nach einer S. epidermidis Inokulation erhöht war. Daher wurde mit H2R KO Mäusen der 
Einfluss des Rezeptors auf die Entwicklung einer Infektion untersucht. Unterschiedliche 
Konzentration an Zytokin- und Antikörper-Produktion wurde beobachtet, wobei dies keinen 
Einfluss auf die bakterielle Bekämpfung hatte. Dies deutet darauf hin, dass H2R bei der 
Infektionsantwort in unserem Modell nicht involviert ist. Zum Schluss wollten wir mit unserem 
Modell herausfinden, welchen Einfluss eine bereits bestehende S. epidermidis Immunität hat. Im 
Gegensatz zu Menschen, welche eine S. epidermidis spezifische humorale Immunität aufweisen, 
haben Labortiere keine. Nachdem subkutan den Mäusen abgetötete S. Epidermidis verabreicht 
wurden, konnte eine spezifische adaptive Immunität beobachtet werden. Jedoch hatte diese in 
unserem Modell,verglichen mit den Kontrolltieren, welchen Kochsalzlösung verabreicht wurde, 
keinen Einfluss auf die Infektionsrate, bakterielle Belastung und Immunantwort. 
 
Zusammenfassend kann gesagt werden, dass ein S. epidermidis Fraktur-bezogenes 
Infektionsmausmodell erfolgreich etabliert und charakterisiert wurde, welches eines der ersten 
Tiermodelle in der Literatur darstellt. Mit diesem Modell haben wir gezeigt dass, die 
Frakturstabilität mit einer höheren bakteriellen Eliminierung verbunden war. Die Immunantwort auf 
S. epidermidis und S. aureus Infektionen wurde untersucht, wobei signifikante Unterschiede auf 
klinischer, zellulärer und molekularer Ebene beobachtet wurden. Zudem wurde dieses Modell 
verwendet, um den Einfluss von IL-17A, H2R und eine bereits vorhandene Immunität auf die 
Infektionsentwicklung zu untersuchen.  
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4. Introduction 
4.1 Bone biology and principles of fracture treatment 
4.1.1 History of fracture management and the AO Principles 
Bone fractures, as may result from road-traffic accidents or falls, occur with an average global 
incidence of approximately 16 cases/1000/year; with higher rates in developing countries [1-4]. 
Bone is one of the few tissues in the human body that is able to heal throughout life without scar 
formation, although fractures can result in permanent disability if not treated appropriately. When a 
bone fracture occurs, there is a loss of structural continuity of the cortical bone resulting in a loss of 
function. Without any intervention, the bone would heal spontaneously by callus formation; 
however, under such conditions, healing is likely to be imperfect, particularly if the respective bone 
fragments are incorrectly aligned. The surgical treatment of fractured bones via the implantation of 
fracture fixation devices was developed to restore bone anatomy and function in a more reliable 
manner [5].  
The earliest evidence of fracture management was discovered in Naga-ed-Der, Egypt (300 BC) and 
consists of rudimentary splints [6]. Splinting, with immobilization in plaster, bracing and traction, 
remained the main approaches to fracture management until the second half of the 19
th
 century [7, 
8]. These early methods of fracture management restrict limb movement during the healing process 
and require patient immobilization for prolonged periods. These treatments, therefore, routinely 
lead to progressive weakening of bone, joint stiffness, muscle atrophy, poor functional outcome and 
prolonged periods of time to achieve fracture healing (from 6-8 weeks to 3-6 months) [9, 10]. Three 
major medical developments in the second half of 19
th
 century allowed for important advances in 
the field of surgical treatment of fractures [7]. These key innovations were anaesthesia, antisepsis 
and radiology. With them, the development of surgical fracture care steadily proceeded. The most 
important early innovations made regarding the surgical treatment of fractures included external 
fixation by Albin Lambotte (1886-1956), internal fixation by Lambotte and William Arbuthnot 
Lane (1856–1943) and the intramedullary nail by Gerhard Küntscher (1900-1972). However, their 
ideas were not widely or rapidly adopted due to scepticism within the surgical community at that 
time and technical limitations [8, 9]. 
In 1958, inspired by Robert Danis (1880-1962), the father of modern osteosynthesis, the AO group 
(Arbeitsgemeinschaft für Osteosynthesefragen/ Association for the Study of Internal Fixation) was 
born. It was established with the aim of overcoming the limitations in bone fracture management by 
providing a better understanding of bone biology and by improving available instruments and 
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surgical protocols for their use. By doing so, it was expected that the surgical fixation of fractured 
bones would become a widely adopted revolution in trauma surgery. From this early work, the AO 
Principles for fracture fixation were established (Table 4-1), which remains to this day the basis of 
bone fracture management. 
Table 4-1 Description of the AO Principles for fracture management. Adapted from Rüedi et al.[9]. 
Principle Description 
Fracture reduction Realignment of bone fragments to restore the anatomy 
Fracture fixation Ensures the maintenance of fragment alignment and provides 
stability (absolute or relative) to the construct 
Blood Supply Preservation of blood supply 
Early mobilization Early mobilization of the limb and patient 
 
4.1.2 The bone healing process 
Bone tissue can heal through primary healing (also known as direct) or secondary (indirect) healing. 
The type of healing is dictated by the distance between the bone fragments and the mechanical 
environment at the fracture site. In general terms, a fixation that provides absolute stability will 
result in primary bone healing, while a fixation that provides relative stability will result in 
secondary bone healing. 
Primary bone healing 
Primary bone healing is a process of osteonal bone remodelling and/or intramembranous 
ossification (direct bone formation by osteoblasts with no cartilage formation). Primary bone 
healing requires absolute stability (a rigid fixation) and reduction of the bone fragments. When 
these conditions are present, primary bone healing can occur through two processes: contact healing 
or gap healing (Figure 4-1).  
Contact healing happens when mechanical continuity between bone fragments is achieved (gap 
between bone ends is less than 0.01 mm) [11]. In this situation, healing occurs via osteonal 
remodelling, i.e. new bone forms directly across the fracture line by direct extension of the osteons 
(or Haversian system, the functional unit of bone). In brief, the osteons extend through the 
formation of a cutting cone, which contains osteoclasts in the tip of the cone and osteoblasts at the 
rear of the cutting cone. Osteoclast drill a tunnel through the dead bone (directing the cutting cone 
across the fracture line), and at the other side the osteoblasts deposit new bone (osteoid) (Figure 
4-1, A).  
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Gap healing occurs if fracture gap is between 0.25-0.5 mm, although is suggested that it can occur 
with fracture gaps up to 0.8 mm [11]. In such cases, osteoblasts migrating from the periosteum or 
resulting from mesenchymal stem cell (MSC) differentiation directly produce osteoid, which is 
deposited along the fracture line (Figure 4-1, B). In this way, the fracture gap is first filled with 
woven and lamellar bone, a process that takes 3 to 8 weeks. Subsequently, the bone undergoes a 
remodelling process resembling the contact healing cascade with cutting cones.  
 
Figure 4-1 Histological sections of rabbit femurs showing primary bone healing A) by contact healing (with a 
schematic image below of a cutting cone crossing the fracture gap, with an arrow showing the direction of progression 
of the cutting cone), or B) by gap healing (with a schematic image below of a fracture gap closing with new lamellar 
bone formation by osteoblasts). Histology images from Rahn et al. [12] 
Secondary bone healing 
Secondary bone healing is the most common form of fracture healing. It consists of a mixture of 
intramembranous ossification and endochondral ossification, which together are the two essential 
processes occurring during foetal development of the skeletal system. In endochondral ossification, 
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MSCs differentiate into chondroblasts that form a stabilizing cartilaginous callus, which is further 
replaced with mineralized bone. Contrary to primary bone healing, it does not require anatomical 
reduction and absolute stability. 
Secondary bone healing consists of consecutive but overlapping phases (Figure 4-2), which could 
be summarized in: inflammatory phase, soft callus phase, hard callus phase and remodelling phase. 
As our knowledge of bone healing progresses, more elaborate classifications have been proposed. 
For example: hematoma formation, inflammation, neovascularization and granulation tissue 
formation, fibrous tissue formation, fibrocartilage, hyaline cartilage (soft callus), cartilage 
mineralization, woven bone (hard callus), and finally remodelling [13].  
The first phase is the acute inflammatory phase and it occurs during the first hours/days after 
fracture. At this stage, an hematoma is formed due to vessel disruption and several inflammatory 
mediators (such as tumour necrosis factor (TNF)-α, interleukin (IL)-6 or CCL2) and growth factors 
are released to attract cells into the fracture site and to induce angiogenesis [10]. Although the role 
of hematoma is not completely understood, it has been observed that its removal can lead to non-
union, highlighting its functional role in the healing cascade [13, 14]. Neutrophils are the first cells 
recruited into the fracture site where they clear dead cells and debris [15], and secrete cytokines, 
chemokines or extracellular matrix (ECM) proteins such as fibronectin [16]. Macrophages have also 
been observed to be recruited in this early phase and they are believed to play an essential role in 
bone healing. Macrophages contribute to tissue debridement and secrete a broad range of cytokines, 
chemokines and growth factors. These secreted factors lead to MSC recruitment from the 
periosteum, bone marrow and surrounding soft tissue, that further differentiate into osteoblasts and 
chondroblasts [17]. One to two weeks post-fracture, a soft cartilaginous callus is formed by 
proliferating chondrocytes (soft callus phase). Afterwards, the soft callus starts to mineralize and 
become woven bone, stiffening the healing tissue (hard callus phase). The last stage, which takes 
from months to years, is the remodelling phase where woven bone becomes lamellar bone [18-20]. 
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Figure 4-2 Schematic of secondary bone healing showing the main phases: the inflammatory phase with hematoma 
formation (days 0-5), the soft callus phase (days 5-16) at the start of the endochondral stage, the hard callus phase (from 
day 16 on) and finally the remodelling phase, which can take up to several months. Figure from Einhorn and 
Gerstenfeld [20] 
Factors affecting bone healing 
Fracture healing process is a complex and well-orchestrated process influenced by mechanical 
environment, together with biological factors. The "diamond concept" by Peter Giannoudis (Figure 
4-3) summarizes these factors into four specific aspects: osteogenic cells, scaffolds, growth factors 
and mechanical environment [21]. More recently, the concept has been updated to now also 
incorporate immune cells and inflammatory mediators as additional essential factors. 
 
Figure 4-3 The diamond concept by Peter Giannoudis, showing the main factors influencing bone healing: osteogenic 
and immune cells, growth factors and other molecules, vascularity, mechanical environment, the scaffold and the host. 
Adapted from Giannoudis et al. [22]. 
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Osteogenic and immune cells 
The cells involved in bone healing primarily differentiate from MSCs and hematopoietic stem cells 
(HSC) (Figure 4-4), although endothelial progenitor cells are also important for bone healing due to 
the need for re-vascularization throughout the healing process. Osteoblasts are cells derived from 
MSCs and are responsible for generating the bone ECM. They produce type I collagen, the main 
organic component of bone ECM, and proteins that stabilize and aid in mineralization of the matrix 
such as osteopontin or alkaline phosphatase [23, 24]. Over time, a small percentage of osteoblasts 
get embedded within the bone matrix and develop into osteocytes. Osteocytes are terminally 
differentiated osteoblasts that form an interconnected network within the mineralized matrix and 
play a major role in the homeostasis of bone. A second cell type important for bone healing are the 
chondrocytes, which are also derived from MSCs and are responsible for producing cartilage [25]. 
When a fracture occurs, MSCs are recruited into the fracture site and differentiate into chondrocytes 
and osteoblasts that are actively involved in fracture repair. The source of these MSCs is not 
completely known but most of the data suggests that they are derived from surrounding soft tissues 
and bone marrow [11]. Equally important to bone homeostasis and bone repair, are the cells that 
degrade bone, osteoclasts. Osteoclasts are multinucleated cells that are derived from HSCs and 
belong to the monocyte/macrophage lineage. They are the main bone resorbing cells, through the 
generation of proteolytic enzymes and acids [23].  
The role of immune cells in fracture healing has received increasing attention over the past years. 
Recent studies have shown that macrophages are essential for bone healing, by initiating the healing 
cascade and by supporting the transition from the soft callus into a hard callus [26, 27]. The role of 
lymphocytes is not entirely clear at the present time. Mice lacking an adaptive immune system have 
been shown to result in accelerated [28] but also delayed [29] bone healing. This apparent 
contradiction could be due to the effect of different lymphocyte subsets in the final outcome: while 
CD8+ T cells have been associated with delay in bone healing [30], B and T regulatory (Treg) cells 
seem to be beneficial [31]. Similarly, the role of γδ T cells is controversial at the present time, with 
contradictory findings also present in the literature [32, 33]. 
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Figure 4-4 Scheme with the main cell types involved in bone homeostasis/healing: osteoblasts and chondrocytes, which 
together with adipocytes and other cell types differentiate from MSCs; and osteoclasts and cells from the immune 
system (e.g. macrophages), which originate from HSCs. 
Scaffolds  
The scaffold referred to in the diamond concept describe the extracellular matrix of bone that 
provides a natural support for cells. In a fracture situation, it may be considered that the hematoma 
(consisting mostly of fibrin) is the first scaffold. Over time, the hematoma evolves into granulation 
tissue and provisional connective tissue. In clinical practice, scaffold may also refer to different 
synthetic or natural biomaterials used as bone void fillers to enhance bone formation [34]. 
Growth Factors and other molecules 
Fracture repair is finely regulated by a broad range of growth factors and other molecules such 
cytokines and chemokines. In the hematoma phase, several pro-inflammatory cytokines (such as IL-
1β, IL-6 or TNF-α), macrophage colony-stimulating factor (M-CSF) and members of the 
transforming growth factor (TGF)-β superfamily (such as bone morphogenetic protein (BMP)-2) 
are secreted to recruit cells into the fracture site [35, 36]. Angiogenic factors are also induced at 
early stages. Among the cells recruited there will be MSCs, which get licensed to exert their 
immunosuppressive functions. MSCs secrete molecules like TGF-β2 and 3, which have been shown 
to peak at the end of the inflammatory phase, to reduce inflammation in the tissue and to initiate the 
repair cascade. From that stage on, BMPs and other growth factors orchestrate the generation of soft 
callus and the further transition into hard callus and the remodelling phase. Some of the most 
relevant factors are described in Table 4-2. 
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Table 4-2 Summary of relevant molecules involved in bone healing. Adapted from selected reviews [35-38]. 
Molecule Role Comments 
Tumour necrosis 
factor (TNF)-α 
Homing of lymphocytes, monocytes/macrophages and 
MSCs during inflammatory phase. Licensing of MSCs to 
perform immunosuppressive functions in order to reduce 
inflammation. In a later phase, aids the transition of 
cartilage into bone. 
High sustained release 
can lead to bone 
destruction but in low 
doses might have a 
beneficial effect 
Interleukin-6 
Homing of lymphocytes and monocytes/macrophages 
during inflammatory phase (induced within first 24 hours). 
Enhances osteoclastogenesis and osteoblastogenesis. 
Its effect seems to be 
limited to the early 
phase. 
Interleukin-1β 
Homing of lymphocytes and monocytes/macrophages 
during inflammatory phase. 
 
CC chemokine ligand 
(CCL)2 / Monocyte 
Chemotactic Protein 
(MCP)-1 
Recruitment of macrophages into the fracture site. 
In CCL2 knock-out 
(KO) mice there is a 
significant impairment 
in bone fracture 
healing. 
Stromal cell-derived 
factor-1 (SDF-1) 
Recruitment and homing of MSCs to the site of trauma 
during hematoma phase. 
 
Fibroblast Growth 
Factor (FGF) 
Secreted during the early stages. Induces fibroblast, 
osteoblast and chondrocyte proliferation as well as 
angiogenesis. 
 
Platelet-derived 
growth factor (PDGF) 
Promote the proliferation and the chondrogenic 
differentiation of MSCs as well as deposition of collagen. 
Important in the soft callus phase. 
 
Transforming growth 
factor (TGF)-β family 
Secreted at the end of the inflammatory phase, probably in 
order to control inflammation and initiate repair cascade. 
 
Bone morphogenetic 
proteins (BMPs) 
Secreted throughout the bone healing process at different 
time-points, suggesting specific roles of the different BMPs 
in different phases of bone healing. BMP-2 is secreted from 
early time-points until the remodelling phase, suggesting a 
regulatory and essential role for this BMP. 
BMP-2 and 7 are 
clinically approved for 
non-union treatment, 
with BMP-2 being the 
most widely used. 
 
Mechanical environment 
The importance of mechanics in bone healing has been described for many decades and constitutes 
one of the AO principles. It is well defined that less stable implants lead to a more endochondral 
bone formation, with the presence of a stabilizing callus, while high stability leads to 
intramembranous ossification as described above.  
The effects of mechanics in bone healing are explained by the strain theory. In brief, strain is the 
deformation of a material when a given force is applied. Normal strain is the change in length (Δ l) 
in comparison to original length (l), and is expressed as a percentage. In a fracture, bone is 
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generated when the local strain is less than the strain that forming woven bone can tolerate. Thus, 
when the movement between the fragments is too great (meaning that there is big deformation of 
the tissue and thus a greater strain), no bone is generated. Nature deals with this by developing a 
soft callus (cartilage) that leads to less deformation and thus allows bone to be formed [9]. Starting 
in 1960 with Friedrich Pauwels, who developed a theory for the tissue differentiation in response to 
local mechanical stresses, several biomechanical models have been proposed to explain the 
connection between physical forces and cell behaviour in a tissue. Most of them are based on shear 
strain and hydrostatic forces. As an example (Figure 4-5), Damien Lacroix et al. have described a 
model based on shear strain and fluid flow forces. The model proposed shows that with low strains, 
MSC differentiate into osteoblasts, while higher strains progressively led to chondrocyte 
differentiation, fibrous tissue or no differentiation [39]. These findings provide a basis to understand 
how the mechanical load can drive to different types of bone healing and are of great importance in 
order to develop treatment opportunities in tissue regeneration [40-42]. 
 
Figure 4-5 Mechano-regulation concept forces influencing cell differentiation to form fibrous connective tissue, fibro-
cartilage or bone. The model is based on two mechanical stimuli: the tissue strain and the interstitial fluid flow. Figure 
from Lacroix and Prendergast [39]. 
4.1.3 Fracture fixation and stability 
Stability is the quality of being firmly fixed, or not likely to move or change. In the surgical field, 
stability is considered as a spectrum that ranges from absolute stability to instability. Fracture 
stability will be determined by the fracture pattern (simple facture versus multiple fragments), the 
type of fixation used, the surgical procedure and the quality of the bone. A stable fracture is defined 
as a fracture that does not visibly displace under physiological load. This stability can be absolute, 
when there is no "micromotion" at the fracture site, in contrast to relative stability, which is 
achieved when certain displacement can occur between the fragments [9]. At the other end of the 
spectrum one can find instability, with high deformation and thus high strain on the repair tissue 
that can lead to non-union, as described by the mechano-regulation model.  
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Absolute stability is achieved through techniques that compress the fragments towards each other 
(interfragmentary compression). Amongst the range of implants available, certain implants and 
application techniques provide interfragmentary compression, and these include lag screws, axial 
compression or tension bands (see examples in Figure 4-6). Absolute stability is more easily 
achieved in simple fractures and is specially required for intra-articular fragments, as callus 
formation is not desired within the articulating surface. Relative stability is achieved when 
"micromotion" can occur between the fragments. As mentioned above, it involves a combination of 
intramembranous and endochondral ossification with the subsequent formation of a callus [34, 43, 
44]. For some type of fractures (e.g. multi-fragmentary fractures) only relative stability can be 
attained. Techniques that provide relative stability include external splinting, such as conservative 
techniques or external fixation, and some type of internal splinting like intramedullary nailing or 
bridging plate (see examples in Figure 4-6).  
Absolute stability Relative stability 
    
 
Figure 4-6 Example of fixation techniques and the type of stability that they provide to the fracture site. On the left side, 
a lag screw and a plate for axial compression are shown, which provide absolute stability by compressing the bone 
fragments against each other. On the right side, a plate bridging several fragments and a cast, which provide relative 
stability. Images from AO Surgery Reference (http://www.aosurgery.org). 
Fracture fixation complications 
Upon fracture treatment, certain complications can occur. The most challenging ones include 
delayed bone-healing or non-union, and implant-related infection. 
As this thesis is focused on implant related infection, a more detailed description will be provided 
of fracture related infection. The main etiologic agents are staphylococci, especially Staphylococcus 
aureus and S. epidermidis and other coagulase-negative staphylococci (CoNS), which together 
account for 50-75% of the isolates [45]. The following section describes the bacteria that have been 
the focus of this thesis, S. epidermidis and has been recently accepted for publication. 
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4.2 Pathogenic Mechanisms and Host Interactions in Staphylococcus 
epidermidis Device-Related Infection 
4.2.1 Introduction 
Staphylococcus epidermidis is a permanent member of the normal human microbiota, commonly 
found on the skin and mucous membranes. By adhering to tissue surface moieties of the host via 
specific adhesins, S. epidermidis is capable of establishing a lifelong commensal relationship with 
humans that begins early in life. Although commensal S. epidermidis isolates display high rates of 
resistance to antibiotics of clinical relevance [46], their default status as commensal bacteria renders 
this phenomenon largely irrelevant for the healthy human host. However, with the advent of 
implanted medical devices such as prosthetic joints and fracture fixation devices, S. epidermidis has 
emerged as an important opportunistic pathogen [47a, 48]. In fact, the implanted medical device 
may actually facilitate infection since any S. epidermidis inadvertently introduced into the surgical 
site are capable of rapidly adhering to, and accumulating on, the surface of the device. This surface-
associated bacterial growth is known as biofilm formation and appears to be the key factor enabling 
invasive, device-related infection (DRI) for an otherwise largely non-pathogenic microorganism. 
The ubiquitous presence of S. epidermidis on human skin has enabled S. epidermidis infection to 
emerge as a significant complication when using medical devices [49-51]. With the increasing use 
of such devices, coupled with high antibiotic resistance rates, S. epidermidis DRI will likely remain 
a clinical problem for generations to come.  
The following paragraphs describe the host interactions with S. epidermidis under both normal 
healthy commensal conditions, and under conditions of an invasive DRI. This includes describing 
how this microorganism has adapted to life on human skin, including biofilm formation, and how 
the same adaptations have enabled invasive DRI. Particular attention will be paid to the impact of 
S. epidermidis in orthopaedic device-related infection (ODRI) since these infections are amongst 
the most burdensome and expensive to treat [52]. Finally, since the impact of ODRI on bone tissue 
is a critical feature of these infections, interactions between S. epidermidis and bone will be also be 
described. 
4.2.2 S. epidermidis as a member of commensal human microbiota 
Under healthy conditions, the skin commensal microbiota is believed to be beneficial to humans 
through aiding in nutrition, outcompeting pathogens and educating the immune system [53]. 
Humans are believed to first encounter S. epidermidis in utero, as evidenced by their presence in the 
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amniotic fluid [54]. The first faeces (meconium) has also been shown to harbour a predominance of 
S. epidermidis [55] and the skin of the new-born will be colonized by S. epidermidis within a few 
days [56]. Thereafter, S. epidermidis becomes part of the "normal" resident human skin microbiota, 
being predominant in moist sites such as nares or fossae, but also present in sebaceous areas such as 
the facial skin [57] and mucosal tissues such as the gastrointestinal and the lower reproductive tracts 
[58, 59].  
In order to persist on human skin, S. epidermidis has evolved diverse mechanisms to sense and 
overcome the physical and chemical features of host antimicrobial defence. Such mechanisms 
include surface adhesins enabling attachment to the host [60], systems to sense host antimicrobial 
peptides (AMPs) and communication molecules (e.g. hormones) [61, 62], mechanisms against 
AMPs [63] (e.g. S. epidermidis derived protease SepA is induced by and directed against the human 
AMP dermicidin [64]), and survival strategies against desiccation and osmotic stress [65, 66].  
S. epidermidis has also been shown to influence host colonization by other species, as shown for 
S. aureus [67, 68]. Negative correlations between these two species have been reported in humans, 
insinuating an antagonism between at least some strains [69, 70]. This effect is at least partially due 
to the secretion of factors that impact on the viability or colonization capacity of other 
microorganisms [71, 72]. Phenol soluble modulins (PSMs) are a family of multifunctional 
amphipathic, alpha-helical peptides that are produced by S. epidermidis isolates [73]. They are 
believed to act on host cells, are important for biofilm maturation [74] and could play a role in the 
competition between microorganisms on human skin. In particular, PSM-γ and PSM-δ produced by 
S. epidermidis have been shown to selectively reduce survival of Streptococcus pyogenes on mouse 
skin, but did not affect S. epidermidis itself [75, 76]. Both PSM-γ and PSM-δ cause membrane 
leakage in target bacteria (S. aureus and S. pyogens) [76], which indicate that they function like 
host-derived AMPs, with whom they share structural similarities. Host-derived AMPs and 
S. epidermidis PSMs have even been shown to act synergistically against bacterial pathogens [75]. 
In contrast, the closely related δ-toxin of S. aureus only seems to possess a very limited 
antimicrobial activity [77, 78] suggesting that the cooperative effect with host AMPs is not a 
widespread phenomenon. In addition, many strains of S. epidermidis also produce bacteriocins, 
which are antimicrobial peptides that act against other species or strains (often closely related to the 
producing bacteria). Gram-positive bacteria usually produce two types of bacteriocins: lanthionine-
containing antibacterial peptides (lantibiotics) and class-II bacteriocins [79, 80]. For S. epidermidis, 
examples include the lantibiotics epidermin [81], Pep5, epilancin K7 [82] and epilancin 15X [83], 
with further examples recently described [72, 84, 85]. Another mechanism employed by 
S. epidermidis to compete with other skin microorganisms involves the degradation of biofilms 
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from other bacterial species. The serine protease Esp is able to mediate S. aureus biofilm 
degradation by targeting several proteins involved in biofilm assembly [68, 86]. It has been 
observed that the presence of Esp-secreting S. epidermidis in the nose correlates with the absence of 
S. aureus in healthy human volunteers [68]. This activity has been supported experimentally with 
the finding that the intranasal application of an Esp-secreting strain was able to decrease S. aureus 
colonization in mice and humans [67, 68]. Finally, metabolic products may also serve to counteract 
other microorganisms. S. epidermidis has been shown to ferment glycerol into short chain fatty 
acids, which have displayed inhibitory activity against Propionibacterium acnes (implicated in acne 
vulgaris) in vitro and in mice [87].  
4.2.3 S. epidermidis as a pathogen 
In contrast to its standard role as a commensal microorganism, S. epidermidis and other CoNS have 
been found to cause invasive infections in selected groups of patients. These higher risk groups 
include preterm neonates, immunocompromised individuals and patients with indwelling medical 
devices [52, 88, 89]. Unlike S. aureus, which typically produces numerous extracellular enzymes 
and toxins that enable invasive infections in otherwise healthy hosts, S. epidermidis seems to retain 
a limited number of virulence factors [90] and normally is unable to cause invasive infection in 
healthy hosts [91].  
S. epidermidis as a pathogen of the musculoskeletal system 
S. epidermidis is second only to S. aureus as the most prevalent species encountered in ODRIs [92, 
93]. S. epidermidis causes approximately 20-30% of ODRIs [45, 49, 93] and the prevalence may 
even increase to 50% in late-developing infections [94]. These late-developing infections may be 
linked to the sub-acute nature of S. epidermidis infections, which may present many months after 
surgery with subtle signs of infection. This differs from the acute and often obvious nature of 
S. aureus infections and may be partially explained by the lack of virulence factors retained by 
S. epidermidis in comparison with S. aureus [95-97]. An illustrative case of a chronic 
S. epidermidis infection is shown in Figure 4-7, detailing the fact that these infections may become 
apparent many months after the presumptive initial colonization event and they result in prolonged 
healing times and a poor functional outcome for the patient. 
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Figure 4-7 Radiographic documentation of a surgically fixed fracture of the lower leg that failed to heal due to 
S. epidermidis infection. A) Plain x-rays (anterior-posterior and lateral view) show the non-union of the fracture (*) due 
to S. epidermidis infection with secondary displacement and screw failure (**) 10 months after surgery. B) The 
infection and non-union required plate removal and resection of necrotic bone leaving a 4cm defect in the bone (*). The 
defect was treated with segmental bone transport using an external fixator. C) Complete consolidation of transport 
segment (*) and docking site (**) required multiple surgeries and an overall treatment period of three years. 
Anonymized radiographs from a patient with S. epidermidis FRI obtained from Trauma Center BGU Murnau 
(Germany). 
The diagnosis of ODRI is based on the combination of clinical presentation, biopsy culture, 
histological analysis and clinical diagnostic criteria, such as high C-reactive protein [98]. Diagnosis 
may be particularly challenging for sub-acute infections due to the lack of obvious clinical signs of 
infection. Therefore, microbiological culture results are often the most critical diagnostic criteria. 
Since the microbes grow in biofilms on the foreign material and in necrotic bone tissue, cultivation 
and identification of the disease-causing pathogens may require the culture of several intraoperative 
tissue samples and removal of the implant for appropriate sampling [99, 100]. To increase the yield 
of positive cultures, it is advised to terminate antibiotic therapy before sampling, acquire at least 
three tissue biopsies, and to perform sonication of removed hardware to remove biofilm-associated 
bacteria from the surface [93, 98, 101-104]. In suspected S. epidermidis infections, where the 
pathogen is also a skin commensal that could contaminate the biopsy if aseptic techniques are not 
followed, the same indistinguishable microorganism must be cultured from at least two separate 
biopsies in order to differentiate a relevant infection from skin contamination. In contrast, in 
virulent species such as S. aureus or Escherichia coli, a single positive biopsy may be sufficient to 
determine the presence of an infection [105, 106].  
The treatment of S. epidermidis ODRI will depend on patient-specific factors, but will possibly 
require implant removal and a minimum of 6 weeks antibiotic therapy [45, 92, 93]. Despite such 
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prolonged and comprehensive therapy, infection recurs in approximately one third of the cases and 
up to one fifth of cases cannot achieve a cure with restoration of limb function [107-110]. 
Morgenstern et al. investigated the clinical course and outcome of staphylococcal ODRIs in elderly 
patients and could show S. epidermidis was associated with prolonged infections and was 
associated with lower cure rates (75%) than S. aureus (84%), although S. aureus related infections 
were associated with a five-fold higher mortality rate [109]. This data therefore supports clinical 
beliefs that S. epidermidis is an agent of sub-acute infection with significantly worse treatment 
outcomes, although those infections may be less life-threatening than S. aureus infections.  
S. epidermidis virulence factors 
Adhesion to host proteins 
As a commensal microorganism, S. epidermidis retains the ability to specifically adhere to host 
proteins in the skin. In a surgical wound, the bacterium utilises these adhesion mechanisms in order 
to adhere to the deeper tissues and to the implanted device, or more specifically, the conditioning 
layer of host proteins deposited on the device. Initial adhesion of bacteria to implant surfaces is 
mediated by non-specific interactions such as hydrophobic interactions [111], and then as shown 
schematically in Figure 4-8, by specific adhesins such as autolysin (AtlE) [112], extracellular DNA 
(eDNA) [113, 114], and staphylococcal surface protein 1 and 2 (SSP-1, SSP-2) [115]. AtlE, SSP-1 
and SSP-2 have been primarily associated with adhesion to native surfaces [112, 115], whilst eDNA 
is generated in S. epidermidis through an AtlE-mediated lysis of a subpopulation of the bacteria, 
promoting biofilm formation within the remaining population [113]. In the context of medical 
devices, the surface of the device becomes coated with host-derived plasma proteins, ECM proteins 
and coagulation products (platelets and thrombin) immediately following implantation [116]. Cell-
wall-anchored (CWA) proteins/adhesins, such as the microbial surface components recognizing 
adhesive matrix molecules (MSCRAMMs) [117] bind bacteria like S. epidermidis directly to these 
molecules Figure 4-9. In S. epidermidis, adhesins for fibrinogen (as serine-aspartate repeat protein 
G (SdrG/Fbe) [118, 119]), fibronectin (extracellular matrix-binding protein (Embp) [120]), collagen 
(SdrF/GehD [121, 122]), vitronectin (AtlE or autolysin/adhesin (Aae) [123]) and elastin (elastin-
binding protein (EbpS)) have all been identified. Peptidoglycan-bound wall teichoic acids (WTA) 
are an essential part of the S. epidermidis cell wall and also play an important role in bacterial 
adhesion. WTA enhances the initial adhesion of S. epidermidis to medical devices by binding to 
adsorbed fibronectin [124] and fibrin clots [125]. 
Introduction 
 
30 
 
Biofilm formation 
The ability to adhere to a surface represents the first step in biofilm formation, commonly believed 
to be the most important virulence factor possessed by S. epidermidis (Figure 4-8), particularly for 
DRI. Biofilm development facilitates resistance against host defence mechanisms [126-129], and 
confers antibiotic resistance [130, 131]. Biofilm formation also complicates medical and surgical 
treatment protocols because implant removal is often required to remove the biofilm. 
 
Figure 4-8 Biofilm formation scheme with scanning electron micrographs of S. epidermidis single cells (lower left) or in biofilm 
community surrounded by EPS (lower right) on a titanium surface. Image adapted with permission from Rochford et al. 2011 [132]. 
Biofilms are defined as complex communities of adherent bacteria encased in a matrix of self-
produced extracellular polymeric substances (EPS) [133] (Figure 4-8). The accumulation and 
maturation of the S. epidermidis biofilm occurs via a number of mechanisms. Polysaccharide 
intercellular adhesin (PIA, or poly-N-acetyl-glucosamine (PNAG)), synthesized by icaADBC 
encoded proteins [134, 135] is responsible for biofilm formation in the majority of S. epidermidis 
isolates [136] and was believed to be the most common molecule associated with biofilm formation 
[134, 135]. This was endorsed by the observation that the ica operon was absent in most commensal 
S. epidermidis strains [137, 138]. However, not all S. epidermidis have the icaADBC genes [134, 
139] and these isolates mediate biofilm formation by proteinaceous factors, such as the 
accumulation associated protein (Aap) [140] that contributes to biofilm formation upon cleavage by 
extracellular or host proteases. The aap gene has been observed in both pathogenic and commensal 
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isolates, more frequently than the ica operon [139, 141, 142]. Other PIA-independent mechanisms 
include biofilm associated homologue protein (Bhp) [143, 144], Embp [145, 146], and 
S. epidermidis surface protein (Ses)C [147] and SesE [139]. Interestingly, Rohde et al.[148] 
suggested that PIA-dependent biofilms are more robust than those formed by proteinaceous factors, 
and another study found they result in a different morphotype or biofilm substructure [139]. WTA 
have also been linked with S. epidermidis biofilm formation. TagO encodes the first enzymatic step 
in WTA biosynthesis and a tagO mutant has been shown to have a biofilm negative phenotype. 
This is partly attributed to an increase in cell surface hydrophobicity, impairing its initial adhesion 
to the surface, and a decreased production of PIA by activating the icaADBC repressor, icaR [149]. 
Both CWA proteins and biofilm formation mechanisms are regulated by several global regulators, 
such as the accessory gene regulator (agr), staphylococcal accessory homologous sar genes, sigma 
factor B (ζB), and luxS [150-153].  
As already mentioned, biofilms play a role in immune evasion, primarily by providing a barrier to 
immune cells. PIA may contribute to innate immune system evasion by promoting generation of 
complement C5a fragment [154, 155], inhibiting phagocytes and neutrophil killing [156, 157], and 
reducing the activity of AMPs [156, 158]. Recently, other studies have reported slightly opposite 
findings, with PIA-producing bacteria inducing greater inflammatory responses and enhanced 
phagocytosis [159, 160], although Spiliopoulou et al. did observe reduced killing in PIA-producing 
strains as discussed elsewhere recently [161]. S. epidermidis also produces a second exopolymer, 
the poly-γ-glutamic acid (PGA), although at comparatively lower levels. Synthesized by the gene 
products of the cap locus, PGA is important in mediating S. epidermidis resistance to neutrophil 
phagocytosis and AMPs, and promoting growth at high salt concentrations (PGA is induced under 
such conditions) [162]. 
It has yet to be elucidated if WTA has a direct role in S. epidermidis immune system evasion. 
However, like S. aureus, S. epidermidis contains the genes for D-alanylation of WTA, a 
modification known to protect the bacteria from the activity of AMPs [163].  
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Figure 4-9 Scheme of the main S. epidermidis pathogenic mechanisms, which include adhesion molecules and biofilm 
formation. The most well described adhesins involved in adhesion to native surfaces or protein-coated surfaces are 
shown in the upper part (molecules also involved in biofilm formation shown in purple). The main described biofilm 
components are shown at the bottom of the figure (PIA, cleaved Aap, eDNA, WTA and Empb). The figure also 
presents some of the most important regulators of biofilm and adhesion molecules (black arrows: activation/positive 
signalling, red lines: inhibition/negative signalling). 
Antibiotic resistance 
Although the majority of S. epidermidis strains remain susceptible to the newer antibiotics such as 
daptomycin, tigecycline, linezolid and dalbavancin [164, 165], high endemic antimicrobial 
resistance within this species represents a significant challenge in the treatment of S. epidermidis 
infections, especially DRI [166]. Methicillin resistance in S. epidermidis (MRSE) is an important 
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characteristic of infecting isolates as it is often associated with additional antibiotic resistance 
mechanisms. Resistance to other antibiotics, such as erythromycin (encoded by erm genes), 
ciprofloxacin, clindamycin, aminoglycosides (encoded in aacA/aphD gene) or trimethoprim-
sulfamethoxazole, are also often observed, especially in MRSE [167]. Methicillin resistance is 
encoded by mecA, an alternative penicillin binding protein with decreased affinity to β-lactam based 
antibiotics such as penicillin, methicillin and oxacillin [168]. It is carried on the mobile genetic 
element, staphylococcal cassette chromosome mec (SCCmec), of which several types have been 
identified for S. epidermidis [169]. MRSE have been found to be common in infection-causing 
isolates (70-87% of all S. epidermidis isolates) [110, 167, 170, 171], and even higher (90%) in 
specific patient cohorts [109]. MRSE prevalence in healthy individuals is low (3-18% of 
S. epidermidis commensal isolates) [167, 170, 172], although prevalence is increased for 
individuals exposed to the healthcare system, as observed in hospitalized patients or in healthcare 
workers [46, 173b, 174]. The specific causes of the increased prevalence of resistant isolates in the 
hospital environment is unknown, although is likely associated with high antibiotic exposure and 
direct or indirect interpersonal transmission.  
It remains unclear whether infection with resistant organisms results in a worse clinical outcome in 
comparison with susceptible counterparts. In a recent study of patients with S. epidermidis ODRIs, 
methicillin resistance status did not influence the clinical course and outcome of treatment [110], 
although further studies are required to confirm this finding. In any case, clear therapeutic 
guidelines are available for the treatment of both MRSE and MSSE, with a high likelihood of 
treatment success in both cases when guidelines are followed closely.  
Phenol soluble modulins 
Until relatively recently it was thought that S. epidermidis did not produce toxins. However, the 
identification and characterisation of the PSMs have now changed that concept [175]. The PSMs 
are a family of genome-encoded peptides, and like the CWA proteins/adhesins, are under the strict 
regulation of the agr quorum sensing system (Figure 4-9) [175-177]. In S. epidermidis, the PSM 
family consists of PSMα, PSMβ1, PSMβ2, PSMδ, PSMε, and PSMγ/δ-toxin [175-177]. PSMβ 
peptides are the primary PSMs produced by S. epidermidis, are expressed at high levels during 
biofilm formation, and have been shown to have a role in the structuring and dispersal of the 
biofilm [74, 177]. They are specifically associated with the formation of channels observed between 
the biofilm layers, which are considered important for nutrient uptake [74]. S. epidermidis-derived 
PSMδ is strongly cytolytic against neutrophils, similar to S. aureus. However S. epidermidis culture 
filtrates were observed to have a very low cytolytic potential in vitro [178]. As growing conditions 
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are likely to have an influence on PSM production, the role of S. epidermidis PSMδ in vivo needs to 
be further addressed.  
Finally, certain S. epidermidis strains have been shown to produce PSM-mec, a PSM encoded in the 
mobile genetic element SCCmec, in contrast to the other PSMs that are chromosomal encoded 
[179]. PSM-mec has cytolytic potential against neutrophils in vitro and its presence has been 
associated with decreased bacterial clearance and higher mortality rates in a murine model of sepsis 
[180]. 
Other pathogenic mechanisms 
Small colony variants (SCVs), a colony phenotype characterized by small size, slow growth and 
downregulation of virulence genes, are recognized as a pathogenic mechanism for several bacterial 
species, including S. epidermidis, and are often associated with chronic infections [181, 182]. SCVs 
seem to be less susceptible to antibiotics and to the immune system, potentially by being able to 
survive intracellularly and inducing a more anti-inflammatory environment due to increased 
secretion of IL-10 [183].  
Finally, internalization and intracellular persistence in non-professional phagocytes (e.g. 
osteoblasts) is a described evasion mechanism for S. aureus [184, 185]. A number of internalization 
mechanisms have been described for S. epidermidis, involving AtlE [186] and SdrG [187]. This 
represents a potentially new pathogenic mechanism for S. epidermidis and a location where bacteria 
could survive to cause persistent/relapsing infections; however its relevance in vivo has not yet been 
proven. 
4.2.4 Host interaction with S. epidermidis 
The interaction between S. epidermidis as a commensal and the host immune system is thought to 
play a role in the development of immunological tolerance. That is, to induce immune responses in 
the host that control aberrant inflammatory responses to non-pathogenic molecules such as those 
found in food but also in commensal bacteria. This question was assessed in recent murine studies 
with the topical application of S. epidermidis [188, 189] (S. epidermidis is typically not a major 
representative of the normal mouse skin microbiota [190]). Scharschmidt et al. reported that the 
application of S. epidermidis to the skin within the first weeks of life established antigen-specific 
tolerance to the bacteria, by generating CD4+ regulatory Treg cells, which homed into neonatal skin 
[188]. Mice that were not colonized during the neonatal period presented with higher inflammation 
and neutrophil recruitment compared to colonized mice, when challenged with the same strain of 
S. epidermidis in a skin-abrasion model. The use of the sphingosine-1-phosphate receptor 
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antagonist FTY720 during neonatal period, which blocked the egression of Tregs into skin, 
suppressed the tolerogenic effect indicating that there may a critical period when Treg mediated 
tolerance can be acquired [188]. On the other hand, Naik et al. showed that S. epidermidis 
application induced cutaneous interferon (IFN)-α and IL-17A producing T cells [189]. In this case, 
IL-17A
+
CD8
+
 T cells were shown to home to the mouse epidermis specifically after S. epidermidis 
application, but not with other tested species. This was mediated through the action of a skin-
resident dendritic cell subset and was not associated with the induction of inflammation [189]. More 
importantly, when an epicutaneous infection model with Candida albicans was used, the 
application of the fungus in mice pre-treated with topical S. epidermidis resulted in decreased 
C. albicans CFU counts compared to not pre-treated ones. The effect was lost when either anti-CD8 
or anti-IL-17A antibodies were co-administered, which highlights the relevance of the adaptive 
immune responses generated. Altogether, the study suggested that resident bacteria in the skin 
(S. epidermidis) can modulate the immune system, generating adaptive immune responses that in 
turn may help in promoting protective innate immune responses and controlling inflammation. The 
effect seemed to be tissue-specific, since S. epidermidis failed to induce IL-17A-producing cells 
when administered in the lung or gut. In two other studies, S. epidermidis lipoteichoic acid (LTA) 
has been shown to decrease skin inflammation [191], for example by inducing regulatory 
microRNAs in a Pseudomonas aeruginosa skin infection model [192]. However, the true nature of 
these observations needs to be clarified, as LTA purity even from commercial preparations has been 
questioned [161].  
Overall, these experimental data reveal the capacity of "commensal" S. epidermidis to specifically 
shape cutaneous immunity (innate and adaptive responses) and consequently decrease infection 
burden in the host. The capacity of S. epidermidis to induce similar effects in humans remains to be 
proven. Nevertheless, this idea can be somewhat supported by in vitro findings, whereby human 
monocytes, monocyte-derived dendritic cells (moDC) and T lymphocytes stimulated with 
S. epidermidis displayed an anti-inflammatory profile, with high production of IL-10 [193]. Further 
in vivo and human microbiome studies may provide a deeper understanding of the complex nature 
of this microorganism-host interaction. 
Innate immune response during infection 
Recognition 
Innate immune responses are triggered by the detection of microbial structures through pattern-
recognition receptors (PRRs) on immune cells and tissue cells. The most studied PRRs are toll-like 
receptors (TLRs), which recognize a broad range of bacterial derived macromolecules [194]. 
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S. epidermidis triggers immune responses partly via TLR-2 (which often forms heterodimers with 
TLR-1 and TLR-6 [195]), similar to S. aureus [196, 197], which can recognize different bacterial 
cell wall molecules including lipoproteins, LTA and peptidoglycan (PDG) (Figure 4-10) [195, 198], 
although some of its ligands are still controversial [199]. Secreted components can also be 
recognized and activate the immune system, as it was shown for S. epidermidis PSM, which is 
recognized by TLR-2/TLR-6 heterodimers [200].  
Recognition of S. epidermidis via TLR-2 has been shown for keratinocytes [201, 202], endothelial 
cells [203], or human fibroblasts [204], and has also been demonstrated in TLR-2 transfected 
human embryonic kidney (HEK)293 cell line [205]. Furthermore, in preclinical models of 
S. epidermidis bacteraemia or subcutaneous/soft tissue foreign-body infection, an up-regulation of 
TLR-2 and the adaptor molecule MyD88 has been observed upon infection [206-208]. The use of 
TLR-2 KO in bacteraemia models with neonatal and adult mice resulted in delayed clearance, 
especially at early time-points after infection [205, 209, 210]. These data suggest that TLR-2 is 
involved in the early responses to S. epidermidis infections although is not essential for clearance of 
the infection [210]. 
Responses towards S. epidermidis can also occur independently of TLR-2, as it was shown in the 
models using TLR-2 KO mice [209]. Other PRRs that may potentially be involved in S. epidermidis 
sensing are NOD-like receptors, as they recognize S. epidermidis-derived PDG [211]. CD14, 
expressed mostly in monocytes and macrophages, is a TLR-2 co-receptor that may contribute to 
S. epidermidis recognition in some cell subsets [204]. PSMs produced by S. epidermidis can be 
sensed by formyl peptide receptor 2 (FPR2/ALX) [212, 213], expressed in neutrophils and involved 
in their recruitment to the infection site [214]. To date, the contribution of these receptors in vivo 
has not been addressed. 
Induction of antimicrobial peptides (AMPs) 
Human AMPs are a heterogeneous group of amphipathic peptides, which may be subdivided 
depending on their structure and function. AMPs functions include rapid, direct killing of microbes 
and activation/modulation of immune responses, such as cell recruitment or chemokine production. 
One of the most effective early responses of the host to pathogenic insults is mediated through 
human β-defensins (hBD). In vitro experiments with keratinocytes or skin explants have shown that 
S. epidermidis or its culture supernatants can elicit high levels of hBD-2 and hBD-3 but not hBD-1 
[202, 215-218], and RNase7 and cathelicidin LL-37 in epithelial cells [219]. This AMP induction 
may be beneficial under healthy conditions to counteract more pathogenic species [217, 218] but 
can be also expected to contribute to host defence in S. epidermidis superficial or ocular infections. 
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Of relevance, some of them (hBD-2, hBD-3, LL-37 and human alpha defensin (HNP)-1) have been 
proven, to different extents, to be effective against S. epidermidis in vitro [220-223], although no 
data is available from in vivo studies. Nevertheless, the studies mentioned above showed some 
discrepancies in terms of AMP killing capacity, which could be explained by differences in strains 
used, as some of them may possess mechanisms against AMPs. More relevant in the context of 
S. epidermidis DRI, other cell types including neutrophils and monocytes can produce AMPs. 
These AMPs will often be located in the phagolysosomes, where they can contribute to bacteria 
killing. Of interest, hBD-3, LL-37 and hepcidin 20, a liver-derived AMP, have been shown to 
reduce S. epidermidis attachment and/or biofilm formation in vitro [224-226]. The mechanisms of 
action is currently unknown, although for hBD-3 a decrease in icaA and icaD expression and 
increase of icaR were associated with the observations [226].  
 
Figure 4-10 Summary of S. epidermidis recognition and subsequent effector mechanisms. Recognition of 
S. epidermidis or its secreted proteins can occur via TLR-2 (in red), which forms heterodimers with TLR-1 and TLR-6 
and can also associate with other non-TLR molecules (unspecified partner coloured in blue). Other receptors 
recognizing S. epidermidis include CD14 and FPR2/ALX. Upon recognition, downstream signalling and effector 
mechanisms are triggered, including secretion of AMPs, phagocytosis by neutrophils and macrophages and secretion of 
cytokines and chemokines from numerous cell types, which will orchestrate additional innate and adaptive immune 
responses. 
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Phagocytosis/killing by neutrophils and macrophages 
Phagocytosis by neutrophils is one of the most important mechanisms for elimination of 
contaminating or infecting bacteria. Neutrophils migrate to the site of infection, following host 
signals (e.g. chemokines, AMPs) or sensing bacterial components as mentioned above. At the 
infection site, neutrophils will internalize opsonized bacteria forming a phagosome and, finally, 
bacteria will be destroyed in the phagolysosome by the action of reactive oxygen species (ROS), 
proteases and AMPs. An additional mechanism to kill bacteria has been described for neutrophils: 
the generation of neutrophil extracellular traps (NETs) or NETosis. Nuclear and mitochondrial 
DNA is released to the extracellular space to form NETs, which contain high local concentrations 
of intracellular antimicrobial proteins. Although literature is still limited, S. epidermidis biofilms 
have been shown to induce DNA release and NETosis in vitro [227, 228]. Macrophages are also 
able to phagocytose and destroy S. epidermidis [229] with similar mechanisms, and further present 
antigens to T cells. Phagocytosis of S. epidermidis by macrophages is enhanced following 
stimulation with IFN-γ in vitro [183] and in vivo [230].  
Phagocytes will also act against biofilms. It has been shown that neutrophils can bind to opsonized 
but also non-opsonized biofilms, partly by recognizing EPS [228]. Nevertheless, it is generally 
accepted that the biofilm mode of growth will protect bacteria from phagocytosis, despite some 
discrepancies in the literature that have been discussed elsewhere [161]. Furthermore, biofilm mode 
of growth, most often studied in PIA-producing strains, has been shown to decrease killing 
efficiency in macrophages and neutrophils [127, 131, 157, 160].  
Interesting observations were made when comparing the phagocytosis of S. epidermidis and 
S. aureus biofilms, with the latter being more likely infiltrated and engulfed [231]. However, 
although S. aureus was more likely phagocytosed, this does not always correlate with the capacity 
of neutrophils to kill the bacteria. In fact S. aureus has several mechanisms to avoid lysis by 
neutrophils and to persist intracellularly [232]. S. epidermidis does not appear to possess similar 
mechanisms. However, some strains are killed less efficiently, potentially by having a low capacity 
to prime the oxidative response of neutrophils [233], or as described before by their biofilm mode 
of growth. These observations, together with lower induction of neutrophil apoptosis, may lead to 
intracellular survival and could partially explain the low inflammatory nature and chronicity often 
associated with S. epidermidis infections.  
Cytokine and chemokine secretion 
Cytokines are a broad group of secreted proteins that play a role in intercellular communication, 
with a broad range of functions within the immune system as cell recruitment, differentiation and 
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activation. Interleukins and other factors play an essential role in leukocyte communication and 
differentiation, while chemokines are mainly involved in cell recruitment. In vitro stimulation of 
peripheral blood mononuclear cells with different staphylococcal species showed a rapid release of 
pro-inflammatory cytokines such as IL-1β, IL-6, IL-12p70 or IFN-α [234]. Of note, S. epidermidis 
induced lower levels of pro-inflammatory cytokines compared to S. aureus [234]. Studies with 
monocytes/macrophages have also observed IL-6, TNF-α and IL-1β release after S. epidermidis 
stimulation [235, 236]. Laborel-Préneron et al. reported that stimulation of moDC with commensal 
S. epidermidis induced a more anti-inflammatory profile in contrast to stimulation with commensal 
strains of S. aureus, with high levels of IL-10 being a key differentiator. Nevertheless, pro-
inflammatory cytokines such as IL-6 and TNF-α were also detected [193]. Similar observations 
have been made from in vivo studies: IL-6, TNF-α and IL-1β are typically observed in serum in the 
first hours post-challenge with live or inactivated S. epidermidis [159, 180, 209, 237, 238], or in 
tissue exudates/homogenates from experimental DRI models [207, 239]. The regulatory cytokine 
IL-10 is also present in vivo [159] and it has been shown that S. epidermidis inoculation result in 
higher IL-10 levels compared to P. aeruginosa in an intradermal infection model [240]. In a 
S. epidermidis DRI mouse model it was shown that IL-10 was involved in reducing infection-
associated morbidity, with higher levels of pro-inflammatory cytokines and greater weight loss in 
IL-10 KO animals. Interestingly, bacterial counts were the same in both wild-type and KO strains, 
suggesting that IL-10 does not impact bacterial clearance [241]. Overall, despite differences due to 
different S. epidermidis strains and its effect in different tissues, it can be hypothesized that lower 
induction of pro-inflammatory cytokines together with high IL-10 production, can contribute to the 
sub-acute nature of S. epidermidis infections. 
Multiple chemokines are also released upon S. epidermidis infection. Secretion of IL-8, important 
for neutrophil recruitment, has been described in vitro and in the first hours post-infection in in vivo 
studies [207, 237-239]. CXCL-1 and CXCL-2, mostly produced by macrophages (via TLR-2 
recognition but also by other mechanisms), have also been observed in bacteraemia and peritonitis 
models [159, 180, 205, 209]. Additionally, a murine peritonitis model revealed increasing levels of 
numerous chemokines upon challenge with S. epidermidis supernatants [242].  
Platelet activation/aggregation 
The aggregation and activation of platelets in the presence of bacteria was first described over 25 
years ago [243] and yet the nature of this interaction has only recently been elucidated. Platelets and 
bacteria can interact in three ways: the indirect binding of bacteria to a plasma protein (which is a 
ligand of a platelet receptor), the direct recognition of bacteria by platelet receptors and the binding 
of secreted bacterial products to platelets [244]. Only the first type has been described for 
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S. epidermidis, where the SdrG has been described to bind platelets in a fibrinogen and Ig-
dependent manner; an interaction that leads to platelet aggregation [118]. S. aureus or 
Streptococcus have been shown to interact with platelets in other ways, which can lead to sepsis or 
thrombosis but also can play a role in internalization of bacteria by platelets or release of 
antimicrobial components and immunomodulatory factors [244]. Future studies will be required to 
elucidate if S. epidermidis-platelets interaction is limited to SdrG or if, like other bacteria, possess 
multiple mechanisms.  
Adaptive immune response during infection 
Adaptive immunity refers to antigen-specific and long-lasting immune responses that are mediated 
by lymphocytes. Adaptive immunity can be broadly divided in cellular responses, represented by T 
helper (Th) and cytotoxic T lymphocytes, and humoral responses, represented by B lymphocytes 
and antibodies. Classically, extracellular bacterial infections have been shown to trigger mostly Th1 
cell responses, but more recently Th17 responses have also been linked to the clearance of bacterial 
infections. Of relevance, an in vivo model using immunocompromised mice have shown a higher 
susceptibility for S. epidermidis DRI in mice lacking T cells or T and B cells [245], highlighting a 
role for adaptive immune responses in infection clearance.  
Arising from its status as a commensal microorganism, S. epidermidis is expected to elicit adaptive 
immune responses in humans from early in life. This has been proposed to be largely triggered by a 
pattern of transient self-resolving infections due to micro-invasions, rather than resulting from local 
response due to colonization [246], but the latter cannot be excluded. These life-long interactions 
will lead to the generation of an antibody repertoire and a set of memory T and B cells that may 
confer partial protection from infection. Generation of adaptive immune responses require the 
presentation of antigens to T cells by antigen presenting cells (APCs), primarily dendritic cells 
(DC), which will also contribute to T cell polarization. It has previously been shown that CD103 
skin-resident DC, after interaction with commensal S. epidermidis, generates CD8+IL-17A+ T cells 
with the capacity to enhance protective responses in the skin [189]. Upon infection, it can also be 
expected that certain DC subtypes, already present in the tissue or that will migrate there, will shape 
adaptive immune responses. Data available for S. epidermidis interaction with DCs is very limited 
but it has been observed, in vitro and in vivo, that S. epidermidis can lead to DC activation with an 
increase in co-stimulatory molecules such as CD86 or CD80 and antigen presenting molecules such 
as MHC-II [193, 247-249]. Studies describing cytokine secretion by DCs stimulated with 
S. epidermidis (whole bacteria or its secreted proteins) have yielded somewhat inconsistent results. 
For example, IL-10 was not highly secreted when bone-marrow DCs were stimulated with 
Introduction 
 
41 
 
S. epidermidis [247], but the stimulation of moDCs with S. epidermidis secreted proteins led to high 
IL-10 secretion [193]. The inconsistency between these reports may be due to the different sources 
of DC and stimuli used, which can lead to different outcomes by activating distinct pathways. The 
relevance of the stimuli is further highlighted in a series of experiments from Durantez et al. [250]. 
S. epidermidis PSM-derived peptides combined with ovalbumin were able to trigger cytotoxic T 
cell responses, however, this was only observed after those peptides were presented via APCs 
together with stimuli specific for TLR-3, TLR-7 and TLR-9 [250]. Further experiments are required 
to clarify the exact role of APCs and different DC subsets in priming and polarizing the T cell 
response. 
With regards to humoral responses, antibodies against S. epidermidis proteins have been detected in 
serum and saliva of healthy individuals [251, 252], but levels are generally lower compared to 
S. epidermidis infected patients [252]. Antibodies against biofilm components and cytoplasmic 
proteins have been found to be predominant [251].  
To assess the potential use of antibody titters in diagnosis of infection, serum antibody titters 
against staphylococcal proteins have been measured in patients with S. aureus or S. epidermidis 
infections (such as wound infections, bacteraemia or DRI). Recently, a multiplex antibody 
detection-based immunoassay was evaluated for the diagnosis of prosthetic joint infections (PJI). 
The assay included protein antigens from several strains: diverse staphylococci, Streptococcus 
agalactiae and P. Acnes [253]. The test showed a slightly lower sensitivity than C-reactive protein 
and erythrocyte sedimentation rate, however was able to diagnose around 50% of patients, which 
were culture positive but presented low systemic inflammation values [253].  
Another goal of humoral response studies is to identify immunogenic proteins, which can lead to 
development of therapeutic and/or prophylactic treatments. Studies employing 2D protein 
electrophoresis or phage display technology with the aim of identifying S. epidermidis 
immunogenic proteins have been performed in rabbits [254] and humans [255]. Sera of rabbits 
immunized with live S. epidermidis were used to detect relevant immunogens from within a cell 
wall fraction. Mice were then immunized with several selected proteins, five of whom (Na+/H+ 
antiporter, Acetyl-CoA C-acetyltransferase, lipoate ligase, cysteine synthase and alanine 
dehydrogenase) lead to a significant reduction of bacterial loads in a murine infection model [254]. 
Other proposed immunogenic proteins include AtlE, Staphylococcal conserved antigen B (ScaB), 
and GehD lipase, which elicited higher antibody titters in infected patients compared to non-
infected subjects. Active immunization of mice with these antigens resulted in production of 
specific antibodies with in vitro opsonisation capacity against S. epidermidis [255]. An anti-SdrG 
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antibody was shown to reduce mortality in a neonate bacteraemia rat model and to decrease 
bacterial counts in a DRI (endocarditis) rabbit model [256], although it failed in a clinical trial to 
prevent late-onset sepsis in low-birth weight neonates [257]. More recently it was shown that 
immunization with staphylococcal Major amidase (Atl-AM), a cell wall hydrolase present in some 
S. epidermidis and S. aureus strains, increases antibody levels against that protein in mice [258]. In 
the same study, immunized animals challenged with a lethal intraperitoneal dose of S. epidermidis 
showed a better survival and lower bacterial counts in tissues compared to mock immunized 
animals [258]. Additionally, immunized mice also presented higher levels of Th1 and Th2 cells, 
although it did not elucidate which responses were the most relevant for the increased survival. 
Immunizations with Aap or with antibodies against surface proteins have also been shown to reduce 
colonization in a murine DRI model by ultimately inhibiting biofilm formation [259, 260]. Despite 
the fact that their efficacy against S. epidermidis infections has not been tested in vivo, antibodies 
against poly-β-1,6-N-acetylglucosamine (PNAG/PIA) and phosphonate ABC transporter substrate 
binding protein (PhnD) have shown efficacy against S. epidermidis biofilm formation in vitro [261, 
262]. A recent study focused on staphylococcal adhesion proteins, which contain long stretches of 
Sdr, and are key virulence factors for S. epidermidis and also S. aureus. The study led to the 
discovery of two novel bacterial glycosyltransferases, SdgA and SdgB, which can modify all Sdr-
proteins to protect them from cleavage by cathepsin G (a neutrophil protein). Neutralization of these 
enzymes may be the next opportunity for an effective anti-staphylococcal approach [263]. To date, 
all anti-staphylococcal antibodies tested against S. epidermidis and other CoNS (Altastaph, INH A-
2 and Pagibaximab) have been found to be ineffective in reducing bacteraemia in neonates [264]. 
Although there is still much work to be done to fully understand effective immune responses 
against S. epidermidis, on-going research offers several candidates and strategies to develop new 
therapeutic products. 
Additionally, there are also T cell-mediated immune responses to S. epidermidis although they are 
poorly characterized. Based on in vitro studies, it has been suggested that S. epidermidis 
opsonisation with IgG promotes Th17 responses [265], although the role of this phenomenon in 
vivo has not been shown. On the other hand, in an in vivo model of foreign-body infection, a 
beneficial effect of IFN-γ injections has been shown, suggesting a protective role of Th1 dominated 
responses in bacterial infections [230]. Based on cytokines induced by S. epidermidis in the 
different studies (e.g. IL-6, IFN-γ or IL-12), a Th1/Th17 polarization may be expected in such 
infections. This goes in line with the findings of Ferreirinha et al., who observed that injection of 
PNAG-producing S. epidermidis in mice lead to IFN-γ and IL-17A producing T cells [159]. Also, 
as mentioned above, immunization of mice with Atl-AM led to an increase in Th1 and Th2 cells 
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(Th17 cells were not evaluated on that study). Immunization also led to a higher survival; however, 
direct effect of T cell responses in that finding was not further addressed [258]. 
Bone system interactions 
The usual chronic nature of S. epidermidis osteomyelitis will eventually lead to an inflammatory 
environment within the bone system, which is of special relevance in the context of ODRIs. Bone 
as an organ is particularly sensitive to chronic inflammation, due to its continuous remodelling 
process that is influenced by different components of the immune system and inflammatory 
pathways [266]. Due to their potent capacity to stimulate the formation and activity of bone 
resorbing osteoclasts, pro-inflammatory cytokines such as TNF-α, IL-1β and IL-6 [267-269] are 
powerful drivers of osteolysis. Conversely, the function of the bone matrix-producing cells, 
osteoblasts, is also negatively affected by pro-inflammatory cytokines, such as TNF-α [270-272] or 
IL-1β [273] (Figure 4-11). Therefore, persistently elevated levels of pro-inflammatory cytokines in 
the local bone microenvironment frequently result in marked osteolysis, driven by enhanced 
osteoclast activity at the site of infection (Figure 4-11) [274], which is likely compounded by a 
diminished capacity of osteoblasts to produce new bone matrix.  
 
Figure 4-11 S. epidermidis direct and indirect effects on bone cells (osteoblasts and osteoclasts), leading to bone 
destruction. ALP: Alkaline Phosphatase. 
Despite the importance of S. epidermidis as a causative agent in ODRI, relatively little information 
exists about the interactions of S. epidermidis with resident bone cells, in particular the molecular 
mechanisms underlying the bone loss observed in S. epidermidis-induced osteomyelitis. The 
production of cytokines by innate and/or adaptive immune cells in response to S. epidermidis is 
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undoubtedly an important contributor to the enhanced bone resorption observed at the site of 
infection, however it is becoming apparent that the osteoblast itself may also directly contribute to 
the production of pro-inflammatory cytokines and therefore further perturb the balance of bone 
formation and resorption in favour of bone destruction. A recent study has shown the induction in 
vitro of IL-6 by primary human osteoblasts stimulated with S. epidermidis [223]. S. epidermidis 
infection also induced chemokines, such as IL-8/CXCL8 and CCL2/MCP-1, suggesting that 
osteoblasts may be capable of further recruiting immune cells following an encounter with 
S. epidermidis. Interestingly, the authors also demonstrated that osteoblasts were activated not only 
by the planktonic form of S. epidermidis but also by components of S. epidermidis biofilms. This 
suggests that, rather than the relatively simplistic view of the osteoblast for producing bone matrix 
and regulating osteoclast activity, osteoblasts may also serve an important role as sensors and 
initiators of immune responses directed against bacteria resident in the local bone 
microenvironment.  
Additionally, in vitro studies have observed a decrease in osteoblast viability when co-cultured with 
S. epidermidis [275, 276]. S. epidermidis products (resulting from washing bacteria) have been 
suggested to induce bone destruction as they increased calcium release from murine bones in vitro 
[277]. This is in stark contrast to S. aureus, which has been extensively studied in this context and 
is capable of influencing the behaviour of both osteoblasts and osteoclasts. For example, S. aureus 
has been demonstrated to induce TRAIL-dependent apoptosis in osteoblasts [278-281] and can 
stimulate expression of osteolytic factors [282] or reduce the expression of its inhibitors [281], 
exacerbating the osteolytic effect. Furthermore, specific bacterial proteins have been identified as 
responsible for some of these effects on osteoblasts such as S. aureus protein A, which has been 
demonstrated to bind directly to TNF receptor 1, resulting in an inhibitory effect on proliferation, 
the induction of apoptosis, and the stimulation of RANKL expression [283, 284].  
Regarding the effects of bacterial infection on osteoclasts, a number of studies have reported the 
effects of inactivated S. aureus, or specific S. aureus components, for affecting osteoclast formation 
and/or activity [285-288]. Conversely, staphylococcal LTA inhibits osteoclastogenesis through 
stimulation of TLR-2 activity [285]. Such conflicting data strongly argues for the use of (preferably 
live) intact bacteria in such osteoclastogenesis assays rather than purified bacterial components. 
When the effect of intact bacteria on osteoclastogenesis was recently investigated, S. aureus was 
demonstrated to have both direct and indirect stimulatory effects on osteoclasts in vitro [289]. By 
inducing activation of macrophages and thereby stimulating the production of pro-inflammatory 
cytokines, S. aureus indirectly enhanced the formation of osteoclasts from precursor cells. 
Additionally, S. aureus could also directly infect mature osteoclasts, resulting in increased cell 
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fusion and enhanced bone resorbing capacity. Much less is known regarding direct interaction of 
S. epidermidis and osteoclasts, although it is expected that induction of pro-inflammatory cytokines 
will enhance bone destruction in similar ways. 
Given the multitude of different effects of S. aureus on osteoblast and osteoclast function, it is 
likely that S. epidermidis can also negatively affect the capacity of osteoblasts to produce bone 
matrix and/or enhance osteoclast formation and function, although much further work is necessary 
to clarify if this is indeed the case. 
Lastly, the interaction of S. epidermidis with bone cells could provide a location where bacteria can 
persist and prolong ODRIs. Both S. aureus and S. epidermidis are capable of invading osteoblasts in 
vitro [290, 291], however the mechanism underlying this phenomenon appears to differ between 
these two species. S. aureus requires binding to the ECM protein fibronectin, mediated by α5β1 
integrin [292], whereas S. epidermidis internalization by osteoblasts is not affected by interfering 
with fibronectin binding or blocking, suggesting a different mechanism [291]. This is supported by 
the findings of a recent study that reported SdrG mediates the binding of S. epidermidis to 
osteoblasts in vitro, an effect likely mediated through SdrG binding to αVβ3 integrin [187]. 
However, this immune evasion mechanism may be of more importance for S. aureus rather than 
S. epidermidis per se, since the capacity of S. epidermidis for invading osteoblasts in vitro does not 
appear to differ between commensal strains and clinical isolates of S. epidermidis obtained from 
infected orthopaedic devices [293]. This is reinforced by a recent in vitro study demonstrating that 
S. epidermidis as well as other opportunistic pathogens such as S. lugdunensis and Enterococcus 
faecalis were incompetent at being internalized by MG63 human osteoblastic cells, being 
internalized at a level approximately three orders of magnitude lower than that observed with 
S. aureus [294]. Osteoclasts are also able to internalize, at least, S. aureus. Given the inherent 
phagocytic capacity of osteoclasts, it may be that internalization of S. aureus by osteoclasts relies 
on such a phagocytic mechanism of uptake. This raises the possibility that S. epidermidis may also 
be the object of uptake by osteoclasts. Together with the previously stated ability of S. epidermidis 
to bind to αVβ3 integrin, which is highly expressed by osteoclasts [295], this further suggests that 
S. epidermidis may bind to and be internalized by osteoclasts, although this and the subsequent 
phenotypical changes resulting from such an interaction requires to be validated experimentally. 
Taken together, this suggests that while the persistence of orthopaedic implant-associated S. aureus 
infections in vivo may well stem from its enhanced ability to invade osteoblasts, and potentially 
osteoclasts, other mechanisms, such as biofilm formation, may underlie the persistence of 
S. epidermidis in implant-related infection. 
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Finally, the integration of immune responses within the bone system in the context of 
S. epidermidis infection has been largely unexplored. The number of models described for 
S. epidermidis bone infection is limited (Table 4-3) and none have really focused on host immune 
responses. Most of the data available is based on S. aureus models, where a combination of 
Th1/Th17 responses has been observed [296, 297], although it is not clear if this response is 
beneficial or detrimental to the host as no bacterial clearance was achieved [298, 299]. The 
observation that anti-IL-12p40 conferred protection in S. aureus infected C57BL/6 mice supported 
the hypothesis that skewed Th1/Th17 responses may be harmful [299], as IL-12/IL-23p40 plays a 
role in polarization of these cell types. This observation, however, could be due to a decrease in 
myeloid-derived suppressor cells (MDSC) that otherwise would impair immune responses in the 
vicinity of an implant, as described by Heim et al. [300]. The use of different murine strains, 
inoculum dose and models are factors contributing to the disparity in the available data. 
Furthermore, the differences between S. aureus and S. epidermidis are quite significant, and so 
further work focused on S. epidermidis is required to provide a proper understanding of adaptive 
immune responses to S. epidermidis bone infection. 
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Table 4-3 Bone-related infection models with S. epidermidis as infective agent 
Species Gender, 
Age/weight 
Strain CFU dose Inoculation 
Method 
Study Purpose Findings Comments Ref. 
Mouse ND ND 108 CU Bacteria inoculated 
at the end of the 
wire (joint area) 
Protocol available 
only 
NA Prosthetic joint 
infection model 
[301] 
Wistar 
rat 
Males, 
250-300 g 
IDRL-8883 
clinical isolate 
(MRSE strain) 
107 CFU and 
colonized wire 
Bacteria injected 
(0.1ml) into the 
tibia and a pre-
colonized wire was 
implanted 
Established a model 
of foreign body-
associated 
osteomyelitis to 
test Tedizolid 
treatment and to 
compare with 
standard treatment 
Tedizolid alone 
presented better 
results than 
vancomycin 
monotherapy. 
Addition of rifampin 
to both treatments 
increased effectivity 
of therapy 
No fracture. 
Addition of 
sclerosing agent 
[302] 
Wistar 
rat 
Males, 
12-week old 
Clinical isolate 
(MRSE strain) 
103, 105 and 
108 CFU 
Bacteria injected 
(0.03 ml) into 
femoral defect 
Establish a model 
to study 
S. epidermidis non-
unions 
Low-grade 
S. epidermidis 
contamination can 
prevent bone healing, 
even in the absence of 
infectious signs 
Bone osteotomy 
performed 
Self-clearance in 
some animals 
from low dose 
group (33%) 
[303] 
Wistar 
rat 
Males, 
12-week old 
Clinical isolate 
(MRSE strain) 
105 CFU Bacteria injected 
(0.03 ml) into 
femoral defect 
Test systemic 
and local 
administration of 
vancomycin or MSC 
on infection 
 Bone osteotomy 
performed 
[304] 
Wistar 
rat 
ND, 
350 - 450 g 
S. epidermidis 
ATCC 35984 
104 CFU Bacteria injected 
into surgical site 
before wound 
closure (calvarial 
defect 
reconstituted with 
different materials) 
Compare silicon 
nitride implants 
with titanium and 
PEEK implants in 
terms of bone 
formation and 
prevention of 
infection 
Silicon nitride 
implants showed 
higher 
osseointegration and 
lower presence of live 
bacteria 
Only histological 
findings with a 
very small group 
size 
[305] 
Sprague
-Dawley 
rat 
Male, adult 
425 ± 37 g 
Clinical isolates 
of S. epidermidis 
and S. aureus 
1.5x107 
(S. epidermidis) 
1.5x104 
(S. aureus) 
Bacteria injected 
(0.05 ml) through a 
PTFE catheter into 
tibia medullary 
canal 
Catheter left on 
place 
To test 68Ga-DOTA-
Siglec-9 PET/CT 
imaging in S. aureus 
and S. epidermidis 
infection 
68Ga-DOTA-Siglec-9 
PET/CT was able to 
detect tissue 
inflammation but not 
able to distinguish 
S. aureus from 
S. epidermidis 
infections 
No fracture 
5% sodium 
morrhuate added 
before 
inoculation in 
S. epidermidis 
group but not in 
S. aureus or 
control group 
[306] 
New 
Zealand 
White 
rabbit 
ND, 
2.5 - 3.5 kg 
S. epidermidis 
ATCC 35984 
103, 104 and 
105 CFU (pilot 
study) 
104 CFU (main 
study) 
Bacteria injected 
(in 1 ml) into knee 
joint, near inserted 
implants (stainless-
steel screw and 
UHMWPE washer) 
To study the effect 
of Allicin 
(antibacterial 
principle of garlic) 
in biofilm 
formation in a 
prosthetic joint 
infection model 
Allicin alone and in 
combination with 
Vancomycin were 
effective in reducing 
biofilm formation 
Prosthetic joint 
infection model 
[307] 
New 
Zealand 
White 
rabbit 
Female, 
adult 
2.46 ± 0.23 
kg 
Clinical isolate 
(MRSE strain) 
107 CFU Bacteria injected 
(in 0.1 ml of saline) 
into tibia medullary 
cavity 
Afterwards, a bone 
cement cylinder 
was inserted 
To test effectivity of 
chitosan loaded 
PMMA bone 
cements in vivo 
Quaternized chitosan-
loaded PMMA was 
able to reduce scoring 
and CFU counts when 
compared to sole, 
gentamicin or 
chitosan loaded 
PMMAs 
No fracture [308] 
New 
Zealand 
White 
rabbit 
Male, 
skeletally 
mature 
3.2 ± 0.37 kg 
Clinical isolates 
and 
S. epidermidis 
ATCC 35983 
108 CFU 
(S. epidermidis) 
104 CFU 
(S. aureus) 
 
Bacteria injected 
(in 0.1 ml) into tibia 
medullary space 
next to a cement 
block 
To test 18F-FDG 
PET/CT imaging in 
S. aureus and 
S. epidermidis 
infection 
S. epidermidis 
infection presented 
low 18F-FDG uptake 
due to limited 
leukocyte infiltration 
No fracture 
5% sodium 
morrhuate added 
in medullary 
canal in 
S. epidermidis 
groups only 
[309] 
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New 
Zealand 
White 
rabbit 
Male, 
2.5 - 3.5 kg 
S. epidermidis 
Xen 43, 
bioluminescent 
strain derived 
from a clinical 
isolate 
104 CFU Bacteria injected 
(in 0.1 ml of saline) 
into tibia medullary 
cavity where an 
intramedullary 
electrode was 
placed 
To compare the 
electricidal effect 
with an antibiotic 
treatment 
Electrical current was 
as effective as 
intravenous 
doxycycline treatment 
in a foreign-body 
infection model 
No fracture [310] 
New 
Zealand 
White 
rabbit 
Male, 
4.0 ± 0.5 kg 
S. epidermidis RP-
62A 
Clinical isolate? 
- Commercially-pure 
titanium implants 
were exposed to a 
106 CFU/ml 
solution for 1h at 
37°C. Implant 
placed into the 
lateral femoral 
condyle 
To study the 
effectivity of cross-
linked albumin 
coating in infection 
prevention 
The albumin coated 
implants presented a 
lower infection rate 
No fracture 
Not clear results: 
animals where 
bacteria were 
detected with 
gram stain 
counted as not 
infected 
[311] 
New 
Zealand 
White 
rabbit 
Female, 
adult, 
3.5 – 4 kg 
Clinical isolate of 
S. epidermidis 
5x107 CFU Bacteria were 
injected into 
femoral medullary 
canal and drill hole 
was closed with a 
stainless steel 
screw 
To test vancomycin 
and minocycline 
alone or in 
combination with 
rifampin in an 
orthopaedic device 
related infection 
model 
Vancomycin plus 
rifampin was the most 
effective treatment, 
followed by 
minocycline plus 
rifampin. No 
clearance or very low 
was used with 
antibiotics alone 
No fracture [312] 
New 
Zealand 
White 
rabbit 
Male, ND S. epidermidis 
G109-83 and 
Bacteroides 
thetaiotaomicron 
N54-83 and 
clinical isolate 
N1660-75B  
107 CFU of 
each strain 
Barium-
impregnated 
silicone rubber 
catheter was 
introduced into 
medullary canal 
and bacteria were 
injected into it 
(0.1ml for each) 
together or 
separately. Second 
group was injected 
directly into 
medullary canal 
without a foreign 
body 
Observe influence 
of foreign-body in a 
model of 
osteomyelitis with 
S. epidermis and 
B. thetaiotaomicron, 
alone or in 
combination 
Both strains, alone or 
in combination were 
able to cause 
osteomyelitis, 
however in the 
presence of a foreign-
body the severity of 
osteomyelitis was 
higher 
No fracture 
5% sodium 
morrhuate added 
[313] 
New 
Zealand 
White 
rabbit 
Male, ND S. epidermidis 
G109-83 and 
clinical isolate 
Bacteroides 
fragilis N17-85  
107 CFU of 
each strain 
(alone or 
combined) 
Barium-
impregnated 
silicone rubber 
catheter was 
introduced into 
medullary canal 
and bacteria were 
injected into it 
(0.1ml for each) 
together or 
separately 
Establish a foreign-
body-associated 
osteomyelitis 
model with 
B. fragilis, 
S. epidermidis or 
combination of 
both 
Both strains, alone or 
in combination were 
able to cause 
osteomyelitis, 
however 
S. epidermidis 
appeared less 
pathogenic than 
B. fragilis 
No fracture 
5% sodium 
morrhuate added 
[314] 
New 
Zealand 
White 
rabbit 
Male, ND S. epidermidis 
G109-83 and 
Bacteroides 
thetaiotaomicron 
N54-83 
107 CFU of 
each strain 
Barium-
impregnated 
silicone rubber 
catheter was 
introduced into 
medullary canal 
and bacteria were 
injected into it 
(0.1 ml for each) 
Study ciprofloxacin 
efficacy in 
polymicrobial 
osteomyelitis 
Ciprofloxacin showed 
little efficacy in a 
polymicrobial device-
related osteomyelitis 
No fracture 
5% sodium 
morrhuate added 
[315] 
Dog ND, 
10 - 15 kg 
S. epidermidis, 
S. aureus and 
E. coli 
102 to 108 CFU? Bacterial 
suspension was 
introduced into 
femoral canal, with 
or without implants 
Study influence of 
different implants 
on infection 
incidence 
(materials tested) 
All materials 
increased likelihood 
of S. aureus infection, 
and only PMMA 
polymerized in vivo 
increased 
S. epidermidis and 
E. coli infection risk 
No fracture [316] 
Goat ND Clinical isolate 
S. epidermidis 
3x105 CFU Bacterial 
suspension 
inoculated (0.1ml) 
into wounds 
around pins placed 
on tibia 
To study the 
effectivity of 
electrical current 
on stainless steel 
fixator in 
preventing 
infection 
Small current applied 
to external fixators 
decreased the 
infection percentage 
No fracture [317] 
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Ile-de-
France 
sheep 
ND, 
4 - 9 years 
Clinical isolate 
S. epidermidis 
1-3x108 CFU Bacteria injected 
(in 1 ml of PBS) into 
femur medullary 
canal. 
Afterwards, a 
stainless steel 
implant was 
inserted (uncoated, 
hydroxyapatite-
coated or PMMA 
cemented) 
To study the effect 
of hydroxyapatite 
and PMMA implant 
coatings on 
infection 
progression 
Higher infection rate 
in animals with an 
hydroxyapatite-
coated implant 
No fracture [318] 
Abbreviations: CFU = Colony forming units; PEEK= poly(ether ether ketone); PTFE = polytetrafluoroethylene; 68Ga-DOTA = 68Ga-labeled 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid; 
Siglec-9 = Sialic acid-binding immunoglobulin-like lectin 9; 18F-FDG = 2-deoxy-2-[fluorine-18]fluoro-D-glucose; PMMA = polymethylmetacrylate; NA= Not applicable; ND = Not described; UHMWPE 
= ultra-high molecular weight polyethylene 
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Abstract 
Fracture related infection (FRI) is a major complication in surgically fixed fractures. Instability of 
the fracture after fixation is considered a risk factor for infection; however, little experimental data 
is available confirming this belief. To study our hypothesis that stable fractures lead to higher 
infection clearance, mouse femoral osteotomies were fixed with either stable or unstable fixation 
and the surgical site was contaminated with either Staphylococcus epidermidis or S. aureus clinical 
isolates. Infection progression was assessed at different time-points by quantitative bacteriology, 
total cell counts in spleen and lymph node, and histological analysis. Non-inoculated mice were 
operated as controls. Two inbred mouse strains (C57BL/6N and BALB/c) were included in the 
study to determine the influence of different host background in the outcome. Stable fixation 
allowed a higher proportion of C57BL/6N mice to clear S. epidermidis inoculation in comparison 
with equivalents with unstable fixation. No difference associated with fixation type was observed 
for BALB/c mice. Inoculation with S. aureus resulted in a more severe infection for both stable and 
unstable fractures in both mouse strains; however, significant osteolysis around the screws rendered 
the stable group functionally unstable. Our results suggest that fracture stability can have an 
influence on S. epidermidis infection, although host factors also play a role. No differences were 
observed when using S. aureus, probably due to a more severe infection which lead to substantial 
bone destruction. Further studies are required in order to address the biological features underlying 
the differences observed. 
Introduction 
Fracture related infection (FRI) remains one of the most significant complications in the surgical 
treatment of fractured bones. FRI is often associated with prolonged antibiotic treatment, repeated 
surgical debridement, implant removal, high healthcare costs and poor functional outcome for 
affected patients [98, 319]. The prevalence of FRI ranges from 0.5-3% for closed fractures, but can 
increase up to 30% in open fractures [98, 320]. S. aureus and the coagulase-negative staphylococci 
(CoNS), in particular S. epidermidis, are the most prevalent species in FRI, accounting together for 
50-75% of all cases [93, 321]. 
The risk of developing an infection associated with any implanted device is increased by the 
presence of the device itself [322, 323]. This is because the device acts as a foreign-body that 
provides a surface for adhesion and biofilm formation to any microorganism entering the wound. 
Other risk factors for implant associated infections include patient characteristics such as advanced 
age, smoking or co-morbidities such as diabetes or obesity [319, 324, 325]. One additional factor 
that is specific to surgically fixed fractures is the biomechanical properties of the fixation. It is 
Results 
 
52 
 
widely known that healing of fractures is influenced by biomechanics [326-328]: when fracture 
fixation provides absolute stability, the fragments are compressed together with little strain under 
loading, leading to primary bone healing. In contrast, when the fixation is less rigid, displacement 
may occur under load and the fracture tends to heal due to secondary bone healing with callus 
formation [36, 329]. The stability of the fixation is also considered to be a critical factor in FRI 
[330, 331]. A few preclinical experimental studies [331-334] have provided supportive evidence for 
the association between stable fixation and reduced infection risk. However, there was poor 
standardization of the stability of the fractures within these models and no studies to date have 
investigated this phenomenon for S. epidermidis FRI. FRI caused by S. aureus has been intensively 
studied in both clinical and basic science literature, with numerous preclinical in vivo models 
available [296, 335-339]. However, the literature describing S. epidermidis FRI is comparatively 
scarce and fewer in vivo preclinical models are available [340]. 
The aim of our study was therefore to study FRI progression under different mechanical 
environments (stable and unstable fixation). We used an established model developed with two 
types of implants (rigid and flexible) that lead to different types of bone healing [329, 341, 342]. 
This model has shown that under rigid fixation, bone healing occur via a mixture of 
intramembranous and some endochondral ossification, while with flexible fixation, healing occurs 
mainly via endochondral ossification with the formation of a large stabilizing callus observed at day 
14 [329, 342]. Mechanical testing data also confirmed that in vertical plane, the flexible plate was 
only ¼ of the stiffness of the rigid plate, when bridging two fragments separated by a 0.45 mm gap 
[329]. These implants were therefore used in our study to determine the role of fracture stability in 
infection rate for both S. epidermidis and S. aureus. Two well-characterized inbred mouse strains, 
C57BL/6N and BALB/c. C57BL/6N mice were selected as they have been previously used in 
previous studies with MouseFix
TM
 implants. As the strain is T helper (Th)-1 skewed, we added a 
Th2-skewed strain (BALB/c) to determine if the observations are consistent across different host 
backgrounds.  
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Materials and methods 
Animals  
The study was approved by the ethical committee of the canton of Graubünden in Switzerland 
(TVB 11/2013) and was carried out in a research facility accredited by Association for Assessment 
and Accreditation for Laboratory Animal Care (AAALAC) International. Skeletally mature (20-28 
weeks old, average weight ± SD: 24.34±2.12 g), female, specific pathogen free (SPF) C57BL/6N 
and BALB/c mice (Charles River, Germany), were used in this study. All animals were allowed to 
acclimatize to experimental conditions for at least two weeks prior to the start of the study. Mice 
were randomly housed in individually ventilated cages (XJ, Allentown) under a 12 hour dark/light 
cycle in groups of three to six. Cages were changed weekly and mice were re-housed in the same 
groups post-surgery. Cages were randomly assigned to the different groups and all animals within 
the same cage were assigned to the same treatment group. Animals were fed with a standard diet 
(3436, Provimi Kliba) and had free access to sterile water at all times. Any animal excluded from 
the experiment due to fracture or implant failure was replaced unless stated otherwise. 
Study design  
The study was performed using groups of mice with rigid fixation to those with flexible fixation 
according to the scheme outlined in Figure 5-1. The first series of experiments compared 
C57BL/6N (Figure 5-1A) and BALB/c (Figure 5-1B) mice with rigid fixation to those with flexible 
fixation under aseptic (non-inoculated) conditions. This was repeated for mice inoculated with 
S. epidermidis (See Figure 5-1A, B for time-points and group size). The second series of 
experiments involved inoculation with S. aureus, which was performed at the standard dose in 
C57BL/6N mice, but that series was discontinued due to rapid onset of osteolysis leading to 
unstable fractures in both groups. Therefore, the experiment was repeated in C57BL/6N and 
BALB/c mice at lower inoculation (See Figure 5-1C-D for time-points and group size). Age-
matched C57BL/6N and BALB/c mice (N=6-8), without any surgical intervention, were euthanized 
as controls to obtain baseline levels of cell counts. 
Bacteria and inoculum preparation  
The two test microorganisms were S. epidermidis Epi 103.1 and S. aureus JAR06.01.31, both of 
which are clinical isolates. S. epidermidis Epi 103.1 was obtained from a patient with chronic 
implant-related bone infection (Trauma Center BGU Murnau, Germany), has a weak in vitro 
biofilm formation capacity according to the scoring system of Stepanovic [343] and is resistant to 
benzylpenicillin and fusidic acid. S. aureus JAR06.01.31, was originally cultured from an infected 
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hip prosthesis (University Hospital Basel, Switzerland) [344, 345], belongs to sequence type (ST) 
15, displays weak biofilm formation capacity, and is resistant only to benzylpenicillin. Both strains 
are deposited in the Culture Collection of Switzerland (CCOS): S. epidermidis Epi 103.1 (awaiting 
number) and S. aureus JAR06.01.31 (CCOS 890). 
For inocula preparation, a single colony was resuspended in 40 ml of tryptone soy broth (TSB) 
(Oxoid) and cultured overnight at 37°C, 100 rpm. On the day of the surgery, the bacteria were sub-
cultured into pre-warmed TSB and incubated at 37°C and 100 rpm for at least 2 hours to obtain a 
log-phase culture. When a pre-defined optical density corresponding to 4.6x10
7
 Colony Forming 
Units (CFU)/ml was reached, the culture was centrifuged at 8500 g for 5 minutes and resuspended 
in the same volume of phosphate buffered saline (PBS) (Sigma-Aldrich). Finally, the suspension 
was further diluted, as required, in PBS to prepare the inoculum, which was used within 1 hour of 
preparation. The target inoculum was set to 1 x 10
4 
CFU for the standard S. epidermidis and 
S. aureus dose, and 1x10
3 
for the low S. aureus dose.  
Implants and surgery 
Commercially pure Titanium (CpTi) 4-hole rigid and CpTi 4-hole flexible MouseFix
TM
 implants 
(Figure 5-2) and Titanium Aluminium Niobium alloy (Ti6Al4Nb (TAN)) screws were used in this 
study (RiSystem AG). The side bars of the flexible implant are composed of Nitinol. Prior to use, 
all implants were cleaned and sterilized as previously described [296]. 
Surgery was performed as previously described [296]. Briefly, under general anaesthesia with 
isoflurane (2-3% isoflurane in 100% O2, 1 l/min) (Isofluran Baxter®, Baxter AG), the animal was 
placed in prone position and a skin incision was made from tail base to left stifle. The subcutaneous 
Fascia lata was cut and the tissue plane between the quadriceps and the biceps femoris muscle was 
bluntly dissected. A Teflon foil was placed around the femur to protect the soft tissue from 
contamination. The implant was then fixed to the bone using four self-tapping, angular stable 
screws. Screw holes were predrilled with a 0.31 mm drill bit (RISystem AG). Once the implant was 
in place, a 0.44 mm defect osteotomy was performed using a jig and a Gigli wire. In the inoculated 
groups, 2.5 µl of bacteria suspension was injected in the osteotomy site. The foil was then removed 
and the Fascia lata and the skin were closed with continuous sutures (5-0 Vicryl rapide, Ethicon, 
Belgium). Following surgery, a lateral radiograph of the femur was taken to confirm proper 
positioning of the implant. Analgesia was provided in the form of subcutaneous injections of 
buprenorphine (0.1 mg/kg, Bupaq, Streuli Pharma AG), pre-operatively and post-operatively 
every 6-8 hours for 16 hours. Additionally, a palatable form of acetaminophen (2 mg/ml, as 
Dafalgan Syrup for Children, Bristol-Myers Squibb SA) was added to the drinking water for 5 
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days. Animals were monitored twice daily for 5 days post-operatively and subsequently once a day, 
using a detailed numerical scoring system that takes into account general behaviour, external 
appearance, wound status and animal movement (scale 0-18, outlined in Supplementary Table 5-1). 
Weights and radiographs of the operated limb were taken weekly. 
Gait analysis 
Gait analysis was performed in a subset of non-inoculated animals in order to compare weight 
bearing between animals receiving different implant types. Mice (N=5 per group) were run through 
the Catwalk XT system (Noldus Information Technology) [346] for the detection of paw footprints 
(camera gain was set to 20 and the detection threshold to 0.1). Three runs with a speed variance 
lower than 60% were recorded per animal pre-operatively and 6, 9, 12, 24, 48 and 72 hours after 
surgery. Footprint area (cm
2
) and light intensity (arbitrary units) of detected paw footprints were the 
selected outcome measures. 
Euthanasia and post-mortem sample processing 
At each scheduled time-point, the animals were euthanized by cervical dislocation after inducing 
general anaesthesia in an induction box (5% isoflurane in 100% O2, 1 l/min). A lateral radiograph 
of the left femur with implant in place was acquired post-mortem. The operated femur, the implant 
and the surrounding soft tissue were harvested separately in sterile containers with cold PBS. The 
soft tissue and the bone were mechanically homogenized (Omni Tissue Homogenizer and Hard 
Tissue Homogenizing tips, Omni International). The number of bacteria associated with the implant 
was determined by sonicating the implant and screws in PBS for 3 minutes (BandelinSonorex at 40 
KHz) and vortex mixing for 10 seconds. Viable bacterial counts were performed by plating serial 
dilutions of each sample on 5% horse blood agar (BA) (Oxoid). All BA plates were incubated at 
37°C for bacterial counts at 24 and 48 hours. Mice were considered as infected when at least one 
sample (bone, soft tissue or implant) was culture positive. Bacteria recovered from each animal 
were confirmed to be S. epidermidis Epi 103.1 by Random Amplification of Polymorphic DNA 
(RAPD) test [347], or to be S. aureus with latex agglutination assay (Staphaurex, Thermo 
Scientific). Spleen and popliteal lymph node were harvested in cold PBS and processed to obtain 
total cell counts in each organ as a measure of lymphocyte infiltration as previously described 
[296]. Animals with osteosynthesis or implant failure were excluded from final analysis and 
replaced when considered necessary (see comments Figure 5-1) 
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Histology and Scanning electron microscopy 
Samples for histology were largely processed as described previously [296]. Immediately after 
euthanasia, the entire operated femur and surrounding musculature underwent fixation with 70% 
(v/v) methanol for polymethylmethacrylate (PMMA) or paraffin embedding. PMMA samples were 
dehydrated through an ascending series of ethanol, transferred to xylene, and finally infiltrated with 
and embedded in PMMA [329]. The polymerized blocks were cut using an annular blade saw 
(Leica SP1600 saw microtome, Leica AG). Two sections were glued with cyanoacrylate onto 
opaque Plexiglas slides, ground and polished down to approximately 100 µm using a microgrinding 
system (Exact®) and stained with Giemsa/Eosin (GE). GE sections were blindly analysed by a 
certified pathologist. For paraffin embedding, the implant was removed and samples were 
decalcified in a 12.5% EDTA 1.25% sodium hydroxide (NaOH) solution. Finally, samples were cut 
longitudinally and both halves were embedded together in paraffin (McCormick). Paraffin blocks 
were cut using a microtome HM 355S (Microm, ThermoFisher Scientific) and sections were 
collected on Superfrost Plus slides (ThermoFisher). Slides were stained with Brown and Brenn 
(BB) for bacteria staining. The removed implants and selected paraffin sections (after 
deparaffinization) were taken for scanning electron (SE) microscopy for observation of any 
bacteria. Afterwards, the samples were dehydrated in an ascending series of ethanol (50-100%, 2 x 
5 minutes). Implants and sections were then left to air dry overnight in a sterile flow hood. Samples 
were sputter coated with 10 nm gold palladium using a BAL-TEC MED 020. Representative SE 
micrographs of the surfaces were acquired using a Hitachi FESEM 4700 (3 kV, 40 μA). 
Statistical analysis 
Statistical analysis was performed with GraphPad Prism 7. Fisher Exact Test was used for 
proportions of infected animals and Mann-Whitney test for quantitative CFU data. Weight change 
and cell counts were compared over time between groups with 2-way ANOVA with Sidak or 
Dunnett post hoc tests. Differences were considered statistically significant with a p-value < 0.05. 
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Results 
Animal monitoring 
In total, 255 C57BL/6N mice and 135 BALB/c mice were operated throughout the entire study. 
There were 38 (9.78%) osteosynthesis/implant failures resulting in early euthanasia. Additionally, 
there were 10 exclusions (2.57%) due to post-operative complications not related to the fracture 
model (lameness, secondary infection, or exitus) and 10 animals (2.57%) excluded due to intra-
operative complications (such as implant misplacement, implant failure or anaesthetic fatality). 
These animals were excluded from analysis and replaced as deemed necessary (details in Figure 
5-1). No differences were observed between mouse strains or implant type in terms of susceptibility 
to failure. S. aureus inoculated animals presented a higher rate of exclusion (17.14%) compared to 
S. epidermidis inoculated animals (10.15%) although the difference was not statistically significant. 
In general, there was no consistent difference for either C57BL/6N or BALB/c mice with regard to 
weight change between groups (rigid versus flexible and non-inoculated versus S. epidermidis 
inoculated). In general, S. aureus inoculated C57BL/6N and BALB/c mice lost more weight than 
S. epidermidis inoculated and non-inoculated counterparts. For standard S. aureus dose (C57BL/6N 
mice), the differences between groups were statistically significant at day 7 for animals with a rigid 
implant, and at all time-points for animals with a flexible implant. For S. aureus low dose 
(C57BL/6N and BALB/c) differences were statistically significant at day 14 for C57BL/6N with 
flexible implant groups, and at all time-points for C57BL/6N rigid implant groups and BALB/c 
mice (both implants) (p<0.05, Supplementary Figure 5-13). The clinical score did not show 
significant differences between groups. 
Gait analysis 
Gait analysis revealed that there was an observable difference in the footprint area of the operated 
limb for mice fixed with rigid and flexible implants during the first 9-12 post-operative hours 
(Figure 5-3). This returned to baseline levels after this time. Of note, there was no significant 
difference between the rigid and flexible groups, although for mice with a flexible device the 
decrease was significant and returned to baseline level with a slight delay compared to rigidly fixed 
equivalents. There was a trend for increased values for the contralateral limb for the first 24 hours, 
remaining high up to 72 hours post-operatively, which most likely was to compensate for the effect 
on the operated limb. 
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Bacteriology 
Quantitative bacteriological analysis of the inocula prepared for the surgeries confirmed that they 
were within the target range. For S. epidermidis, the average inoculum was 1.35x10
4
 CFU (SD: 
5.69x10
3
) in C57BL/6N and 1.95x10
4
 CFU (SD: 5.02x10
3
) in BALB/c. For the S. aureus study the 
inoculum was 1.13x10
4
 CFU (SD: 4.28x10
3
) for the high dose study, and 1.98x10
3
 CFU (SD: 
3.83x10
2
) for the low dose study. No significant differences were observed between the inocula 
administered to the rigid and flexible implant groups.  
Post-mortem, mice were confirmed as infected or not-infected on the basis of quantitative 
bacteriological evaluation of bone, soft tissue and implant from the operated limb. The results of the 
bacteriological assessment for the C57BL/6N mice receiving the S. epidermidis inoculum are 
shown in Figure 5-4. On day 3, all S. epidermidis inoculated C57BL/6N mice were found to be 
culture positive for Epi 103.1. The total number of bacteria at day 3 had increased approximately 
ten-fold relative to the initial inoculated dose. From day 7 onwards the total CFU count reduced in 
all groups and in all compartments (bone, soft tissue and implant), and some mice in both rigid and 
flexible implant groups were culture negative in all compartments. Importantly, the proportion of 
animals that cleared the infection in the rigid implant group (14/28) was significantly greater than 
the number of mice that cleared the infection in the flexible implant group (6/28) when all data 
points were considered (p=0.049, Fisher Exact Test, 2-tailed). The quantitative bacteriology data 
revealed that mean CFU counts were often higher in mice with flexible implants, although this only 
reached statistical significance in soft tissue at day 7 (Figure 5-4c). 
Results for BALB/c mice inoculated with S. epidermidis are shown in Figure 5-5. All BALB/c mice 
were infected 7 and 14 days post-operatively, and CFU counts were ten to one hundred fold higher 
in bone and implant samples compared to equivalent measurements for C57BL/6N mice 
(significant differences between total CFU counts at day 7, Kruskal Wallis test with Dunn's post 
hoc: p=0.0093). Clearance of the infection in BALB/c mice was first observed at day 30, with no 
differences observed between the rigid and flexible groups. With all time-points included, the 
proportion of mice that cleared the bacterial infection in the rigid implant group (4/17) did not differ 
from the flexible group (3/18). Similarly, there were no differences for CFU counts between mice 
with flexible or rigid implants, except at day 14 when soft tissue had significantly higher levels of 
bacteria in the flexible implant group (Figure 5-5c).  
In the S. aureus study 100% of C57BL/6N mice from both groups were found infected at all time-
points at the standard dose (Figure 5-6). The number of bacteria cultured from the tissues and the 
implant on day 3 was 2-3 orders of magnitude higher than CFU counts from S. epidermidis-infected 
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mice. At days 7 and 14, the mean number of bacteria decreased in all compartments in both implant 
groups, however it maintained an average CFU burden of 10
6
 -10
7
 CFU per sample, with no 
clearance of bacteria being observed. In addition, the mean CFU counts between the rigid and 
flexible implant groups were very similar across the experiment. At all time-points, S. aureus total 
CFU counts were significantly higher compared to S. epidermidis total CFU counts in C57BL/6N 
mice (Kruskal-Wallis test with Dunn's post hoc: p<0.0001). As no clearance was observed in 
C57BL/6N strain, together with severe osteolysis and tissue damage observed, experiments were 
not performed in BALB/c background. 
As the initial S. aureus inoculum dose resulted in a 100% infection rate for the entire study period, 
we could not identify any impact of fixation type on infection. Thus, we repeated the experiment at 
a lower dose in both mice strains, where we anticipated the animals may have a better chance of 
clearing the infection and a role for fracture stability may emerge. However, even when the initial 
dose was reduced 10-fold, neither mouse strain cleared the infection by day 14 and CFU counts 
were similar to those measured for the S. aureus standard dose group (Figure 5-7). Total S. aureus 
CFU counts in those animals were significantly higher compared to S. epidermidis total CFU counts 
in both C57BL/6N and BALB/c mice at day 14 (Mann-Whitney test, p<0.0001 for both 
comparisons). 
Spleen and popliteal lymph node cell counts 
Total cell counts were performed in lymph node and spleen to evaluate inflammation in local and 
systemic secondary lymphoid organs respectively. The type of fixation did not have an impact on 
cell counts from spleens or popliteal lymph nodes of C57BL/6N mice either with or without 
S. epidermidis inoculation (Figure 5-8). Levels were only slightly increased at day 3 compared to 
day 0, probably due to inflammation caused by surgical procedure, but they returned to baseline 
levels afterwards. S. aureus infection resulted in a significant increase in spleen and lymph node 
cell counts at days 7 and 14 when compared to the non-inoculated or S. epidermidis inoculated 
equivalents for both rigid and flexible implant groups (Figure 5-8, a and b). Finally, cell counts in 
the bone samples did not show significant differences (data not shown).  
In BALB/c mice, S. epidermidis inoculated animals showed an increase in cell numbers at day 7 in 
spleen and lymph node compared to non-inoculated animals (Figure 5-8, c and d). This higher 
number of cells in inoculated animals may be linked to the higher percentage of infected animals 
and higher CFU counts in BALB/c mice compared to C57BL/6N. Levels returned to baseline 
values from day 14. For femur cell counts, there were again no significant differences between the 
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groups with regards to implant type or between non-inoculated and S. epidermidis inoculated 
animals.  
Histological evaluation 
Additional animals were used to obtain intact soft tissue and femurs with implant in place for 
histological samples (Figure 5-1). Representative overview images of the histological features of 
C57BL/6N mice with rigid and flexible implants at day 14 and 30 are shown in Figure 5-9 (for non-
inoculated mice) and Figure 5-10 (for inoculated mice).  
Non-inoculated mice with rigid implant fixation were observed to undergo a mixture of 
intramembranous and endochondral ossification at day 14 (Figure 5-9, a-b), with the osteotomy gap 
filled with new bone (Figure 5-9, b). At the same time-point, non-inoculated mice fixed with the 
flexible implant were undergoing endochondral ossification with a large stabilizing, mainly 
cartilaginous, callus (Figure 5-9, e-f, white asterisk: cartilaginous callus). The osteotomy gap in 
these mice was filled with mostly fibrin and cartilage (Figure 5-9, f) and a region of fibrous tissue 
was observed in the bone marrow, in the distal side of the osteotomy (Figure 5-9, f, black asterisk). 
Early granulation tissue was observed over the screw heads and implant of both groups, often more 
obvious in flexible group (Figure 5-9, c-d for rigid and g-h for flexible, black arrows: blood 
vessels), as well as muscle regeneration.  
At day 30, the osteotomy gap was completely closed in animals with a rigid implant (Figure 5-9, i-j, 
black arrow), while the gap was still visible in most of the animals with a flexible implant (Figure 
5-9, m-n, black arrow), suggesting a delay in bone healing in the flexible group. The large 
cartilaginous callus observed at day 14 was under remodelling by day 30, consisting predominantly 
of woven bone and secondary bone marrow (Figure 5-9, m-n, black asterisk). The granulation tissue 
overlying the plate at that time-point was only a thin layer of fibrous tissue (Figure 5-9, k-l and o-p, 
white asterisk).  
S. epidermidis inoculated animals are shown in Figure 5-10. Inoculation did not seem to impair the 
progression of bone healing at day 14 in either of the implant groups, when compared to non-
inoculated equivalents (Figure 5-10, a-b and e-f), with new bone formation in the osteotomy of 
animals with a rigid implant and a big cartilaginous callus in the flexible implant group. Higher soft 
tissue inflammation was observed in inoculated animals at that time-point, as reflected in a higher 
lymphocyte and granulocyte infiltration in surrounding soft tissue and the presence of fluid filled 
spaces (Figure 5-10, a,c-d and e,g-h, black arrows). Such signs were often localized to small foci, 
and not widespread throughout the tissues. In some cases, osteolysis around screws was observed 
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(Figure 5-10, a and b, white arrows) with more granulocytic infiltrate compared to aseptic 
osteolysis that occurred in some non-inoculated animals due to instability or stress shielding (Figure 
5-11).  
By day 30, the osteotomy was mostly closed in inoculated animals with a rigid implant, while in 
mice with a flexible implant the cartilaginous callus was in a remodelling phase. The soft tissue 
showed a similar appearance to the non-inoculated animals (Figure 5-10, k-l and o-p). Signs of 
infection were found as higher bone remodelling, indicated by larger regions with secondary bone 
marrow (Figure 5-10, i and m). Osteolysis was observed in some inoculated animals, with some 
granulocyte infiltrates. However, these were not general features and evidence of infection was 
weak or even absent in both implant groups, which supports the microbiology data that indicates 
many of the animals had cleared the infection by this time-point.  
In BALB/c mice, the histological observations were similar (data not shown) regarding bone 
healing, with often earlier closure in animals with a rigid implant and a cartilaginous callus, which 
remodels at day 30 in animals with a flexible implant. Interestingly, a more inconsistent healing was 
detected, with some animals showing no gap closure at all at day 14. To our knowledge, this is the 
first study using flexible MouseFix
TM
 plate in BALB/c background and thus, we cannot compare 
this observation with other authors work. Importantly, this phenomenon was not linked to the 
presence of bacteria. Signs of infection were also similar to that observed for C57BL/6N mice, only 
being evident in soft tissue over the plate at day 14 and becoming less pronounced at day 30. 
Bacteria were observed on the implants from C57BL/6N and BALB/c mice at day 14 and also in 
paraffin sections (Figure 5-12).  
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Discussion 
Despite the prevalence of S. epidermidis and other CoNS in orthopaedic implant related infections, 
the scientific literature in the field is dominated by S. aureus [340]. To the best of our knowledge, 
there has been only one model described for S. epidermidis FRI [303, 304], which was performed in 
rats. In the present study, we have established and characterized an S. epidermidis FRI model in 
mice, and further developed the model to study the influence of fracture stability on infection 
progression. To overcome the limitations of previous preclinical in vivo models assessing the 
influence of stability on infection [331-334], we have used a standardized femoral fixation system 
previously described for monitoring fracture healing under different biomechanical conditions [329, 
342]. Using gait analysis, we could show that both fixations allowed the mice to return to baseline 
mobility within a short period after surgery, and histological observations confirmed healing to 
proceed under mostly intramembranous ossification and endochondral ossification respectively, as 
expected for the implant fixation used. In terms of the clinical appearance of the infections in this 
study, and its relevance to clinical FRI in humans, S. epidermidis inoculated mice (both mice 
strains) did not show major differences over time in weight change or cell counts, suggesting a 
subclinical type of infection. This closely matches the typical clinical picture of S. epidermidis 
infection [94, 98]. Animals infected with S. aureus exhibited instead higher weight loss, higher 
CFU counts in tissues and higher cell numbers in spleen and lymph node, suggesting overall greater 
inflammation. In addition, it could visually be observed purulent tissue over the plate and osteolysis 
around the screws, below the implant and in the osteotomy site. This also correlates with clinical 
observations, whereby S. aureus infection is associated with acute onset of symptoms. 
The S. epidermidis infection was seen to resolve in many animals, which is similar to previous 
implant associated infection models for this organism [303, 309, 318]. Higher inocula may 
guarantee a persistent infection, however, as reported recently for S. aureus, infectious dose might 
alter immune responses and has to be considered carefully [348]. Considering our experimental 
hypothesis that fracture instability predisposes to infection, a low inoculum enabled us to 
differentiate between the development of infection (or not) rather than merely looking for changes 
in CFU counts, which would be less indicative of an effect. Of note, even when using a low 
inoculum, infection persisted in some animals up to 30 days. It was in general difficult to detect 
bacteria in our histology samples to better characterize persistence sites. We did observe some 
biofilm-like structures in our SEM images, and located bacteria in locations of difficult access such 
as bone vessels within the bone. In addition, S. epidermidis has been shown to be able to persist 
intracellularly in vitro [183] and in vivo [229, 230], although we did not assess intracellular 
presence. 
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In testing our hypothesis under controlled conditions, we wished to advance the field from the data 
provided by early studies [331-334]. Friederich and Klaue [332] showed that stable fractures were 
associated with a lower S. aureus infection rate in rabbits. However, in this study animals were 
allocated to the stable or unstable group after radiographic observations, with both plate and nail 
fixation methods present in both arms of the study as pre-allocation based on implant type was 
evidently unable to provide predictable mechanics. In 1986 Merritt et al. performed a study with 
open fractures in hamsters [333], however they compared a K-wire fixed fracture with a non-fixed 
fracture and so there was no foreign body in that study, which thereby misses an important fact in 
device associated infection, i.e. the device itself. Finally, in the most recent experimental study on 
this topic by Worlock et al.[334], the stable construct (plate) showed a lower S. aureus infection 
rate compared with the unstable construct (an intramedullary rod). This study therefore once again 
has a confounding factor of whether different fixation systems (plate vs. intramedullary rod) may 
also have influenced infection rates. Our study provides the first standardized model, allowing 
controlled conditions. We successfully used two similar implant types with reliable healing 
outcomes, confirming previous observations in C57BL/6 mice regarding bone healing [329, 342] 
and extending the model into the FRI field. The study provides evidence that S. epidermidis 
infection can, in fact, be influenced by implant stability. After inoculating with S. epidermidis, we 
found that infection clearance was enhanced in C57BL/6N mice fixed with rigid plates over time, 
and the bacterial burden displayed a trend towards lower numbers. This result does agree in general 
with all earlier studies that instability is a risk factor for infection or infection progression. Ongoing 
work is attempting to provide some understanding of this phenomenon by assessing immune 
markers in samples obtained in this study. Previous publications focusing on bone healing have 
described different gene and protein expression patterns between both implant types [349, 350] and 
we would like to extend this knowledge by studying samples from infected animals, where we 
predict that environment may also differ between both implant types. 
The observation that stability influences S. epidermidis infection did not hold true for the second 
mouse strain. Interestingly, BALB/c mice first achieved clearance of infection at day 30, a time-
point when the osteotomies in both rigid and flexible groups had already healed. As such, 
mechanical differences may be low or non-existent between groups at this time. In fact, the 
clearance of infection was equal between both groups at that time, which may in fact further support 
to the need for stability to eradicate infection. There was again no difference in infection rate 
between the groups when inoculated with S. aureus. It is important to note however that S. aureus 
displays a virulent behaviour in this model, leading to peri-implant osteolysis six days post-
operatively as shown previously in a different model [351]. This osteolysis was observed at both the 
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standard and low doses, making comparison between groups irrelevant as all animals were 
effectively "unstable". This data therefore does not discredit the requirement for implant stability, 
although the effect may be more pronounced under conditions of a low grade infection.  
Patient factors such as age or co-morbidities are known to influence infection risk and also need to 
be considered for treatment management [319, 352, 353]. In our study, when using two different 
inbred strains, we observed that C57BL/6N mice more rapidly cleared bacteria and presented lower 
CFU counts at most of the time-points compared to BALB/c animals. A higher bacterial burden was 
also associated with higher cell counts in draining lymph node. Other studies using S. epidermidis 
foreign-body infection models have shown similar results, with BALB/c mice showing higher CFU 
counts and/or bigger abscesses compared to C57BL/6 equivalents [354, 355]. Nevertheless, the 
number of studies is limited and the topic remains controversial when considering studies using 
S. aureus, which have obtained contradictory results [299, 356-359]. It is known that the immune 
system of C57BL/6 and BALB/c mice have differences [360], with C57BL/6 mice being more T 
helper (Th)1 polarized and BALB/c mice being more Th2 polarized. Overall, our results support the 
notion that host genetic background may influence study outcomes, and needs to be considered 
together with the infecting pathogen. Further analysis into immune system differences between 
these murine strains could provide valuable data regarding the effective immune responses required 
to clear S. epidermidis infections. Deeper analysis into inflammatory markers at gene and protein 
level is the subject of ongoing studies in our laboratory to characterize the cell environment in the 
different mechanical contexts. 
  
Results 
 
65 
 
Conclusion 
An S. epidermidis model of FRI was established, which recapitulates many of the clinical features 
of this infecting agent such as mild clinical signs and low levels of tissue inflammation. This was 
especially evident when compared to animals inoculated with S. aureus, in terms of weight loss, 
macroscopic observations or cell counts. This model was used to study the impact of fracture 
stability on i clearance, with stable fixation resulting in a lower infection rate for S. epidermidis but 
not for S. aureus. Detailed understanding of this process is the subject of ongoing studies.  
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Figures: 
 
Figure 5-1 Graphic scheme of animals per group in the different studies, with C57BL/6 represented as a brown mouse 
and BALB/c as a white mouse. Surgery (Sx) and time-points in days are indicated in each axis. SE: S. epidermidis, SA: 
S. aureus. Note: day 3 was not performed in BALB/c as no differences in clearance were observed neither at day 7 or 
14; and thus it was not deemed necessary to evaluate impact on clearance. For the same reason, it was not deemed 
necessary to replace animals in some groups at day 7 and 14 (marked with an asterisk). For S. aureus low dose, only 
one time-point was performed. Again, as no differences were observed in CFU counts and clearance, earlier time-points 
were not studied. 
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Figure 5-2 Post-mortem contact radiographs of rigid and flexible plates in non-inoculated (left) and S. epidermidis 
inoculated (right) mice at day 14 post-operatively. Note osteotomy starts to show closure in animals with rigid implant 
fixation while there is no such closure observed in animals with flexible fixation.  
 
Figure 5-3 Area (cm
2
) of left (a) and right (b) hind paws measured in Catwalk XT System, pre-operatively and at 6, 9, 
12, 24, 48 and 72 hours post-operatively, for rigid (black) and flexible (grey) implant groups. Mean values with SEM 
(n=5), * = p<0.05). Significant differences were observed between several time-points and baseline values for both 
implant groups (rigid group in black, flexible group in grey), while no significant differences were observed between 
animals from rigid or flexible group. 
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Figure 5-4 Percentage of S. epidermidis infected C57BL/6N mice at each time-point (a) and quantitative bacteriology 
from each compartment (b, bone; c, soft tissue; d, implant). Upper panel of each graph shows proportion of culture 
positive animals/ total animals per group. Mean values and SD (n=5-10). LOD = Limit of detection (1x10
2
 CFU for 
bone and soft tissue, 0.5x10
2 
CFU for the implant), samples below LOD were represented as 1. It can be observed that 
animals with a rigid device cleared infection (culture negative for all samples) in a higher percentage when compared to 
flexible group, at all time-points. 
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Figure 5-5 Percentage of S. epidermidis infected BALB/c mice at each time-point (a) and quantitative bacteriology 
from each compartment (b, bone; c, soft tissue; d, implant). Upper panel of each graph shows proportion of culture 
positive animals/ total animals per group. Mean values and SD (n=4-7). LOD = Limit of detection (1x10
2
 CFU for bone 
and soft tissue, 0.5x10
2 
CFU for the implant), samples below LOD were represented as 1. It can be observed that 
contrary to C57BL/6N mice, BALB/c did not clear infection at 7 or 14 days post-operatively, irrespective of implant 
type. At day 30, mice from both implant groups cleared the infection. 
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Figure 5-6 Percentage of S. aureus infected C57BL/6N mice at each time-point (a) and quantitative bacteriology from 
each compartment (b, bone; c, soft tissue; d, implant). Upper panel of each graph shows proportion of culture positive 
animals/ total animals per group. Mean values and SD (n=6-8). LOD = Limit of detection (1x10
2
 CFU for bone and soft 
tissue, 0.5x10
2 
CFU for the implant), samples below LOD were represented as 1. As shown, no animal cleared bacteria 
at any time-point. In addition, high bacterial counts were recovered from all compartments, being significantly higher 
compared to S. epidermidis counts in C57BL/6N. 
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Figure 5-7 Percentage of low dose S. aureus infected C57BL/6N and BALB/c mice at day 14 (a) and quantitative 
bacteriology from each compartment (b, bone; c, soft tissue; d, implant). Upper panel of each graph shows proportion of 
culture positive animals/ total animals per group. Mean values and SD (n=5-8). LOD = Limit of detection (1x10
2
 CFU 
for bone and soft tissue, 0.5x10
2 
CFU for the implant), samples below LOD were represented as 1. Despite using a 10-
times lower dose compared to standard inoculum, all animals remained infected, with high bacterial counts in all 
compartments.  
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Figure 5-8 Total cell counts in spleen and popliteal lymph node single cell suspensions of C57BL/6N and BALB/c 
mice. Total cell counts in spleen and popliteal lymph node of C57BL/6N (a and b) and BALB/c (c and d) mice with a 
rigid (black) or flexible (grey) implant at 3, 7 and 14 days. BL (dashed line): baseline levels from average values of 
control animals. Mean and SEM (N=4-10); * = p<0.05. All operated animals present an early increase in spleen and 
lymph node cell counts, probably due to the inflammation induced by surgical procedure. This increase was not 
significant compared to baseline levels. At later time-points, only S. aureus inoculated animals (in C57BL/6N mice) 
present significantly higher cell counts, which supports a more severe infection process and higher inflammation 
process. 
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Figure 5-9 Light microscopic images of GE stained MMA sections, of non-inoculated C57BL/6N mice at days 14 and 
30 post-operatively, treated with rigid or flexible implants. First column: overviews of femur with implant in place and 
surrounding soft tissue (scale bar: 1000 µm). Second column: close-up of the osteotomy site (scale bar: 500 µm). Third 
column: tissue over the plate (scale bar: 200 µm). Fourth column: higher magnification of an area of third column (scale 
bar: 100 µm). Screw (S) and plate (P) are indicated in high magnification images to help orienting in the sample, 
asterisk and arrows are used to point at some of the described details. At day 14, rigid implant group (a) presented 
periosteal and endosteal new bone closing the osteotomy site (b) while flexible implant group (e) at the same time-point 
showed non-closure of the osteotomy site but a big cartilaginous callus (e and f, white asterisk). In addition, for animals 
with flexible implants bone marrow in distal site looked unstained, consisting in fibrotic tissue (e, black asterisk). Early 
granulation tissue (c-d and g-h) consisting of fibroblasts, new vessels (d and h, black arrows) and leukocyte infiltrate, 
with different grade of inflammation, was observed over the plate for both implant types. At day 30, in rigid implant 
group (i) the osteotomy was closed (j, black arrow). In flexible implant group (m) the callus was still remodelling (m 
and n, black asterisk) with still substantial amounts of cartilage tissue present and full closure of the osteotomy was not 
achieved (n, black arrow). The inflammation of the tissue over the plate was reduced to a thin layer of fibrous tissue (k 
and o, white asterisk), especially in the rigid implant group. 
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Figure 5-10 Light microscopic images of GE stained MMA sections of inoculated C57BL/6N mice at day 14 and 30 
treated with rigid and flexible implants. First column: overviews of femur with implant in place and surrounding soft 
tissue (scale bar: 1000 µm). Second column: close-up of osteotomy site (scale bar: 500 µm). Third column: tissue over 
the plate (scale bar: 200 µm). Fourth column: higher magnification of an area of third column (scale bar: 100 µm). Plate 
(P) is indicated in high magnification images to help orienting in the sample, asterisk and arrows are used to point at 
some of the described details. At day 14, once again, the osteotomy site in the rigid group showed a high degree of 
closure (a and b), while a complete non-closure of the osteotomy site and a large cartilaginous callus was observed in 
the flexible group (e and f). In both implant groups, the soft tissue presented small foci of inflammatory cell 
accumulation (a and e, black arrow). These foci, with high infiltrate of polymorphonuclear (PMN) cells, are shown in 
high magnification images (c and d, g and h). In some cases the presence of a fibrous capsule was observed (g, black 
asterisk), suggesting that this foci could be defined as a small encapsulated abscess. Bone edges at osteotomy site and 
near screws shown signs of osteolysis (a and e, white arrows). At day 30, closure of the osteotomy site was advanced in 
both, rigid and flexible implant groups. In contrast to day 14, inflammation of the tissue above the plate was reduced to 
a minimal degree (k and l, o and p).  
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Figure 5-11 Light microscopic images of GE stained thick-sections at day 14 in C57BL/6N mice with a rigid implant. 
Note small areas of low osseointegration near screws in both groups. In non-inoculated animals there is new bone 
formation (callus) and the tissue mainly consist of fibroblasts/-cytes, low number of capillaries and very little 
inflammatory cells mainly of mononuclear type (late granulation tissue). In contrast, in inoculated animals scalloped 
bone surface and osteoclasts can be observed (osteolysis), and the inflammatory cell infiltration of the granulation tissue 
is much higher consisting predominately of PMN cells and tissue debris (microabscess). Scale bar: 100 µm (first 
column) and 50 µm (second column, magnification images). 
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Figure 5-12 SE micrographs and light microscope images of bacteria on the implant and bone. SE micrograph images 
show clusters of coccoid bacteria attached to the implant surface (a) and in the periosteum (b). They were also observed 
in paraffin sections stained with BB (bacteria in blue) in a bone vessel (c) or in the periosteum/delaminated bone 
fragments (d). Scale bars shown in image: 5 µm (a and b) and 10 µm (c and d). 
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Supplementary Figure 5-13 Weight change of S. epidermidis and S. aureus infected C57BL/6N (a and b) and BALB/c 
mice (c and d). Percentage of weight change (compared to post-operation weight) in a) C57BL/6N mice with a rigid 
implant, b) C57BL/6N mice with a flexible implant, c) BALB/c mice with a rigid implant and d) BALB/c mice with a 
flexible implant. Mean and SEM (N=10-43). Repeated measures 2-way ANOVA with Tukey post hoc; #/*/&/§ = 
p<0.05. Statistically significant differences are marked as follows: # for significant differences between non-inoculated 
and S. aureus inoculated, * for significant differences between S. epidermidis inoculated and S. aureus inoculated, & for 
significant differences between non-inoculated and S. aureus low dose inoculated and § for significant differences 
between S. epidermidis inoculated and S. aureus low dose inoculated. 
Supplementary Table 5-1 Self-designed animal scoring system 
Parameter Scores 
Behaviour / Overall impression 0 / 2 / 4 
Breathing 0 / 2 / 3 
Fur / Eyes / Skin 0 / 1 / 3 
Movement 0 / 1 / 2 / 3 
Faeces / Urine 0 / 2 
Wound healing 0 / 1 / 3 
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Abstract 
Biomechanical stability plays an important role in fracture healing, with stable fixation being 
required to achieve optimal conditions for bone repair. Furthermore, the lack of stability has been 
considered a known risk for failure to treat fracture related infection (FRI), although literature 
addressing this topic is limited. Infection is one of the major complications in trauma surgery, being 
associated with increased hospital stays, prolonged treatment, poor functional outcome of the 
affected limb or even amputation, and high socio-economic costs. Recently, using an experimental 
model in mice, we have shown that animals with fractures fixed with a rigid implant (stable 
fixation) cleared infection more frequently than equivalents fixed with a flexible implant (unstable 
fixation). In this study, we aimed to characterize the immune responses associated with stable and 
unstable fracture fixation in this model, both under sterile conditions and after inoculation with 
either Staphylococcus epidermidis or S. aureus. Under unstable fixation, inflammation markers 
such as interleukin (IL)-6 were increased, and this was exacerbated by S. epidermidis infection. 
S. aureus inoculation led to very high inflammation for both type of implants, but also greater in 
unstable fixation. We also observed differences in terms of cell recruitment or mRNA levels, with 
again unstable fixation showing higher levels of inflammatory markers. We observed that IL-17A 
was upregulated on the presence of S. epidermidis infection and that this cytokine was mostly 
produced by CD4+ and γδ T cells. Using an IL-17A knock out mouse strain, we aim to address the 
role of IL-17A in infection progression. KO strain cleared infection at a slower rate, although no 
significant differences were observed, which may be associated to an increase in interferon (IFN)-γ 
production in those animals. 
Introduction  
Fracture healing is a complex process influenced by several interconnected factors, as summarized 
in the so called "diamond concept" [21]. Classically, this concept includes osteogenic cells, an 
osteoconductive scaffold, growth factors and the biomechanical environment. The first stage in the 
healing cascade is now known to involve acute inflammation [361] and the importance of immune 
cells in bone healing is now also widely recognised. For example, it has been shown that immune 
cells, such as T cells [32, 362, 363], B cells [31], macrophages [26, 27, 364, 365] or granulocytes 
[366], as well as soluble mediators such as pro-inflammatory cytokines or chemokines [367, 368] 
can contribute to fracture healing. The interaction between skeletal and immune systems (known as 
osteoimmunology) has been studied increasingly over the last years, including its application to 
fracture treatment [35, 361, 369, 370]. 
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Fracture related infections (FRI) are a major complication in trauma surgery, and are associated 
with long hospital stays, long-term antibiotic treatment, multiple revision surgeries, and, overall, a 
reduced quality of life and high healthcare costs. S. aureus and coagulase-negative staphylococci 
(CoNS) are the leading etiologic agents in such infections accounting for more than 60% of 
infections. S. epidermidis is the most prominent member of the CoNS and causes approximately 
20% of orthopaedic device-related infections [93]. However, its prevalence may even increase to 
50% in late-developing infections [94], which is often attributed to the sub-acute nature of 
S. epidermidis infections, with patients often only presenting many months after surgery.  
Despite its prevalence in orthopaedic device and fracture-related infection, relatively little is known 
about host defences against S. epidermidis, or how these infections progress in humans. Innate 
immune responses to S. epidermidis have been studied outside the context of FRI and are known to 
involve the secretion of interleukin (IL)-6, IL-1β, tumour necrosis factor (TNF)-α or IL-8, most of 
which occurs through toll-like receptor (TLR)-2 recognition. This results in the recruitment of 
neutrophils and macrophages, which will subsequently attempt to phagocytose and kill the bacteria 
through the production of reactive oxygen species, antimicrobial peptides, or proteases. While these 
mechanisms are highly effective against planktonic bacteria, the causative bacteria in FRI 
frequently reside in a biofilm and, as such, are more resistant to host defences [131, 160, 371, 372]. 
Currently, the specific details concerning adaptive immune responses to S. epidermidis are 
relatively unknown, although the use of immunodeficient mice has shown that mice lacking T and 
B cells present a delay in infection clearance [245].  
Recently, we established a S. epidermidis FRI model in mice [373], in order to provide a reliable 
model to study FRI caused by this pathogen. Using this model, we assessed the influence of fracture 
fixation stability on infection progression and we observed that different mechanical environments 
led to different infection outcomes in C57BL/6 mice. Specifically, unstable fractures displayed a 
delay in clearance of the infection from the tissues. This phenomenon was not observed in BALB/c 
mice, suggesting that host genetics play a key role in these models. In addition, we examined 
S. aureus infection in the same murine model and observed a more severe infection associated with 
higher osteolysis, compared to that seen with S. epidermidis. 
The aim of this study was to characterize the immune responses during fracture healing for stable 
and unstable constructs, under both sterile conditions and following inoculation with S. epidermidis 
or S. aureus. We aimed to determine if the differing infection rates could be linked to features of the 
immune response impacted by the different mechanical contexts [373].   
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Materials and methods 
Animals 
The study was approved by the ethical committee of the canton of Graubünden in Switzerland 
(TVB 11/2013 and TVB 2016/03) and was carried out in a research facility accredited by 
Association for Assessment and Accreditation for Laboratory Animal Care (AAALAC) 
International. Skeletally mature (20-28 weeks old, average weight ± SD: 25.85 ± 2.79 g), female, 
specific pathogen free (SPF) C57BL/6 mice, purchased from Charles River (Germany), and 
C57BL/6 IL-17A knock-out (KO), kindly provided by Prof. Dr. Manfred Kopf (ETH Zürich, 
Switzerland), were used in this study. All animals were allowed to acclimatize to experimental 
conditions for at least two weeks prior to the start of the study. Mice were housed under a 12 hour 
dark/ 12 hour light cycle, in groups of three to six in individually ventilated cages (XJ, Allentown), 
changed weekly, and they were re-housed in the same groups post-surgery. Animals were fed with a 
standard diet (3436, Provimi Kliba) and had free access to water at all times.  
Study design 
Samples for the study of immune responses during fracture healing, with and without infection, 
were obtained from C57BL/6 and BALB/c SPF mice (females, 20-28 weeks old) (Groups described 
in Table 5-2). That study was conducted in a similar way as the one described here, although all 
specific details can be found elsewhere [373]. 
Table 5-2 Model characterization study design. Samples were obtained from a previous study using the following set 
up. NA: Not applicable. 
 Day 3 Day 7 Day 14 Day 30 
Group C57BL/6 BALB/c C57BL/6 BALB/c C57BL/6 BALB/c C57BL/6 BALB/c 
Non-inoculated 
Rigid 6 NA ≥ 6 5 ≥ 6 4 ≥ 6  ≥ 6 
Flexible 6 NA ≥ 6 6 ≥ 6 3 ≥ 6 ≥ 6 
S. epidermidis Inoculated 
Rigid 6 NA 6 4 ≥ 6 6 6 ≥ 6 
Flexible ≥ 6 NA 5 6 ≥ 6 6 ≥ 6 6 
S. aureus Inoculated 
Rigid 6 NA ≥ 6 NA ≥ 6 NA - - 
Flexible ≥ 6 NA 5 NA ≥ 6 NA - - 
After characterizing the model, we aimed to assess mRNA expression in C57BL/6 with and without 
S. epidermidis infection. Based on data from the previous study, we selected two time-points to 
observe mRNA expression changes over time (Table 5-3). 
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Table 5-3 mRNA expression study design. Final number of animals per group. 
mRNA expression study groups (C57BL/6 mice) 
 Day 0 Day 7 Day 14 
Group Non-operated Rigid Flexible Rigid Flexible 
Non-inoculated 7 6 5 6 5 
S. epidermidis inoculated - 6 6 6 5 
Finally, we aimed to determine the role for IL-17A in S. epidermidis infection outcome, in 
C57BL/6 and IL-17A KO C57BL/6 mice (Table 5-4). 
Table 5-4 IL-17A study groups. Final number of animals per group. 
IL-17A study groups (C57BL/6 mice) 
 Day 0 Day 14 Day 30 
Group Non-operated Non-inoculated 
S. epidermidis 
inoculated 
Non-inoculated 
S. epidermidis 
inoculated 
Wild type 4 9 8 - 9 
IL-17A KO 3 9 8 - 7 
Bacteria and inoculum preparation 
In all studies, the test microorganism was S. epidermidis Epi 103.1, obtained from a patient with 
chronic implant-related bone infection. This strain has a weak in vitro biofilm formation capacity 
(our unpublished observations) according to the scoring system of Stepanovic et al. [343]. The 
inocula were prepared as described before [373]. The administered inoculum was 1x10
4
 Colony 
Forming Units (CFU). 
Surgery 
Commercially pure Titanium (CpTi) 4-hole rigid and CpTi 4-hole flexible MouseFix
TM
 implants, 
and Titanium Aluminium Niobium alloy (Ti6Al4Nb (TAN)) screws (RiSystem AG) were used in 
the mRNA expression study, while in IL-17A KO animals only the rigid plates were used. Prior to 
use, all implants were cleaned and sterilized as previously described [296]. 
Surgery was performed as previously described [373]. Briefly, under general anaesthesia with 
isoflurane (2-3% isoflurane in 100% O2, 1 l/min) (Isofluran Baxter®, Baxter AG), the animal was 
placed in prone position and a skin incision was made from tail base to left stifle. The subcutaneous 
Fascia lata was cut and the tissue plane between the quadriceps and the biceps femoris muscle was 
bluntly dissected. A Teflon foil was placed around the femur to protect the soft tissue from 
contamination. The implant was then fixed to the bone using four self-tapping, angular stable 
screws. Screw holes were predrilled with a 0.31 mm drill bit (RISystem AG). Once the implant was 
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in place, a 0.44 mm defect osteotomy was performed using a jig and a Gigli wire. In the inoculated 
groups, 2.5 µl of bacteria suspension was injected in the osteotomy site. The foil was then removed 
and the Fascia lata and the skin were closed with continuous sutures (5-0 Vicryl rapide, Ethicon, 
Belgium). Following surgery, a lateral radiograph of the femur was taken to confirm proper 
positioning of the implant. 
Analgesia was provided in the form of subcutaneous injections of buprenorphine (0.1 mg/kg, 
Bupaq, Streuli Pharma AG), pre-operatively and post-operatively every 6-8 hours for 16 hours. 
Additionally, a palatable form of acetaminophen (2 mg/ml, as Dafalgan Syrup for Children, 
Bristol-Myers Squibb SA) was added to the drinking water for 5 days. Animals were monitored 
twice daily for 5 days post-operatively and subsequently once a day, using a detailed numerical 
scoring system that takes into account general behaviour, external appearance, wound status and 
animal movement (scale 0-18). Weights and radiographs of the operated limb were taken weekly. 
Euthanasia and sample collection 
At each scheduled time-point, the animals were euthanized by cervical dislocation after inducing 
general anaesthesia in an induction box (5% isoflurane in 100% O2, 1 l/min). Immediately prior to 
euthanasia, blood was collected via retro-orbital bleeding to prepare serum for subsequent analysis 
(centrifuged at 5000 rpm for 10 minutes). Post-mortem, a lateral radiograph of the left femur with 
implant in place was acquired. The operated femur, the implant, and the surrounding soft tissue, 
were harvested separately in sterile containers with cold phosphate buffered saline (PBS), or 
RNAlater (Qiagen) for mRNA expression analysis. Some contralateral femurs were also collected 
as additional controls. The soft tissue and bone samples collected for quantitative bacteriology were 
mechanically homogenized (Omni Tissue Homogenizer and Hard Tissue Homogenizing tips, Omni 
International). Aliquots of the tissue homogenate were kept for quantitative bacteriology and for 
cytokine/chemokine quantification. The remaining sample was filtered through a 70 µm cell 
strainer (BD Falcon) and finally resuspended in complete RPMI (cRPMI: RPMI 1640 (Gibco)), 
penicillin (1 U/ml, Sigma-Aldrich), streptomycin (1 μg/ml, Sigma-Aldrich), kanamycin (0.1 μg/ml, 
Gibco), MEM vitamin (1x, Sigma-Aldrich), L-glutamine (2 mM, Sigma-Aldrich), sodium pyruvate 
(1 mM, Sigma-Aldrich), non-essential amino acids (1x, Sigma-Aldrich) and heat-inactivated foetal 
calf serum (10%, Sigma-Aldrich)). Spleen and popliteal lymph node were harvested in cold PBS 
and cRPMI respectively. To obtain single cell suspensions, samples were mashed with a syringe rod 
through a 70 µm cell strainer. For the spleen, erythrocytes were haemolysed with ddH2O for 1 
minute. Both single cells suspensions were finally resuspended in cRPMI. Cells were counted in all 
samples with Scepter™ 2.0 Cell Counter (Millipore) and adjusted to 2x106 cells/ml. 
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Quantitative bacteriology 
Viable bacterial counts were determined by plating bone homogenate and soft tissue homogenate on 
5% horse blood agar (BA) (Oxoid). The number of bacteria associated with the implant was 
determined by sonicating the implant and screws in PBS for 3 minutes (Bandelin Sonorex at 
40 KHz), vortex mixing for 10 seconds, and finally plating serial dilutions on 5% horse BA. All BA 
plates were incubated at 37°C for performing bacterial counts at 24 and 48 hours. Mice were 
considered as infected when at least one sample (bone, soft tissue or implant) was culture-positive. 
Bacteria recovered from each animal were confirmed to be S. epidermidis Epi 103.1 by Random 
Amplification of Polymorphic DNA (RAPD) test [347]. 
Multiplex assays 
Bone homogenates stored at -20°C were thawed, centrifuged (9000 g, 4°C, 10 minutes) and the 
supernatants collected for cytokine and chemokine quantification. Those were measured using a 
Milliplex MAP Mouse cytokine/chemokine Magnetic Bead Panel (Merck) for: granulocyte colony-
stimulating factor (G-CSF), interferon (IFN)-γ, IL-2, IL-4, IL-6, IL-10, IL-13, IL-17A, keratinocyte 
chemoattractant (KC), monocyte chemoattractant protein (MCP)-1 and TNF-α. Additionally, spleen 
single cell suspensions resuspended in cRPMI were plated in 24-well plates (1x10
6
 cells/well) and 
were stimulated with phorbol 12-myristate 13-acetate (PMA) (20 ng/ml, Sigma-Aldrich) and 
ionomycin (200 ng/ml, Sigma-Aldrich) then incubated at 37°C, 5% CO2. Culture supernatants were 
collected 48 hours later. Using Milliplex MAP Mouse cytokine/chemokine Magnetic Bead Panel 
(Merck) the following analytes were measured: IFN-γ, IL-2, IL-4, IL-10, IL-17A and TNF-α. Bone 
homogenates from the IL-17A study were centrifuged (9000 g, 4°C, 10 minutes) and supernatants 
were collected and stored at -80°C until use. IFN-γ, IL-4, IL-6, IL-17A, IL-17F, IL-22, IL-33 and 
KC were then measured in those samples using a U-PLEX Biomarker Group 1 (mouse) assay 
(Mesoscale Discovery), following the manufacturer's instructions. Samples were incubated in the 
plate at 4°C overnight to improve detection sensitivity.  
Flow cytometry 
Bone single cell suspensions were stained with Fixable Viability Dye eFluor780 (eBioscience) and 
for surface markers, as described in Supplementary Information Table 5-5. Single cell suspensions 
from lymph nodes and bones of IL-17A KO animals were stimulated with PMA (50 ng/ml), 
ionomycin (500 ng/ml) and Brefeldin A (1x, eBioscience) for 4 hours at 37°C, 5% CO2. Cells were 
subsequently stained with Fixable Dye eFluor780 and for surface markers before fixation and 
permeabilization using Intracellular Fixation & Permeabilization Buffer (eBioscience). Finally, 
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samples were stained intracellularly for cytokines, as described in Supplementary Information 
Table 5-5. All samples were analysed using a Gallios flow cytometer (Beckman Coulter). Gating 
strategies are shown in Supplementary figures: Figure 5-24, Figure 5-25 and Figure 5-26. 
Myeloperoxidase analysis 
Bone homogenates (from day 3 post-surgery), previously frozen at -80°C, were thawed and the 
supernatant collected before myeloperoxidase (MPO) levels were measured using a mouse MPO 
ELISA kit (Boster Biological Technology), according to the manufacturer's instructions. 
RNA extraction and mRNA expression evaluation 
Femoral bone diaphysis from the mRNA expression study groups were collected in RNAlater 
(Qiagen) and stored at -80°C after 24 hours at 4°C. RNA extraction was performed using a Tissue 
Lyse kit (Qiagen) following the manufacturer's instructions. RNA amount and quality was 
quantified using a NanoDrop 1000 Spectrophotometer (Thermo Fisher) and integrity was assessed 
using P200 Screen Tape (Agilent Technologies). Reverse transcription was performed on 400 ng of 
RNA/sample using Reaction Buffer (5x), dNTP Mix (10 mM), Random Hexamer Primer 
(0.2 µg/µl), RiboLock RNase Inhibitor (20 U/µl) and RevertAid Reverse Transcriptase (200 U/µl) 
(Thermo Scientific). mRNA expression was assessed using 48-gene custom TaqMan® Array Micro 
Fluidic Cards (Affymetrix/Thermo Fisher), with 100 ng of cDNA loaded into each port (selected 
genes, representative of bone healing process, tissue regeneration and immune responses are listed 
in Supplementary Information Table 5-6. mRNA expression in the microfluidic cards were 
measured using a QuantStudio 7 Flex Real-Time PCR System (Thermo Fisher). To evaluate mRNA 
level differences, the ΔΔCt method was used, with 18S, Eef2 and Gapdh as endogenous controls, 
and a control group (femurs of non-operated mice) was used as a calibrator when possible 
(otherwise indicated in results section). 
Statistical Analysis 
Statistical analysis was conducted using GraphPad Prism 7 software (GraphPad Software). 
Statistical tests performed are indicated in each figure legend. Differences were considered 
significant with p<0.05 (p-values reported in the figures).  
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Results 
Cytokine production locally for non-inoculated and inoculated (C57BL/6 and BALB/c) 
Bone homogenate supernatants were analysed to determine cytokine and chemokine levels at the 
fracture site of non-inoculated and inoculated C57BL/6 (Figure 5-14) and BALB/c animals 
(Supplementary Figure 5-27). We assessed innate immune response markers such as G-CSF, KC, 
MCP-1 and IL-6. Cytokines associated with T cell differentiation/responses were also measured 
such as IFN-γ, IL-17A, IL-2, IL-4, IL-13 and IL-10. IL-4 and IL-13 were in general not detected, 
while for IL-2 and IL-10 levels were very low and close to the detection limit.  
For non-inoculated C57BL/6 animals, the innate immune response markers (G-CSF, KC, MCP-1 
and IL-6) increased at 3 and 7 days post-operatively, and returned to baseline levels between days 
14 and 30. There were no statistically significant differences in cytokine levels between non-
inoculated animals with flexible or rigid devices, although groups with a flexible device tend to 
present higher levels. 
Inoculation with S. epidermidis in C57BL/6 mice resulted in a similar trend in innate immune 
markers. Values peaked between days 3 and 7 and decreased afterwards, reaching baseline levels 
between days 14 and 30. Animals with a flexible implant presented with higher levels of cytokines 
and chemokines, with statistically significant differences at day 3 for G-CSF, KC and IL-6. MCP-1 
and IFN-γ did not show differences between implant types, while IL-17A was slightly increased in 
S. epidermidis inoculated compared to non-inoculated animals, although differences were not 
statistically significant. Interestingly, inflammation markers generally did not differ significantly 
between non-inoculated and inoculated animals with a rigid device.  
Inoculation with S. aureus lead to significant changes in innate markers, with G-CSF, KC and IL-6 
being significantly higher at all time-points when groups were compared to non-inoculated or 
S. epidermidis inoculated counterparts. IL-17A was highly elevated in S. aureus inoculated animals 
compared to non-inoculated animals. Similar to S. epidermidis inoculated animals, mice with a 
flexible implant displayed higher G-CSF, KC and IL-6 responses to S. aureus infection compared to 
animals with a rigid device. 
In the BALB/c animals, similar trends were observed (Supplementary Figure 5-27). Once more, 
animals with a flexible implant (non-inoculated or S. epidermidis inoculated) often presented with 
higher inflammation markers compared to their counterpart group with a rigid implant 
(Supplementary Figure 5-27).  
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Figure 5-14 Cytokine levels (pg/ml) in bone homogenate supernatants of C57BL/6 mice at 3, 7 and 14 days post-
operatively. Mean values and SD (n=5-11). BL: baseline, mean of the control group; grey area: BL±SD of the control 
group. 2-way ANOVA per time-point with Tukey or Sidak post hoc correction. Grouped statistics summarizes the 
following comparisons, with only largest p-value reported: Non-inoculated Rigid vs S. aureus Inoculated Rigid, S. 
epidermidis Inoculated Rigid vs S. aureus Inoculated Rigid, Non-inoculated Flexible vs S. aureus Inoculated Flexible, 
S. epidermidis Inoculated Flexible vs S. aureus Inoculated Flexible. R: rigid implant; F: flexible implant 
Infection influences immune cell populations within the bone marrow 
Cell populations in the femoral bone marrow were analysed by flow cytometry (gating strategy: 
Supplementary Figure 5-24). Macrophages (F4/80+Ly6G-), T cells (CD3+CD19-) and B cells 
(CD19+CD3-), as well as T lymphocyte subclasses (CD4+, CD8+ and CD4-CD8-), were analysed 
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at day 3, 7 and 14. As no significant differences were observed in total cell counts and viability, 
results are reported as a proportion of all live cells, or as a percentage of total CD3+ cells. In non-
inoculated C57BL/6 mice, macrophage proportions were seen to increase at early time-points and 
they decreased over time (Figure 5-15A). T cells and B cells reached their peak at day 14, although 
for T cells the increase was not statistically significant, while B cells experienced a significant 
increase in proportion (Figure 5-15A). For S. epidermidis inoculated animals, similar results were 
observed, with a significant increase in macrophages at day 3 and B cells at day 14. Finally, for 
S. aureus inoculated animals a significant increase in macrophages was also observed at days 3 and 
7, while B cells showed an opposite trend, with a decrease in proportion. Within T cell subclasses, 
no significant differences were observed for non-inoculated mice. S. epidermidis inoculated animals 
with a flexible device and all S. aureus inoculated animals experienced a decrease in CD8+ and 
CD4+ T cells in favour of double-negative T cells (Figure 5-15B). In BALB/c animals, similar 
trends were observed, with recruitment of macrophages at early time-points, and a peak in T and B 
cells at day 14 (Supplementary Figure 5-28).  
 
Figure 5-15 Percentage of macrophages (Ly6G-F4/80+), T cells (CD3+CD19-) and B cells (CD19+CD3-) over viable 
cells (A), and percentage of CD4+, CD8+ and CD4-CD8- over CD3+ cells (B), in bone single cell suspensions of 
C57BL/6 mice at days 3, 7 and 14 post-operatively. Mean values and SD (n=5-9). BL: baseline, mean of the control 
group. R: rigid implant; F: flexible implant 
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Early granulocyte infiltration 
Early granulocyte infiltration (day 3 post-operatively) was assessed with MPO measurements in 
bone homogenates of C57BL/6 mice. Higher levels of MPO were observed after surgery, in all 
groups, being statistically significant only for animals with a flexible implant. Flexible implant 
groups tend to have higher levels in comparison to rigid counterparts, although this did not reach 
statistical significance (Figure 5-16).  
 
Figure 5-16 MPO levels (pg/ml) at day 3 in bone homogenate supernatants. Mean values and SD (n=4-7). Control: 
contralateral femurs. Normality test with Shapiro-Wilk test.1-way ANOVA, Sidak post hoc correction. 
Infection development in C57BL/6  
In additional groups of animals, the experiment was repeated and S. epidermidis numbers quantified 
in both the soft tissue and those associated with the implant. Animals with a rigid device tended to 
clear the infection more quickly than animals with a flexible implant (Figure 5-17). 
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Figure 5-17 Percentage of C57BL/6 mice infected at days 7 and 14, and total CFU counts (from soft tissue and 
implant). Number of culture-positive animals/total number of animals per group are shown in the upper panel of each 
graph. Mean values and SD (n=5-6). LOD: Limit of detection, 0.5x10
2
. Fisher's exact test and Mann-Whitney test. No 
significant differences observed. 
mRNA expression data in C57BL/6 
mRNA expression within bone homogenates was analysed at days 7 and 14 in C57BL/6 mice 
(Figure 5-18). All samples analysed had an A230/A260 index greater than 2 and RIN values were 
bigger than 6. Expression was detected for most of the genes, however, Col10a1 and Csf3 were 
only expressed in operated femurs, while Csf2, Hrh4, Il23 and Il4 appeared only at very late cycle 
numbers, or were not detected at all. Interestingly, Il17a was almost only expressed in the 
inoculated animals (Figure 5-18). 
From the mRNA expression data, several patterns could be observed (Figure 5-18). Some genes, 
such as Arg1, Ccl2, Nos2, Il6 and Hif1a (Supplementary Figure 5-29), were maximally expressed at 
day 7 and decreased by day 14, although they were still upregulated compared to control group. Of 
note, they were often upregulated in flexible groups compared to rigid counterparts, although this 
was not always statistically significant. Interestingly, a group of genes linked to bone regeneration 
including Col1a1, Acp5, Col10a1 and Sox9, showed a continuous increase over time, with highest 
levels detected at day 14. Both Col10a1 and Sox9 were especially increased in animals with a 
flexible device, probably due to their role in endochondral ossification. We also observed some 
genes whose expression decreased over time but only in non-inoculated animals, while in 
inoculated mice they remained slightly upregulated. Genes included in this category are mostly 
associated to immune responses and pathogen recognition such as Cd80, Tlr2, Tlr4, Tnf and 
Adgre1. A gene that was almost exclusively expressed in inoculated animals was Il17a, with very 
low levels in the non-inoculated samples where expression was detected. Finally, some genes were 
downregulated at all time-points in all operated femurs (e.g. Casp3, Elane, Hmgb1 and Sell), or 
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were downregulated at day 14 (Ccr2, Hdc, Hrh2, Mrc1, S100a8, S100a9 and Tgfb1). Interestingly 
several of these genes are associated with cell damage signalling or neutrophil products. 
 
Figure 5-18 Heatmap of mRNA expression at days 7 and 14. Values represent log (2
-ΔΔCT
), using Control group as a 
calibrator except for Col10a1, Csf2 and Il17a (bottom of the chart) where Non-inoculated Rigid group was used as no 
mRNA expression was detected in Control group. SE: S. epidermidis, R: rigid, F: flexible 
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Adaptive immune responses: Lymph node and Spleen 
To evaluate adaptive immune responses, popliteal lymph nodes and spleens were collected. Lymph 
node single cell suspensions were stimulated for 4 hours with PMA, ionomycin and brefeldin A, 
and stained with surface and cytokine antibodies (Figure 5-19). In general, an increase of activated 
cells was observed in all groups after day 3. Some significant differences were observed between 
the different groups, especially at day 14. Of note, total cell counts in lymph nodes of S. aureus 
inoculated mice were significantly higher at days 7 and 14, when compared to non-inoculated or 
S. epidermidis inoculated animals and thus the differences in percentage at those time-points may 
mean no differences in cell numbers 
 
Figure 5-19 Percentage of IL-17A, IFN-γ and IL-10 producing T cells (CD3+CD4- and CD3+CD4+) in popliteal 
lymph node of C57BL/6 mice. Mean values and SEM (n=6-9). 2-way ANOVA per time-point, Tukey post hoc test. 
Additionally, day 30 spleen samples from non-inoculated and inoculated C57BL/6 and BALB/c 
mice were stimulated with UV-killed S. epidermidis. After 72 hours, secretion of several innate 
immunity markers were observed for both conditions (non-inoculated versus inoculated). IL-17A 
was the cytokine more differentially expressed between both groups, being almost only secreted in 
animals that had been previously inoculated with S. epidermidis (Figure 5-20) for both C57BL/6 
and BALB/c strains. 
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Figure 5-20 Cytokine production by splenocytes from non-inoculated and S. epidermidis inoculated C57BL/6 and 
BALB/c mice (rigid and flexible samples grouped together) after stimulation with UV-killed S. epidermidis in vitro 
(dose indicated in the x-axis: ratio of bacteria per splenocyte). Mean values and SD (n=5-8). Two-way ANOVA, Sidak 
post hoc correction. 
IL-17A KO model 
As IL-17A seemed to be selectively induced by the presence of S. epidermidis, IL-17A KO mice 
were used to study the role of IL-17A in infection clearance. As observed above, at day 14 some 
WT animals had become culture-negative, while none of the IL-17A KO animals cleared the 
infection at that time-point. However, differences were not statistically significant. At day 30, 
culture-negative animals were found in both groups, with more WT animals clearing the infection 
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compared to the KO animals. In terms of bacterial counts, no significant differences were observed 
at any time-point (Figure 5-21). 
 
Figure 5-21 Percentage of WT and IL-17A KO C57BL/6 mice infected at days 14 and 30, and total CFU counts (from 
bone, soft tissue and implant). Mean values and SD (n=7-9). LOD: Limit of detection, 0.5x10
2
. Fisher's exact test and 
Mann-Whitney test. No significant differences observed. 
We aimed to identify the cellular source of IL-17A, previously detected in bone. From flow 
cytometric analysis (gating strategy in Supplementary Figure 5-26), we observed several cell types 
producing IL-17A such as CD4+ T lymphocytes, γδ T lymphocytes, NK cells and lineage-negative 
cells (negative for all the markers included). Following surgery, there was an increase in IL-17A+ 
CD4+ and γδ T lymphocytes compared to control groups (Figure 5-22). CD4+IL-17A+ cells were 
significantly increased in inoculated animals in comparison to non-inoculated or control mice. Of 
note, animals that were found culture-negative (infection considered cleared), had the lowest levels 
of IL-17A+ CD4+ and γδ T lymphocytes, suggesting once more that IL-17A seems to be induced 
on an active infection. 
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Figure 5-22 Percentage of IL-17A producing cells in control, non-inoculated or S. epidermidis inoculated for WT and 
IL-17A KO C57BL/6 mice at day 14. Each graph title shows over which population percentage is expressed. Note in A 
and B, WT mice that were found culture negative are indicated with a black arrow. Mean values and SD (n=7-11). 1 
way-ANOVA or Kruskal-Wallis, with Tukey or Dunn's post hoc test. 
Cytokines were measured in bone homogenate supernatants (Figure 5-23). Once more, levels for 
most of the cytokines were quite low when comparing non-inoculated and inoculated animals, with 
only slightly higher levels of inflammatory markers such IL-33 or IL-6. We could detect IL-17A 
only in inoculated WT animals, supporting the increase seen in the previous study at the mRNA 
expression level. IFN-γ was detected in low concentrations in all groups, with both inoculated WT 
and KO presenting the highest levels. Nevertheless, only the KO inoculated group was significantly 
different compared to non-inoculated counterpart animals. 
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Figure 5-23 Cytokine levels in bone homogenates of control animals (wilt-type and KO pooled together as no 
differences were observed), wild-type and IL-17A KO C57BL/6 mice, non-inoculated and inoculated. Mice that were 
found culture negative are indicated with a black arrow Mean values and SD (n=7-9). 2 way-ANOVA with Tukey post 
hoc for day 14, Mann-Whitney test for day 30. 
Discussion 
In this study we aimed to characterize the immune responses associated with bone fracture, with a 
focus on S. epidermidis and S. aureus FRI. Our model included implants with different mechanical 
properties, which, based on our previous findings [373], can lead to different kinetics of infection 
clearance. We have previously demonstrated that S. epidermidis inoculated C57BL/6 mice were 
more likely to clear infection when a rigid fixation device was implanted compared to a flexible 
device. We therefore sought to investigate if differential immunological responses to fixation 
stiffness could explain the differences observed in our previous study. 
The fact that non-inoculated animals with a flexible implant had a tendency for higher 
inflammatory markers compared to mice with a rigid implant (both in C57BL/6 and BALB/c), 
suggests that instability leads to a more inflamed local microenvironment. This was also supported 
by MPO analysis in bone marrow and in mRNA expression analysis. However, differences in levels 
of individual mediators were often small and did not reach statistical significance in the majority of 
cases. Similar observations were done in a sheep model of mechanically-induced impaired bone 
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healing. In that study, Schmidt-Bleek et al. reported a higher percentage of cytotoxic T cells and 
macrophages in the hematoma and bone marrow of less stable fractures, which they associated to a 
higher/prolonged inflammatory environment [374]. Thus, in non-inoculated conditions, the more 
inflammatory environment observed in the unstable context could have a negative impact in bone 
healing. Consistent with this, the link between increased inflammation (acute or chronic) and 
fracture healing complications has already been proposed [375-380]. In clinics, politrauma patients, 
who often have high systemic levels of inflammatory cytokines (such as IL-6 or TNF-α) present a 
high percentage of fracture healing complications [381]. Also, pronounced inflammatory responses 
were observed in hematomas (at 72 hours) of patients considered immunologically compromised 
(e.g. patients with autoimmune diseases, cancer or osteoporosis), which often exhibit delayed 
healing and other complications [382]. While inflammation is required to initiate the healing 
process, the effective resolution of this inflammation is believed to be necessary for effective 
healing to occur [361]. Therefore, the prolonged inflammatory microenvironment due to the use of 
a flexible plate (unstable context) can be a factor contributing to a higher risk of delayed or non-
union often associated with fracture instability.  
For S. epidermidis, differences at cytokine or mRNA expression level between non-inoculated and 
inoculated animals were often not significant. This data supports the idea that our model closely 
resembles a low-grade infection, also described in other models [303]. The only exception was mice 
with flexible implants at early time-points (both for C57BL/6 and BALB/c), which showed 
significantly higher levels of inflammatory markers such as IL-6, G-CSF or KC. Although we did 
not specifically identify the cellular sources of these cytokines/chemokines, macrophages recruited 
into the tissue, and also osteoblasts, have been shown to secrete similar cytokines upon 
S. epidermidis stimulation [235, 236, 383]. At later time-points, cytokine levels decreased to levels 
observed in control mice (baseline levels). The mRNA expression data in non-inoculated and 
S. epidermidis inoculated C57BL/6 mice are consistent with the cytokine quantification data 
described above. We again observed a tendency for higher inflammatory/tissue damage markers in 
animals with a flexible implant compared to rigid counterparts. Furthermore, the combination of 
flexible implant and S. epidermidis led to the highest responses in cytokine/chemokine release (e.g. 
Csf3, Il6, Nos2 or Ccl2). Interestingly, the increased expression of Hif1a suggests that the instability 
and/or infection results in a more hypoxic environment, although this did not translate to significant 
differences in hypoxia-inducible factor (Hif)-1α regulated genes such as Vegfa, which could suggest 
an inadequate adaptation to hypoxia as suggested by Hoff et al.[384]. Further studies to investigate 
the responses of other Hif-1α regulated genes, such as Ldha or Pgk1, are therefore warranted to 
elucidate the role of hypoxia in unstable fixation associated with FRI. Taken together, we observed 
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that the combination of a flexible implant and infection results in higher levels of inflammation, 
hypoxia and tissue damage markers.  
A number of important differences in the immune response were observed following inoculation 
with S. epidermidis compared to S. aureus. S. aureus inoculation led to a much higher and sustained 
inflammation in the tissue; in line with the acute nature of S. aureus infections and the consequent 
host immune responses to the infection [373]. Almost all cytokines measured (IL-6, G-CSF, KC, 
MCP-1) were significantly increased up to day 14, when compared to non-inoculated or 
S. epidermidis inoculated mice. This highly inflamed environment was accompanied with 
significant bone destruction. Similar to other studies, we observed high levels of IL-17A in the 
infected tissues [296, 297], which may be relevant for infection clearance but has also been 
suggested to contribute to pathogenesis due to the stimulatory effects of IL-17A on bone destruction 
and tissue damage [298, 299]. 
To summarize, cytokine secretion in full bone homogenates early after surgery depicted an increase 
for several innate immune markers (such as G-CSF, TNF-α or IL-6) in all groups, often increased in 
animals with a flexible implant compared to animals with a rigid implant. This was especially 
evident upon infection with S. epidermidis or S. aureus. It can be hypothesized that the enhanced 
inflammatory environment may lead to the delayed bacterial clearance observed in unstable 
fractures. However, the specific contribution of inflammation per se to delayed bacterial clearance 
is difficult to assess, since inflammatory responses are directly induced by the infection itself. In 
future, studies involving anti-inflammatory treatments may help to elucidate inflammation 
requirements for a successful bacteria clearance, although this needs to be carefully addressed. In 
addition, it would also be interesting to combine the fracture-model presented here with other 
disease models (such as obesity or diabetes) together with infection, in order to determine how 
fixation stability influences infection risk and progression in groups of patients known to be at 
higher risk of post-surgical complications. 
At the cellular level, we observed a recruitment of macrophages in the bone marrow/fracture site at 
early time-points, in line with the peak of innate immunity markers. Despite the fact that we could 
not detect neutrophils directly, MPO measurements also suggested recruitment of neutrophils at day 
3. Macrophage numbers also peaked at early time-points, in line with their role in bone healing [27, 
369], and their levels did not return to baseline levels up to day 30 (data not published) suggesting a 
role throughout the healing process. In general, no significant differences were observed between 
non-inoculated and inoculated animals except for day 7 in C57BL/6 mice, when S. epidermidis 
inoculated animals presented lower levels. Unfortunately, we could not further characterize 
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macrophage phenotype so far, which would be interesting to understand if they play a more pro- or 
anti-inflammatory role. Conversely, the numbers of adaptive immune cells (T and B cells) peaked 
at day 14. This is consistent with previous observations, where two recruitment waves of T and B 
cells were observed during bone healing [385]. Regarding immune cell subclasses, an increase in 
percentage of double negative (CD4-CD8-) cells was noted at day 3; especially in the flexible plate 
S. epidermidis inoculated group, and S. aureus inoculated animals (both rigid and flexible 
implants). The fact that these 3 groups demonstrated higher inflammatory responses suggests that 
different levels of inflammatory markers may alter the pattern of cells recruited. Of note, γδ T cells, 
which are frequently CD4-CD8- [386], have been associated with S. aureus infection (specifically 
peritonitis and surgical site infection models) responses, at least in early time-points [387, 388], and 
could be partly responsible for this observed increase. Currently it is unknown whether γδ T cells 
play any role in S. epidermidis infection. 
We observed that within the leukocyte compartment in bone marrow/fracture site, T helper cells 
and γδ T cells were the main sources of IL-17A. IL-17A producing lymphocytes, which have been 
proposed to contribute to bone healing [32, 389] but also to bone destruction [390, 391], were also 
detected in non-inoculated animals. However, in those, cell number and Il17amRNA expression 
were much lower, which could be linked to time-points studied. Nevertheless, we performed 
histology in IL-17A KO mice and we did not observe major differences in terms of bone healing 
when compared to WT (Supplementary Figure 5-30 and [373]). Upon infection, it was observed 
that IL-17A was induced at both the mRNA and the protein level, as well as in adaptive immune 
responses, suggesting a role for Th17 responses during infection. Similar observations were 
previously reported in S. aureus FRI [296] and there is evidence that Th17 responses are important 
for S. aureus clearance in other infection models [388, 392, 393], or in reducing S. aureus nasal 
carriage [394]. Concerning a role for Th17 cells in S. epidermidis infection, there is currently 
limited data to support such a role, although it is known that adaptive immunity is required for 
infection clearance [245]. The importance of IL-17A-associated responses in our model was 
investigated using IL-17A KO mice. Since IL-17A is involved in neutrophil recruitment and 
activation, this may indicate a beneficial effect of IL-17A in bacterial infection, although the pro-
inflammatory and pro-osteolytic effects of IL-17A in murine models of inflammatory arthritis is 
suggestive of tissue damaging effects [395]. This has also been proposed for S. aureus infections, 
suggesting that bacteria skew adaptive immunity towards a Th17/Th1 profile in order to evade the 
immune system [298]. We observed that there was a trend for IL-17A KO animals to clear the 
S. epidermidis infection less effectively than in WT animals, although differences were not 
statistically significant. While IFN-γ was not significantly increased in WT animals following 
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infection, we did observe an increase in this cytokine in IL-17A KO animals, suggesting a 
compensatory mechanism of IFN-γ in the absence of IL-17A. IL-17F, which has a high homology 
with IL-17A and can signal through the same receptor [396] or IL-22, produced also by Th17, 
would be other candidates with potential to compensate IL-17A loss of function, however we did 
not find detectable levels of IL-17F or IL-22 cytokines in WT or KO mice. Moreover, other studies 
have demonstrated a positive role for IFN-γ in S. epidermidis infections [230]. This would suggest a 
need for both Th1 and Th17 responses, which should be assessed in future studies. Nevertheless, 
due to the osteolytic effect of cytokines such IL-17A, it may be expected that therapeutic strategies 
aimed at modulating IL-17-based immunotherapies should be carefully considered. Furthermore, 
since we only used the rigid plate in the IL-17A KO animals it is currently unknown whether 
enhanced pro-inflammatory responses using the flexible implant would be again observed, and 
which influence this would have on the relative efficacy of IL-17A.  
Conclusion 
Our data suggests that fracture instability contributes to inflammatory processes locally. The 
combination of S. epidermidis infection and instability led to a significant increase in several 
inflammatory markers at early time-points, with the trend being maintained at later time-points. 
S. aureus infections resulted in a much more severe inflammatory response, associated with the 
higher secretion of pro-inflammatory cytokines. A trend for higher inflammation during S. aureus 
infection was also observed in animals with a flexible implant. However, since all animals remained 
infected in the S. aureus group, it is currently not possible to hypothesize how mechanical stability 
influences bacteria clearance. Levels of inflammation were associated with different patterns of 
local immune cell recruitment, but no significant differences were observed systemically. Finally, 
the role of IL-17A in infection clearance was addressed, with the use of IL-17A KO animals. 
Bacterial clearance was impaired in the IL-17A KO animals but differences to WT animals were 
not significant, perhaps due to increases in compensatory IFN- or Th1 responses.  
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Supplementary Tables and Figures: 
Table 5-5 Flow cytometry panels, with antibodies and related products used 
Product 
Clone 
(If applicable) 
Reference 
number 
Company 
Fixable Viability Dye eFluor780 NA 65-0865-14 eBioscience 
Bone panel 
FITC anti-mouse Ly6G Antibody 1A8 127605 Biolegend 
PE anti-mouse CD8a Antibody 53-6.7 100708 Biolegend 
PerCP/Cy5.5 anti-mouse CD19 Antibody 6D5 115534 Biolegend 
PE/Cy7 anti-mouse F4/80 Antibody BM8 123114 Biolegend 
APC anti-mouse CD138 (Syndecan-1) Antibody 281-2 142506 Biolegend 
Pacific Blue anti-mouse CD3ε Antibody 145-2C11 100334 Biolegend 
Brilliant Violet 510 anti-mouse CD4 Antibody RM4-5 100553 Biolegend 
Lymph node panel 
PE/Cy7 anti-mouse CD3ε Antibody 145-2C11 100320 Biolegend 
Pacific Blue anti-mouse CD4 Antibody RM4-5 100531 Biolegend 
Alexa Fluor 488 anti-mouse/rat IL-17A Antibody eBio17B7 53-7177-81 eBioscience 
PE anti-mouse IL-10 Antibody JES5-16E3 12-7101-81 eBioscience 
PerCP-Cy5.5 anti-mouse IFN-γ Antibody XMG1.2 45-7311-80 eBioscience 
APC anti-mouse IL-4 Antibody 11B11 17-7041-82 eBioscience 
IL-17A Bone panel 
PE anti-mouse CD19 Antibody 6D5 115507 Biolegend 
PE anti-mouse TER-119/Erythroid Cells Antibody TER-119 116207 Biolegend 
PE anti-mouse Ly-6G/Ly-6C (Gr-1) Antibody RB6-8C5 108407 Biolegend 
PE anti-mouse F4/80 Antibody BM8 123109 Biolegend 
PE anti-mouse/rat CD61 Antibody 2C9.G2 (HMß3-1) 104307 Biolegend 
Alexa Fluor® 700 anti-mouse CD45 Antibody 30-F11 103128 Biolegend 
PerCP/Cy5.5 anti-mouse NK-1.1 Antibody PK136 108728 Biolegend 
PE/Cy7 anti-mouse CD8a Antibody 53-6.7 100722 Biolegend 
APC Anti-mouse TCR γ/δ Antibody GL3 118116 Biolegend 
Pacific Blue anti-mouse CD3ε Antibody 145-2C11 100334 Biolegend 
Brilliant Violet 510 anti-mouse CD4 Antibody RM4-5 100553 Biolegend 
Alexa Fluor 488 anti-mouse/rat IL-17A Antibody eBio17B7 53-7177-81 eBioscience 
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Figure 5-24 Flow cytometry gating strategy to determine macrophage, T and B cell populations in bone single cell 
suspensions. 
 
 
Figure 5-25 Flow cytometry gating strategy to determine T cell populations and cytokines secreted by those cells in 
popliteal lymph node cell suspensions. 
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Figure 5-26 Flow cytometry gating strategy to determine IL-17A source within the leukocyte compartment in the bone 
marrow. Cells selected for final evaluation were positive for CD45+ and negative for the following lineage markers: 
Gr-1 (Ly6G/Ly6C), F4/80, CD19, Ter119 and CD61. 
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Table 5-6 List of genes included in the microfluidic card 
# Gene name* (common abbreviation) 
Gene 
symbol* 
Gene ID* 
Applied 
Biosystems® 
Assay ID 
Amplicon 
Length 
1 Adhesion G protein-coupled receptor E1 (F4/80) Adgre1 13733 Mm00802529_m1 92 
2 Mannose receptor, C type 1 (CD206) Mrc1 17533 Mm00485148_m1 76 
3 Arginase, liver (Arg-1) Arg1 11846 Mm00475988_m1 65 
4 Nitric oxide synthase 2, inducible (iNos-2) Nos2 18126 Mm00440502_m1 66 
5 Elastase, neutrophil expressed Elane 50701 Mm01168928_g1 69 
6 
Tumour necrosis factor (ligand) superfamily, member 
11 (RANKL) 
Tnfsf11 21943 Mm00441906_m1 66 
7 CD80 antigen Cd80 12519 Mm00711660_m1 117 
8 Tumour necrosis factor (TNF-α) Tnf 21926 Mm00443258_m1 81 
9 Interleukin 4 (IL-4) Il4 16189 Mm00445259_m1 79 
10 Interleukin 6 (IL-6) Il6 16193 Mm00446190_m1 78 
11 Interleukin 10 (IL-10) Il10 16153 Mm00439614_m1 79 
12 Interleukin 17A (IL-17A) Il17a 16171 Mm00439618_m1 80 
13 Interleukin 17F (IL-17F) Il17f 257630 Mm00521423_m1 85 
14 Interleukin 23, alpha subunit p19 (IL-23) Il23a 83430 Mm01160011_g1 109 
15 transforming growth factor, beta 1 (TGF-beta1) Tgfb1 21803 Mm01178820_m1 59 
16 transforming growth factor, beta 2 (TGF-beta2) Tgfb2 21808 Mm00436955_m1 82 
17 transforming growth factor, beta 3 (TGF-beta3) Tgfb3 21809 Mm00436960_m1 60 
18 colony stimulating factor 1, macrophage (M-CSF) Csf1 12977 Mm00432686_m1 70 
19 colony stimulating factor 3, granulocyte (G-CSF) Csf3 12985 Mm00438335_g1 63 
20 
colony stimulating factor 2, granulocyte-macrophage 
(GM-CSF) 
Csf2 12981 Mm01290062_m1 125 
21 Interleukin 33 (IL-33) Il33 77125 Mm00505403_m1 83 
22 Chemokine (C-C motif) ligand 2 (CCL2) Ccl2 20296 Mm00441242_m1 74 
23 chemokine (C-C motif) receptor 2 (CCR2) Ccr2 12772 Mm01216173_m1 88 
24 Toll-like receptor 2 (TLR-2) Tlr2 24088 Mm00442346_m1 69 
25 Toll-like receptor 4 (TLR-4) Tlr4 21898 Mm00445273_m1 87 
26 Vascular endothelial growth factor A (VEGF-A) Vegfa 22339 Mm01281449_m1 81 
27 Hypoxia inducible factor 1, alpha subunit (HIF1- α) Hif1a 15251 Mm00468869_m1 75 
28 Endothelial PAS domain protein 1 (HIF2-α) Epas1 13819 Mm01236112_m1 63 
29 Histidine decarboxylase (HDC) Hdc 15186 Mm00456104_m1 99 
30 Histamine receptor H1 (H1R) Hrh1 15465 Mm00434002_s1 70 
31 Histamine receptor H2 (H2R) Hrh2 15466 Mm00434009_s1 64 
32 Histamine receptor H4 (H4R) Hrh4 225192 Mm00467634_m1 68 
33 S100 calcium binding protein A8 (S100A8) S100a8 20201 Mm00496696_g1 131 
34 S100 calcium binding protein A9 (S100A9) S100a9 20202 Mm00656925_m1 162 
35 High mobility group box 1 (HMGB1) Hmgb1 15289 Mm00849805_gH 158 
36 Caspase 3 Casp3 12367 Mm01195084_m1 79 
37 Selectin, lymphocyte (CD62L) Sell 20343 Mm00441291_m1 101 
38 
Tumour necrosis factor receptor superfamily, 
member 11b (osteoprotegerin, OPG) 
Tnfrsf11b 18383 Mm01205928_m1 75 
39 Secreted phosphoprotein 1 (OPN) Spp1 20750 Mm00436767_m1 114 
40 Collagen, type I, alpha 1 (ColIα1) Col1a1 12842 Mm00801666_g1 89 
41 Collagen, type X, alpha 1 (ColXα1) Col10a1 12813 Mm00487041_m1 77 
42 Bridging integrator 1 (ALP-1) Bin1 30948 Mm00437457_m1 72 
43 Runt related transcription factor 2 (Runx2) Runx2 12393 Mm00501584_m1 91 
44 Acid phosphatase 5, tartrate resistant (TRAP) Acp5 11433 Mm00475698_m1 79 
45 SRY (sex determining region Y)-box 9 (Sox9) Sox9 20682 Mm00448840_m1 101 
46 Eukaryotic translation elongation factor 2 (eEF-2) Eef2 13629 Mm01171434_g1 74 
47 
Glyceraldehyde-3-phosphate dehydrogenase 
(GAPDH) 
Gapdh 14433 Mm99999915_g1 109 
48 Ribosomal 18S 18s - - - 
* Details according to NCBI 
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Figure 5-27 Cytokine levels (pg/ml) in bone homogenate supernatants of BALB/c mice at 7, 14 and 30 days post-
operatively. Mean values and SD (n=3-7). BL: baseline, mean of the control group; grey area: BL ± SD of the control 
group. 2-way ANOVA per time-point, Tukey or Sidak post hoc correction; except day 14 when Rigid and Flexible 
groups were analysed with Mann-Whitney. NA= Not available. 
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Figure 5-28 Percentage of macrophages (Ly6G-F4/80+), T cells (CD3+CD19-) and B cells (CD19+CD3-) over viable 
cells (A), and percentage of CD4+, CD8+ and CD4-CD8- over CD3+ cells (B), in bone single cells suspensions of 
BALB/c mice at days 7, 14 and 30 post-operatively. Mean values and SD (n=3-8). BL: baseline, mean of the control 
group. 
 
Figure 5-29 2
-ΔΔCT
 of Arg1, Nos2, Ccl2, Cd80, Il33 and Hif1a in mRNA isolated from operated and not operated 
femurs (controls and contralateral femurs); at 0, 7 and 14 days post-operatively.18S, Eef2 and Gapdh used as 
endogenous controls, control group used as reference group (calibrator). Mean values and SD (n=5-7). 2-way ANOVA 
per time-point, with Tukey post hoc test. R: rigid implant, F: flexible implant. 
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Figure 5-30 Light microscopic images of Giemsa/Eosin stained MMA sections of C57BL/6 IL-17A KO mice non-
inoculated and S. epidermidis inoculated at day 14. Scale bar overview images: 1000 µm. Scale osteotomy 
magnification: 500 µm. Similar observations were done when comparing with WT prior data [373]. The osteotomy gap 
was filled with new bone in both groups (black arrows). S. epidermidis inoculated mice only showed localized signs of 
infection as osteolytic regions around the screws with granulocyte infiltrate (white arrows). Histology sections were 
generated as described before [373] 
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Abstract 
Histamine is a biogenic amine produced by numerous cell types and with various 
immunoregulatory roles. The response to histamine is influenced by which of its four receptors 
through which the signal is transduced. After a traumatic bone fracture, histamine will be secreted 
in the fracture site as part of the inflammatory phase responses, leading to higher vascular 
permeability. In a previous fracture-related infection model in mice, we observe an increase of 
histamine receptor 2 (H2R) mRNA expression in animals inoculated with S. epidermidis. The role 
of H2R in infection has been not yet been fully described, with conflicting results reported in the 
literature in different pre-clinical models. The clinical data from human patients is also not 
conclusive about H2R and H2R antagonists in infection risk.  
In this study, we used a H2R knock-out mouse strain (in BALB/c background) in order to address 
the role of this receptor in our S. epidermidis fracture-related infection model. Despite we observed 
differences in local immune responses, as shown by cytokines and chemokine secreted in the 
fracture site (e.g. tumour necrosis factor-alpha), this did not lead to bacteria clearance differences. 
Introduction  
Histamine (2-[4-imidazolyl]-ethylamine) is a short-lived and low-molecular-weight biogenic amine 
produced by mast cells and basophils, who store histamine in intracellular granules and release 
them upon activation. Other immune cells, like dendritic cells or T cells, can synthesize histamine 
de novo and release it immediately [397]. Histamine is a potent regulator of the immune system, 
and is able to act in both a pro-inflammatory and in an anti-inflammatory manner, depending on 
which cell type and what receptor through what it is signalling [398]. Histamine has been shown to 
modulate granulocyte function or to alter cytokine secretion by dendritic cells [399, 400] and 
thereby influence T cell polarization, among other mechanisms [397].  
The role of histamine in the antibacterial immune response is to increase the permeability of the 
capillaries, facilitating access of host defence cells to infected tissues. Nevertheless, the complete 
role of histamine and its receptors in bacterial infections is not completely clear, with positive and 
negative effects being reported in different studies [401-403]. We observed an upregulation of 
histamine 2 receptor (H2r) mRNA expression in mice femurs with an implant related bone infection 
caused by Staphylococcus epidermidis (Results 5.2). The infected mice then transitioned to a down-
regulation at later time-points, mirroring uninfected controls.  
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A wide diversity of cells and tissues, including T and B lymphocytes, dendritic cells or smooth 
muscle cells, express histamine 2 receptor (H2R). H2R has been shown to regulate immune 
responses. Signalling through H2R can inhibit mast cell degranulation, impair neutrophil 
chemotaxis and reduce oxidative burst in neutrophils and monocytes [404-406]. In the adaptive 
immune system, H2R signalling may polarize T cell responses into Th2 and/or Treg phenotype 
[398, 407]. However, as described above, the role of this receptor in infection is not clear. 
It has also been shown that mast cell degranulation (which will lead to the release of histamine) 
may be involved in mediating acute inflammatory responses to implanted biomaterials [408]. By 
contrast, histamine secretion nearby the implant may contribute to the immunosuppressive 
environment suggested to accompany foreign bodies [409]. 
We hypothesized that histamine secretion in the fracture site, due to tissue damage and bacterial 
[410] and/or foreign body presence [408, 411], may impair immune responses in the vicinity of the 
implant through H2R signalling. We aimed to determine if H2R deletion could play a beneficial role 
in our S. epidermidis fracture-related infection (FRI) model. 
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Materials and methods 
Animals 
The study was approved by the ethical committee of the canton of Graubünden in Switzerland 
(TVB 2016/03) and was carried out in a research facility accredited by Association for Assessment 
and Accreditation for Laboratory Animal Care (AAALAC) International. Skeletally mature (20-28 
weeks old, average weight ± SD: 26.46 ± 5.56 g), female, specific pathogen free (SPF) BALB/c 
mice, purchased from Charles River (Germany), and BALB/c H2R knock-out (KO), provided by 
Prof. Takeshi (Watanabe, Osaka, Japan) and bred in our facilities, were used in this study. All 
animals were allowed to acclimatize to experimental conditions for at least two weeks prior to the 
start of the study. Mice were housed under a 12-hour dark/ 12-hour light cycle in groups of three to 
six in individually ventilated cages (XJ, Allentown), changed weekly, and they were re-housed in 
the same groups post-surgery. Animals were fed with a standard diet (3436, Provimi Kliba) and had 
free access to water at all times.  
Wild-type (WT) and KO mice underwent surgery, as non-inoculated or S. epidermidis inoculated 
(n=8/group). Animals were euthanized 14 days post-operatively.  
Bacteria and inoculum 
The test microorganism was S. epidermidis Epi 103.1, obtained from a patient with chronic 
implant-related bone infection, which has a weak capacity for in vitro biofilm formation according 
to the scoring system of Stepanovic et al. [343]. The inocula were prepared as described previously 
[373]. The target inoculum was set to 1x10
4
 Colony Forming Units (CFU). 
Surgery 
Commercially pure Titanium (CpTi) 4-hole rigid and CpTi 4-hole flexible MouseFix
TM
 implants 
and Titanium Aluminium Niobium alloy (Ti6Al4Nb (TAN)) screws (RiSystem AG) were used to 
fix a transverse mid femoral osteotomy in mice. Prior to use, all implants were cleaned and 
sterilized by steam autoclave. 
Surgery was performed as previously described [373]. Briefly, under general anaesthesia with 
isoflurane (2-3% isoflurane in 100% O2, 1 l/min) (Isofluran Baxter®, Baxter AG), the animal was 
placed in prone position and a skin incision was made from tail base to left stifle. The subcutaneous 
Fascia lata was cut and the tissue plane between the quadriceps and the biceps femoris muscle was 
bluntly dissected. A Teflon foil was placed around the femur to protect the soft tissue from 
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contamination. The implant was then fixed to the bone using four self-tapping, angular stable 
screws. Screw holes were predrilled with a 0.31 mm drill bit (RISystem AG). Once the implant was 
in place, a 0.44 mm defect osteotomy was performed using a jig and a Gigli wire. In the inoculated 
groups, 2.5 µl of bacteria suspension was injected in the osteotomy site. The foil was then removed 
and the Fascia lata and the skin were closed with continuous sutures (5-0 Vicryl rapide, Ethicon). 
Following surgery, a lateral radiograph of the femur was taken to confirm proper positioning of the 
implant. 
Post-operative care and euthanasia 
Analgesia was provided in the form of subcutaneous injections of buprenorphine (0.1 mg/kg, 
Bupaq®, Streuli Pharma AG), pre-operatively and twice post-operatively every 6-8 hours. 
Additionally, a palatable form of acetaminophen (2 mg/ml, as Dafalgan® Syrup for Children, 
Bristol-Myers Squibb SA) was added to the drinking water for 5 days. Animals were monitored 
twice daily for 5 days post-operatively and subsequently once a day, using a detailed numerical 
scoring system which takes into account general behaviour, external appearance, wound status and 
animal movement [373]. Weight was taken pre-operatively and 3, 7 and 14 days post-operatively, 
while radiographs of the operated limb were taken weekly to ensure no implant/osteosynthesis 
failure. 14 days post-operatively, mice were euthanized and samples collected as previously 
described (in Materials and Methods of Results 5.2). 
Quantitative bacteriology  
Viable bacterial counts were performed by plating serial dilutions of bone homogenate and soft 
tissue homogenate on 5% horse blood agar (BA) (Oxoid). The number of bacteria associated with 
the implant was determined by sonicating the implant and screws in PBS for 3 minutes (Bandelin 
Sonorex at 40 KHz), vortex mixing for 10 seconds and finally also plating serial dilutions in 5% 
horse BA. All BA plates were incubated at 37°C for bacterial counts at 24 and 48 hours. Mice were 
considered as infected when at least one sample (bone, soft tissue or implant) was culture positive. 
Bacteria recovered from each animal were confirmed to be S. epidermidis Epi 103.1 by Random 
Amplification of Polymorphic DNA (RAPD) test [347] 
In vitro stimulation of bone  
Bone single cell suspensions were plated in 24-well plate (1x10
6
 cells/well) with complete RPMI 
(cRPMI: RPMI 1640 (Gibco), penicillin (1 U/ml, Sigma-Aldrich), streptomycin (1 μg/ml, Sigma-
Aldrich), kanamycin (0.1 μg/ml, Gibco), MEM vitamin (1x, Sigma-Aldrich), L-glutamine (2 mM, 
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Sigma-Aldrich), Na-pyruvate (1 mM, Sigma-Aldrich), non-essential amino acids (1x, Sigma-
Aldrich) and heat inactivated foetal calf serum (10%, Sigma-Aldrich)). Cells were left unstimulated 
or stimulated with phorbol 12-myristate 13-acetate (PMA) (20 ng/ml, Sigma-Aldrich) and 
ionomycin (200 ng/ml, Sigma-Aldrich). Samples were incubated at 37°C, 5% CO2 and supernatants 
were collected after 48 hours. Cytokines and chemokines present in supernatants were measured 
using Milliplex Map Mouse cytokine/chemokine Magnetic Bead Panel (Millipore). The following 
cytokines were measured: G-CSF, IL-4, IL-6, IL-10, IL-17A, KC/GRO, MCP-1 and TNF-α. 
Flow cytometry 
Bone single cell suspensions were stained with life viability dye (eBioscience) for 30 minutes at 
4°C in darkness, followed by staining with the following panel: FITC anti-mouse Ly6G, PE anti-
mouse CD8, APC anti-mouse CD138, PerCP-Cy5.5 anti-mouse CD19, PE-Cy.7 anti-mouse F4/80, 
Pacific Blue anti-mouse CD3ε and Brilliant Violet 510 anti-mouse CD4 (all from Biolegend). At 
least 0.5x10
6
 cells were acquired in Gallios flow cytometer (Beckman Coulter). Lymph node single 
cell suspensions were stimulated for 4 hours with PMA (50 ng/ml), ionomycin (500 ng/ml) and 
Brefeldin A (1x, eBioscience) at 37°C, 5% CO2. Afterwards, cells were stained with life viability 
dye as described above and stained with the following surface markers: PE/Cy7 anti-mouse CD3ε 
and Pacific Blue anti-mouse CD4 (all from Biolegened). Cells were fixed and permeabilized with 
the Intracellular Fixation & Permeabilization Buffer kit (eBioscience) and finally stained for 
intracellular cytokines: Alexa Fluor 488 anti-mouse/rat IL-17A, PE anti-mouse IL-10, PerCP-Cy5.5 
anti-mouse interferon (IFN)-γ and APC anti-mouse IL-4. All samples were measured using a 
Gallios flow cytometer (Beckman Coulter). Anti-S. epidermidis antibody ELISA 
UV killed S. epidermidis Epi 103.1 in PBS was processed to obtain a lysate for plate coating. The 
process included 5 cycles of snap-freezing in liquid nitrogen, 1 hour incubation at 37°C with 
200 µg/ml of Lysostaphin (Sigma-Aldrich) resuspended in 20 mM Sodium Acetate (Sigma-
Aldrich) pH 4.5 at 10 mg/ml and 1 mM of EDTA 0.5 M (Sigma-Aldrich). Subsequently, samples 
were sonicated 4 times (each step: 10 minutes, 60 Hz, on ice) with sterile glass beads (90-150 µm, 
VWR). Finally, the sample was centrifuged at 200 rpm for 10 minutes to remove glass beads. 
Protein in the collected supernatant was quantified and adjusted to 550 µg/ml with PBS before it 
was aliquoted and frozen at -20°C.  
For the ELISA, Maxisorp Nunc 96 flat-bottom well plates (ThermoFisher) were coated with 
2.5 µg/ml of S. epidermidis Epi 103.1 lysate (overnight, 4°C). Afterwards, wells were blocked with 
5% milk powder in PBS 0.05% Tween 20 (Fluka) and incubated with serum dilutions ranging from 
1:20 to 1:320. Antibodies against S. epidermidis were detected using biotinylated goat anti-mouse 
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IgG and IgM (Mabtech), HRP-streptavidin (Sigma-Aldrich), tetramethylbenzidine (TMB) mix and 
1M H2SO4 as a stop solution. Plates were read at 450nm in a plate reader (Berthold Technologies). 
Statistical analysis 
Statistical analysis was performed using the software GraphPad Prism 7 software. Test performed 
are included in figure legend. D'Agostino-Pearson normality test was used to determine if sample 
distribution was not normal. Differences were considered significant with p<0.05.  
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Results 
Animal monitoring 
All animals survived the surgical procedure and there was 1 animal euthanized prior to the 
scheduled time-point. When observing weight change over time (Figure 5-31), we observed a more 
pronounced weight loss in H2R knock-out (KO) mice when compared to their wild-type (WT) 
counterparts. This was again observed for both inoculated and non-inoculated mice, although it only 
reached statistical significance for the non-inoculated groups at days 7 and 14. The S. epidermidis 
inoculated groups showed a tendency to lose more weight than non-inoculated counterparts for both 
WT and KO groups, although this did not reach statistical significance. The clinical scoring did not 
show significant differences between the different groups.  
 
Figure 5-31 Percentage of weight change compared to time-point 0 at days 3, 7 and 14 post-operatively. Data shown 
for wild-type (black) and KO animals (grey), non-inoculated (dashed lines) or S. epidermidis inoculated (solid lines). 
Data shown is mean +/- SEM (n=8-9 per group). Repeated measures 2-way ANOVA, * = p<0.05. All animals lost 
weight after surgery, and was more pronounced in H2R KO mice than in their WT counterparts. Significant differences 
were observed between non-inoculated WT and KO (p<0.05) at days 7 and 14.  
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Quantitative bacteriology 
Infection was assessed by total viable bacterial counts in the different compartments (bone, soft 
tissue and implant) at day 14 (Figure 5-32). All WT and H2R KO mice were found to be culture 
positive at euthanasia. The WT group tended to have more culture negative samples (9 culture 
negative samples in WT versus 6 in KO) although this was not statistically significant. CFU counts 
were often lower in H2R KO, although once again this did not reach statistical significance (Figure 
5-32). 
 
Figure 5-32 CFU counts for bone, soft tissue and implant, for WT (black) and H2R KO (grey) mice at day 1 post-
operatively. Mean and SD (n=8). Samples found culture negative are represented as 1. LOD: Limit of detection, 1x10
2
 
CFU for bone and soft tissue and 0.5x10
2
 CFU for implant. Mann-Whitney test, no significant differences found. 
Cytokine production in bone 
Bone single cell suspensions were prepared from homogenized femurs. Total cell numbers obtained 
were similar between both groups (Supplementary Figure 5-37). Cells were re-stimulated and 
cytokine secretion was measured after 48 hours. Secretion of G-CSF, TNF-α and IL-10 (Figure 
5-33 A-C) were elevated in KO mice compared with WT in both inoculated and non-inoculated 
groups, although differences were not always significant (Figure 5-33). IL-17A secretion was only 
observed in inoculated animals, and was increased in inoculated KO mice compared with 
inoculated WT mice, although this did not reach statistical significance (Figure 5-33 D). 
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Figure 5-33 G-CSF (A), TNF-α (B), IL-10 (C) and IL-17A (D) levels (pg/ml) in 48 hours re-stimulated bone single cell 
suspensions of non-inoculated and S. epidermidis inoculated mice. Mean and SD (n=8). One-way ANOVA with Sidak 
post hoc or Kruskal-Wallis with Dunn's post hoc test, significant p-values indicated (p<0.05). 
Flow cytometry of bone single cell suspensions  
We also analysed the percentages of macrophages, T cells and B cells in the bone single cell 
suspensions (Figure 5-34). Total cell number (Supplementary Figure 5-37) and the relative 
percentage of macrophages (F4/80+Ly6G-, Figure 5-34 A) was similar between each group. T 
lymphocytes (CD3+CD19-, Figure 5-34B) were significantly increased in WT mice inoculated with 
S. epidermidis compared to non-inoculated WT equivalents. There was a trend for reduced B cell 
percentage H2R KO animals although this did not reach statistical significance.  
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Figure 5-34 Percentage of macrophages (F4/80+Ly6G-) (A), T cells (CD3+CD19-) (B) and B cells (CD19+CD3-) (C) 
in all groups, expressed as a percentage of viable cells. Mean and SD (n=8). One-way ANOVA with Sidak post hoc, 
significant p-values indicated (p<0.05). 
Adaptive immune responses in popliteal lymph node 
Popliteal lymph node cells were re-stimulated and treated with Brefeldin A to determine cytokine 
production. We observed that both KO mice groups (non-inoculated and S. epidermidis inoculated) 
had a slightly reduced CD3+CD4- percentage and significantly lower CD3+CD4+ percentage 
(Figure 5-35, A and D) compared to WT equivalents. However, KO mice T cells were producing 
higher levels of IFN-γ and IL-17A (Figure 5-35, B-C and E-F), and although levels were low this 
was also true for IL-10. No association was found with T cell levels and infection. 
 
Figure 5-35 Percentage of total CD3+CD4- and cells producing IFN-γ or IL-17A (A-C), and percentage of total 
CD3+CD4+ and cells producing IFN-γ or IL-17A (D-F) in popliteal lymph node. Mean and SD (n=8). One-way 
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ANOVA with Sidak post hoc or Kruskal-Wallis with Dunn's post hoc test, significant p-values indicated in the figure 
(p<0.05). 
Anti-S. epidermidis IgG levels were measured at day 14 (Figure 5-36). In general, levels were low 
for all the groups, except for S. epidermidis inoculated H2R KO mice. Nevertheless, values were 
very variable within the group, with some animals presenting very low antibody levels. In addition, 
we observed that even non-inoculated H2R KO had slightly higher levels of antibodies compared to 
WT counterpart. 
 
Figure 5-36 Levels of IgG recognizing S. epidermidis proteins (expressed as optical density measured at 450nm) at 
different serum dilutions. Mean and SEM (n=8-9). 
Discussion 
Histamine is a potent biogenic amine with multiple functions. After tissue damage or biomaterial 
implantation, it is expected that histamine may be released. This will lead to vasodilatation on the 
site, which will allow cell recruitment in the affected tissue. This study showed that H2R influenced 
the immune responses against S. epidermidis but this was not related to differences in infection 
clearance. 
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H2R has previously been shown to play a role in infection by gram-negative bacteria, although the 
data is somewhat inconsistent. Cimetidine (H2R antagonist) treatment reduced mortality in diabetic 
mice in a sepsis model (induced by cecum ligation and puncture) and histamine administration lead 
to a higher survival rate [401]. Contrasting with this, the same antagonist led to an increased 
mortality in a Yersinia enterocolitica infection model [402] and lead to higher morbidity in a 
peritonitis model [403]. This apparent contradiction has been attributed to the different effects that 
histamine can have in different cell types and tissues. Furthermore, certain bacteria are capable of 
producing histamine [412], which is hypothesized that could be used in their benefit to modulate 
immune system. While the gene used for histamine production (hdc) has been found in some 
S. epidermidis strains [413] we could not detect it in our S. epidermidis strain (12 different primers 
tested, data not shown). Thus, in our model, the only source of histamine in the infected bone/soft 
tissue would be the host. 
In this study, differences were observed between WT strains and H2R KO, with higher post-
operative weight loss for KO, higher cytokine levels in the tissues or reduced T lymphocytes 
numbers in lymph node, which presented greater cytokine secretion compared to WT. Nevertheless, 
differences in immune responses observed did not lead to significant differences in terms of 
infection clearance. With regards to bacterial burden, H2R KO animals often showed lower CFU 
counts in bone and implant, while for soft tissue the average was higher than WT. Of note, in this 
FRI model, BALB/c mice have been shown to clear bacteria only late time-points [373] and a 
longer observation period may provide better evidence to clarify if there is a role for histamine and 
H2R in this FRI model.  
At our observation point of 14 days, few differences were associated to the presence of infection. 
However, our S. epidermidis FRI model results in a subclinical type of infection and after the first 
few days, clinical differences (e.g. weight loss or behaviour scoring) between non-inoculated and 
inoculated animals are minimal [373]. Higher levels of IL-17A and higher percentage of T cells in 
bone single cell suspensions were the main differences between non-inoculated and S. epidermidis 
inoculated mice.  
Finally, in the context of bone, histamine has been associated with rheumatoid arthritis [414], and 
seems to act by stimulating the production of prostaglandin E and matrix metalloproteinase (MMP)-
1, which eventually leads to bone damage and destruction [415]. Similarly, the use of Cimetidine 
(H2R antagonist) reduced bone loss by downregulating IL-6, MMP-1 and MMP-9 [416]. Other 
authors have reported that histamine can directly promote osteoclastogenesis by increasing 
histamine receptors in osteoclasts and osteoblasts [417]. Although we did not perform 
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measurements to evaluate bone healing, we did observe a better healing outcome in H2R KO mice 
which could be linked to this finding and that would be of interest to evaluate in future. 
Conclusion 
Despite significant differences in immune responses observed between wild-type and H2R knock-
out animals, this did not translate in infection clearance differences, with similar percentage of 
samples found negative and similar CFU counts. 
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Supplementary Figures 
 
Figure 5-37 Total cell counts in bone (A), spleen (B) and popliteal lymph node (C) for non-inoculated and 
S. epidermidis inoculated mice. Mean and SD (n=4-9). One-way ANOVA with Sidak's post hoc test, significant values 
indicated (p<0.05). 
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Abstract 
Staphylococcus epidermidis is a common member of the commensal human microbiota. Life-long 
exposure of this microorganism results in the development of a specific adaptive immune response 
as revealed by the presence of anti-S. epidermidis antibodies in human serum. In an apparent 
contradiction to its role as a commensal, S. epidermidis has also emerged as an important 
opportunistic pathogen in device related infection (DRI). To date, the influence of pre-existing 
specific adaptive immunity in the development or progression of S. epidermidis DRI remains 
unclear.  
We have recently developed a model for S. epidermidis fracture-related infection (FRI) in specific-
pathogen free (SPF) mice, although these mice are naïve to S. epidermidis. The present study was 
therefore performed to determine whether pre-existing specific adaptive immunity to S. epidermidis 
can influence infection rate, bacterial burden or immune responses in this model. SPF C57BL/6 
male and female mice (n≥8 per group) were inoculated by subcutaneous injection of UV inactivated 
S. epidermidis and observed for four weeks. Upon confirmation of the presence of specific antibody 
in these mice, a fracture fixation device was applied to fix femoral osteotomies and the surgical site 
was contaminated with a clinical strain of S. epidermidis. The mice were observed for a further 14 
days, at which time quantitative bacteriological evaluation was performed to determine if infection 
rate, bacterial burden or immune responses were affected by pre-exposure. Mice receiving saline 
injections were included as controls.  
We observed a trend for lower CFU counts in mice pre-exposed to S. epidermidis, although no 
significant differences were observed in overall infection rate. Local and systemic immune 
responses 14 days after infection establishment showed minor differences between S. epidermidis 
exposed and saline groups. Levels of several cytokines and chemokines (IL-6, G-CSF, IL-17A or 
VEGF) were increased at the site of infection, and after stimulation with inactivated S. epidermidis, 
secretion of IL-17A and IFN-γ was increased in splenocytes. Thus, it can be concluded that 
previous humoral immunity has only a limited effect in subsequent infection, with a trend for lower 
bacterial counts, but no significant impact on infection. 
Introduction  
S. epidermidis is part of the normal human commensal microbiota, with life-long colonisation of the 
skin commencing within a few days after birth [56]. It is predominant in moist areas such as nares 
or fossae, but also present in sebaceous areas such as the facial skin [57] and mucosal tissues such 
as the gastrointestinal and the lower reproductive tracts [58, 59]. The presence of S. epidermidis at 
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these locations has been suggested to play a beneficial role for the host by inducing immune 
maturation [188, 189] and by outcompeting more pathogenic strains [67, 68, 71, 72]. Colonisation 
will also result in the generation of a specific adaptive immunity that has been proposed to be due to 
numerous transient self-resolving infections due to micro-invasions, rather than directly from 
colonization itself [246]. The nature of the adaptive immunity to commensal S. epidermidis has not 
been extensively studied, although antibodies have been detected in serum and saliva of healthy 
individuals against S. epidermidis proteins [251, 252], and experimental studies have shown 
S. epidermidis interaction with CD103+ skin-resident dendritic cells generates CD8+IL-17A+ T 
cells with the capacity to enhance protective responses in the skin [189]. 
In contrast to its conventional role as a commensal microorganism, the use of implanted medical 
devices has resulted in S. epidermidis becoming one of the most prominent causes of device related 
infection (DRI). S. epidermidis is not recognised as a highly virulent pathogen, however, the ability 
to rapidly adhere to and form a biofilm on the implanted device are considered critical to its ability 
to cause DRI [47a, 48]. How the specific adaptive immune response, that under normal 
circumstances may be expected to confer partial protection from infection, can influence the 
development and progression of DRI remains unclear. Antibodies against biofilm components and 
cytoplasmic proteins have been found to be predominant in patients with confirmed S. epidermidis 
infection [251], and titres are elevated in patients in comparison with healthy volunteers [252]. 
However, there remains limited understanding of the importance of specific adaptive immunity in 
this context.  
We have previously described a mouse model of FRI. In this model, the device is a fracture fixation 
device used to fix osteotomies of the mouse femur. Using specific pathogen free (SPF) mice, we 
established a reliable S. epidermidis infection model. The presence of S. epidermidis on rodent skin 
is not well-characterized and has been reported as absent or at very low levels in studies with SPF 
mice [189, 190]. It may, however be present in wild/feral mice [418] and some inbred strains [419]. 
Presuming a much-reduced presence of S. epidermidis in murine skin, we aimed to generate 
adaptive immune responses via subcutaneous injection of UV-killed bacteria, to further study the 
impact of such immunity in a subsequent deep tissue infection. This would resemble a situation 
where skin commensal bacteria, against which immunity may exist, would colonize deeper tissues 
and arise as a pathogen. Our aim was to assess the effect of previous systemic exposure to 
S. epidermidis on subsequent infection with the same bacteria in an established mouse fracture 
model. 
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Materials and methods 
Mouse skin bacteria isolation 
Dorsal skin pieces (approximately 1 mm
2
) of SPF mice kept in our facilities were incubated in 
tryptone soy broth (TSB) for 48 hours at 37°C in agitation at 100 rpm. Afterwards, serial dilutions 
of the broth were plated in tryptone soy agar (TSA) (Oxoid), for total counts, and in mannitol-salt 
agar (MSA) (Oxoid) to identify staphylococcal strains. Single colonies were re-plated to ensure 
pure strains and sent for identification to Synlab (Luzern, Switzerland). 
Animals 
The study was approved by the ethical committee of the canton of Graubünden in Switzerland 
(TVB 30E-2015) and was carried out in a research facility accredited by Association for 
Assessment and Accreditation for Laboratory Animal Care (AAALAC) International. Skeletally 
mature (24 weeks old), male (average weight ± SD: 36.85 ± 3.44g) and female (28.27 ± 2.78g), SPF 
C57BL/6N mice, purchased from Charles River (Germany), were used in this study. All animals 
were allowed to acclimatize to experimental conditions for at least two weeks prior to the start of 
the study. Mice were housed under a 12 hour dark/ 12 hour light cycle in groups of four to six in 
individually ventilated cages (XJ, Allentown), changed weekly. Animals were fed with a standard 
diet (3436, Provimi Kliba) and had free access to water at all times. The study design is summarized 
in Figure 5-38. It consisted of two subcutaneous injections of either saline or UV killed 
S. epidermidis Epi 103.1 at 30 and 14 days before surgery. Equal groups of mice were blindly 
allocated in one of the two treatment groups and randomly operated/inoculated (n≥8 per group). 
The mice were re-housed in the same groups post-surgery. In addition, non-operated age-matched 
males and females were used as control group. 
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Figure 5-38 Experimental scheme of the studies, with final number of animals analysed per group. Syringe schemes 
indicate time of subcutaneous injection of saline or UV-killed S. epidermidis. 
Bacteria preparation for subcutaneous injections 
The strain used in this study, S. epidermidis Epi 103.1, is a clinical isolate obtained from a patient 
with chronic implant-related bone infection. UV killed bacteria were prepared for subcutaneous 
inoculations. Briefly, bacteria were grown in TSB (Oxoid) at 37°C, under agitation (100 rpm), until 
they reached an optical density corresponding to 9.33x10
8
 CFU/ml. They were washed twice in 
phosphate-buffered saline (PBS) (Sigma-Aldrich), sonicated for 3 minutes (Bandelin Sonorex at 
40 KHz) and exposed to flow-hood UV light (254 nm) for 4 hours. Bacteria were pelleted (3000 g, 
15 minutes) and resuspended in sodium chloride (NaCl) 0.9% (B.Braun). One ml of the initial 
suspension was cultured overnight in TSB (37°C, 100 rpm) to ensure that the inactivation of all 
bacteria was successful. The suspension obtained was aliquoted and frozen at -20°C. Prior to use, 
aliquots were thawed and diluted in NaCl 0,9% to a final concentration of 4x10
7
 CFU/ml.  
Subcutaneous exposure and antibody levels 
Thirty and fourteen days before surgery, mice were injected subcutaneously with 100 µl of NaCl 
0,9% or 100 µl of bacteria suspension (estimated dose: 4x10
6
 CFU). Injections were performed 
under general anaesthesia with isoflurane (2-3% isoflurane in 100% O2, 1 l/min) (Isofluran 
Baxter®, Baxter AG). Dorsal skin was clipped and prepped aseptically (washed with Hibiscrub® 
soap and then cleaned with Softasept® N (B.Braun) solution) before treatment solution was 
injected with a 25G needle. Two weeks after the second injection, blood was collected via tail vein 
for antibody measurements. 
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Implants and surgery 
Commercially pure Titanium (CpTi) 4-hole rigid and CpTi 4-hole flexible MouseFix
TM
 implants 
and Titanium Aluminium Niobium alloy (Ti6Al4Nb (TAN)) screws were used in this study 
(RiSystem AG). Prior to use, all implants were cleaned and sterilized as previously described [296]. 
Surgery and inoculum were performed as described previously [373]. 
Euthanasia and post-mortem sample processing 
Fourteen days post-operatively, animals were anesthetized in an induction box (5% isoflurane in 
100% O2, 1 l/min) and blood was taken from retro-orbital sinus for serum isolation (5000 rpm, 10 
minutes). Afterwards, mice were euthanized by cervical dislocation. A lateral radiograph of the left 
femur with implant in place was acquired post-mortem. The operated femur, the implant and the 
surrounding soft tissue were harvested separately in sterile containers with cold PBS. Contralateral 
femurs were collected from some of the operated animals (from both saline and Epi 103.1 pre-
exposed groups) as additional controls. The soft tissue and the femurs were mechanically 
homogenized (Omni Tissue Homogenizer and Hard Tissue Homogenizing tips, Omni 
International). To determine bacteria associated with the implant, all metal hardware were sonicated 
in PBS for 3 minutes (BandelinSonorex at 40 KHz) and vortex mixing for 10 seconds. Viable 
bacterial counts were performed by plating serial dilutions of each sample on 5% horse blood agar 
(BA) (Oxoid). All BA plates were incubated at 37°C for bacterial counts at 24 and 48 hours.  
Aliquots of bone homogenates were also used for cytokine and chemokine quantification. A 700 µl 
aliquot sample was centrifuged at 9000 g at 4°C, and the supernatant was aliquoted and frozen until 
measurement. Finally, the remaining sample was filtered through a 70 µm cell strainer (BD Falcon) 
and resuspended in complete RPMI (cRPMI: RPMI 1640 (Gibco), penicillin (1 U/ml, Sigma-
Aldrich), streptomycin (1 μg/ml, Sigma-Aldrich), kanamycin (0.1 μg/ml, Gibco), MEM vitamin 
(1x, Sigma-Aldrich), L-glutamine (2 mM, Sigma-Aldrich), Na-pyruvate (1 mM, Sigma-Aldrich), 
non-essential amino acids (1x, Sigma-Aldrich) and heat inactivated foetal calf serum (10%, Sigma-
Aldrich)). Spleen and popliteal lymph node were harvested in cold PBS and cRPMI respectively. 
To obtain single cell suspensions, samples were mashed with a syringe rod through a 70 µm cell 
strainer. For the spleen, erythrocytes were haemolysed with ddH2O for 1 minute. Both single cells 
suspensions were finally resuspended in cRPMI. Cells were counted in all samples with Scepter™ 
2.0 Cell Counter (Millipore) and adjusted to 2x10
6
 cells/ml. 
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Cell suspension re-stimulation 
Spleen single cell suspensions were plated in 24-well plate (1x10
6
 cells/well) with cRPMI. Cells 
were left unstimulated or stimulated with phorbol 12-myristate 13-acetate (PMA) (20 ng/ml, 
Sigma-Aldrich) and ionomycin (200 ng/ml, Sigma-Aldrich), or UV killed S. epidermidis (1:1 and 
1:10, cells:bacteria). Samples were incubated at 37°C, 5% CO2 and supernatants were collected 
after 24 and 72 hours. 
Cytokine and chemokine quantification 
Cytokines and chemokines were quantified in bone homogenates and spleen supernatants using 
Milliplex Map Mouse cytokine/chemokine Magnetic Bead Panel (Millipore). The following 
cytokines were measured in supernatants of bone homogenate: G-CSF, IFN-γ, IL-2, IL-4, IL-6, IL-
10, IL-13, IL-17A, KC/GRO, MCP-1 and TNF-α. The following cytokines were measured from 
supernatants of stimulated splenocytes: IFN-γ, IL-2, IL-4, IL-10, IL-17A and TNF-α. 
Flow cytometry 
Bone single cell suspensions were stained with the following antibodies after life viability dye with 
Fixable Viability Dye eFluor 780 (eBioscience) for 30 minutes at 4°C in darkness: FITC anti-mouse 
Ly6G, PE anti-mouse CD8, APC anti-mouse, PerCP-Cy5.5 anti-mouse, PE-Cy.7 anti-mouse, 
Pacific Blue anti-mouse and Brilliant Violet 510 anti-mouse CD4 (all from Biolegend). At least 
0.5x10
6
 cells were acquired in Gallios flow cytometer (Beckman Coulter). Lymph nodes were 
stimulated for 4 hours at 37°C and 5% CO2 in cRPMI with PMA (50 ng/ml), ionomycin 
(500 ng/ml) and brefeldin A (1x, eBioscience). Afterwards, medium was washed and cells were 
stained with Fixable Viability Die eFluor 780 as above and with the following antibodies for 
surface markers: PE/Cy7 anti-mouse CD3 and Pacific Blue anti-mouse CD4 (all from Biolegend). 
Afterwards cells were fixed and permeabilized with the Intracellular Fixation & Permeabilization 
Buffer Set (eBioscience) and stained intracellularly with Alexa Fluor 488 anti-mouse/rat IL-17A, 
PE anti-mouse IL-10, PerCP-Cy5.5 anti-mouse IFN-γ and APC anti-mouse IL-4 (all from 
eBioscience). Samples were measured in a Gallios (Beckman Coulter) flow cytometer and analysed 
using the Kaluza software. 
Anti-S. epidermidis antibody ELISA 
UV killed S. epidermidis Epi 103.1 in PBS was processed to obtain a lysate for plate coating. The 
process included 5 cycles of snap-freezing in liquid nitrogen, 1 hour incubation at 37°C with 
200 µg/ml of Lysostaphin (Sigma-Aldrich) resuspended in 20 mM Sodium Acetate (Sigma-
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Aldrich) pH 4.5 at 10 mg/ml and 1 mM of EDTA 0.5 M (Sigma-Aldrich). Subsequently, samples 
were sonicated 4 times (each step: 10 minutes, 60 Hz, on ice) with sterile glass beads (90-150 µm, 
VWR). Finally, the sample was centrifuged at 200 rpm for 10 minutes to remove glass beads. 
Protein in the collected supernatant was quantified and adjusted to 550 µg/ml with PBS before it 
was aliquoted and frozen at -20°C.  
For the ELISA, Maxisorp Nunc 96 flat-bottom well plates (ThermoFisher) were coated with 
2.5 µg/ml of S. epidermidis Epi 103.1 lysate (overnight, 4°C). Afterwards, wells were blocked with 
5% milk powder in PBS 0.05% Tween 20 (Fluka) and incubated with serum dilutions ranging from 
1:20 to 1:320. Antibodies against S. epidermidis were detected using biotinylated goat anti-mouse 
IgG and IgM (Mabtech), HRP-streptavidin (Sigma-Aldrich), tetramethylbenzidine (TMB) mix and 
1M H2SO4 as a stop solution. Plates were read at 450nm in a plate reader (Berthold Technologies). 
Statistical Analysis 
Statistical analysis was conducted using GraphPad Prism 7 software (GraphPad Software). 
Statistical tests performed are indicated in each figure legend. Differences were considered 
significant with p<0.05. 
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Results 
Staphylococcus presence in mouse skin 
At two different times, we collected skin samples from mice euthanized in our facilities for other 
projects to address if we could isolate S. epidermidis. Skin samples were incubated in TSB to allow 
bacteria to grow and after 48 hours they were plated MSA, a selective medium for staphylococci. 
From 7 different mice (7 samples), 15 staphylococcal strains were isolated (Supplementary Figure 
5-45), which were identified mostly as S. xylosus and S. cohnii. One mouse was found to be culture 
positive for S. aureus isolate, and none for S. epidermidis. 
Weight change and animal welfare in pre-exposure study 
All animals lost weight after each subcutaneous injection and again after surgery. Differences were 
not statistically significant. After surgery males tended to lose less weight compared to female 
groups, although this was not significant. No differences in weight regarding implant type were 
observed (data not shown). 
 
Figure 5-39 Weight change in percentage during treatment and post-surgery (Sx). Day 0 is used as a reference to 
calculate weight change before surgery. Pre-operative weight is used as a reference to calculate weight change post-
operatively. Mean and SEM (n=5-6 for males / 10-12 for females). Repeated measures 2-way ANOVA with Tukey post 
hoc test, p<0.05. 
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Quantitative bacteriology 
Mice were inoculated with an average dose of 1.84x10
4
 CFU (no significant differences between 
saline and Epi 103.1 pre-exposure groups). At euthanasia (14 days post-operatively), all animals 
treated with saline were culture positive and 81.25% of the animals previously exposed to Epi 103.1 
were culture positive (Figure 5-40). CFU counts were not significantly different at any time-point 
but did show a trend for lower counts in Epi 103.1 pre-exposure group. 
 
Figure 5-40 A) Percentage of culture positive and culture negative mice in saline and Epi 103.1 pre-exposed groups. B) 
CFU counts in the different compartments: bone, soft tissue and implant. LOD: Limit of detection. Fisher Exact test for 
proportions and Mann-Whitney test for CFU counts. No statistical significant differences observed. 
Local response: cytokine production in bone marrow 
Cytokines in bone homogenate were quantified at euthanasia. Innate immune markers were slightly 
increased in the operated limb of inoculated and ultimately infected animals (saline and Epi 103.1 
pre-exposed groups) compared to non-operated controls or contralateral femurs. This reached 
statistical significance for G-CSF and KC (Figure 5-41, A and C), whereby both the saline and UV 
killed S. epidermidis pre-exposure resulted in an increased secretion. Pre-exposure significantly 
increase IL-2, IFN-γ, IL-17A (Figure 5-41, D-F) and VEGF (Supplementary, A) relative to the 
control group, while in the saline treated animals, only IL-17A was significantly increased 
compared to controls (Figure 5-41, F). IL-10, MCP-1 and TNF-α presented very low levels in all 
groups (Supplementary Figure 5-47, B-D). When data was subdivided by gender, still no 
differences were observed between saline and S. epidermidis exposure (Supplementary Figure 
5-48). When samples were subdivided by implant type, we could observe a trend for higher 
inflammatory markers in flexible implant groups, although this was reduced after exposure, being 
significant for G-CSF (Supplementary Figure 5-49). 
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Figure 5-41 Cytokine and chemokine levels in bone homogenates of C57BL/6N mice, from control (non-operated 
mice), saline, Epi 103.1 pre-exposed groups and contralateral femurs (for contralateral femurs, no differences were 
observed between samples from saline or S. epidermidis exposed animals and thus, values were pooled together). Mean 
values and SD (n=5-17 per group). One-way ANOVA with Sidak post hoc or Kruskal-Wallis test with Dunn's post hoc. 
Systemic responses: Spleen and Lymph Node 
Splenocytes were stimulated with S. epidermidis Epi 103.1 to measure cytokine secretion (Figure 
5-42). We observed that inoculated animals (saline and Epi 103.1 pre-exposed groups) had a greater 
response compared to the negative control group, with significant differences observed for IL-10, 
IFN-γ and IL-17A. In general, Epi 103.1 pre-exposed animals had higher levels of cytokines than 
saline treated animals, although the differences were not statistically significant. IL-4 was also 
measured but was not detected.  
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Figure 5-42 Cytokine levels in splenocytes of C57BL/6N mice, from control, saline, Epi 103.1 pre-exposed groups 
after 72 hours stimulation with Epi 103.1 (10 bacteria: 1 cell). Mean values and SD (n=6-17). Kruskal-Wallis test with 
Dunn's post hoc. 
Popliteal lymph nodes were also analysed, after stimulation with PMA/ionomycin. We did not 
observe statistically significant differences between treated groups and controls. A trend towards a 
decrease in CD3+CD4- and CD3+CD4+ proportions was observed for treated groups (saline and 
Epi 103.1 pre-exposed) in comparison to control animals. In terms of cytokine production, within 
the T helper compartment (CD3+CD4+) we did not observe significant differences. Some treated 
animals (both saline and Epi 103.1 pre-exposed) tended to have higher percentages of IFN-γ and 
IL-17A T helper cells but values were highly variable across the groups. Animals with high values 
did not correspond to animals that cleared infection. 
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Figure 5-43 Percentage of T cells (total CD3+CD4- or CD3+CD4-, and positive for IFN-γ or for IL-17A) in popliteal 
lymph node of C57BL/6N mice, from control, saline, Epi 103.1 pre-exposed groups. Mean values and SD (n=6-17). 
Kruskal-Wallis test with Dunn's post hoc. No significant differences observed. 
S. epidermidis specific antibodies 
Specific antibodies against S. epidermidis 103.1 were measured pre-operatively and at day 
euthanasia with an ELISA, where the plate was coated with a S. epidermidis 103.1 total lysate. Pre-
operatively, we observed that some of the S. epidermidis exposed mice had developed IgM or IgG 
antibodies, although the response was not homogeneous and some animals did not show increased 
values. At day 14, IgM values had increased, with no significant differences between groups or 
controls (Figure 5-44). IgG responses seemed to be related to implant-associated S. epidermidis 
infection as control animals had very low levels of S. epidermidis–specific IgG. However, no 
differences were observed between saline and Epi 103.1 pre-exposed groups at euthanasia. 
Control Saline Epi 103.1 Exposure
0
10
20
30
40
50
CD3+CD4-
P
e
r
ce
n
ta
g
e
Control Saline Epi 103.1 Exposure
0
5
10
15
20
25
CD3+CD4-IFNg+
%
 C
D
3
+
C
D
4
-
Control Saline Epi 103.1 Exposure
0
2
4
6
8
CD3+CD4-IL17A+
%
 C
D
3
+
C
D
4
-
Control Saline Epi 103.1 Exposure
0
10
20
30
40
CD3+CD4+
P
e
rc
e
n
ta
g
e
Control Saline Epi 103.1 Exposure
0
2
4
6
8
CD3+CD4+IFNg+
%
 C
D
3
+
C
D
4
+
Control Saline Epi 103.1 Exposure
0
2
4
6
8
10
CD3+CD4+IL17A+
%
 C
D
3
+
C
D
4
+
Results 
 
135 
 
 
Figure 5-44 IgG and IgM antibody levels against S. epidermidis 103.1 at day 14, two different dilutions (1:20 and 
1:80). Mean and SD (n=6-17). Kruskal-Wallis test with Dunn's post hoc test. 
Discussion 
The use of SPF mice in DRI studies is widespread, although these mice have limited exposure to 
S. epidermidis. As a result, there is no pre-existing specific adaptive immunity towards these 
bacteria. On the contrary, in humans S. epidermidis represents one of the main colonizers. This 
raises questions about the use of SPF mice in DRI models with commensal pathogens, as the impact 
of specific immunity to the pathogen is not replicated in these models. In this study, we compared 
the infection rate and immune responses in mice with a four-week subcutaneous pre-exposure to 
inactivated S. epidermidis with naïve controls. The aim was to provide an understanding about 
whether a specific immunity will influence the risk and progression of DRI. Although minor 
differences were observed in bacterial burden and immune responses, there was no significant 
impact on infection rate.  
The confirmation of the mice as negative for S. epidermidis is important to clarify. We attempted to 
isolate S. epidermidis from mice kept in our facilities and, although other staphylococci were 
present (Supplementary Figure 5-45), S. epidermidis could not be isolated. A more comprehensive 
analysis of murine skin with more specimens and combining different techniques such as 16s 
sequencing would be possible to provide further confirmation. Nevertheless, we believe that even if 
some S. epidermidis might be present, their limited number would lead to very residual adaptive 
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immune responses and thus, pre-exposing the animals subcutaneously is still an interesting 
approach to better understand the role of adaptive immunity. Moreover, other recent studies aiming 
to elucidate host immune modulation by human commensal bacteria, did not observe significant 
levels of S. epidermidis in mice skin [189]. 
Presuming that S. epidermidis was absent from our mice, we injected the bacteria subcutaneously to 
simulate the access of the bacteria to the more superficial tissues, which would generate adaptive 
immune responses. We injected UV-inactivated S. epidermidis subcutaneously twice in a 4 week 
period, as it is expected that adaptive immune responses will be built up within approximately 7 
days. In a previous pilot study performed in a small number of animals, we compared the injection 
of UV-inactivated S. epidermidis alone or with Freund's adjuvant (complete and incomplete).Both 
methods were shown to elicit adaptive immune responses (Supplementary Figure 5-50). For this 
study, we decided to use the bacteria alone, as Freund's adjuvant resulted in skin irritation in some 
animals. We already observed at that time that adaptive immune responses were not equally 
induced in all animals; however, as our aim was not to generate a protective vaccine or strong 
immunity, we did not modify the exposure protocol. In the main study, we did assess antibody 
levels before surgery, although we encountered some limitations. On one hand, the amount of blood 
obtained was very small and was often haemolytic, which could interfere with the readout of the 
ELISA. In some mice, we could observe anti-S. epidermidis IgM and IgG antibodies at the time of 
surgery, however, results were not homogenous and also some saline group animals showed signal 
in the ELISA. Of note, we used the whole bacteria lysate to coat the plate, in order to have a broad 
range of antigenic molecules present. However, these molecules may present cross-reactivity with 
other antibodies present, which were not specific of S. epidermidis. It is also important to note that 
the study was performed blinded until the euthanasia, and so we could not intervene at that stage 
and extend the exposure period. Nevertheless, our aim was not to elicit strong adaptive immune 
responses, which would completely protect animals, instead we aimed to simulate a previous 
contact with the bacteria as may occur in superficial tissues. 
After surgery and infection generation, we observed that the only group with culture negative 
animals was the S. epidermidis pre-exposed group, with also a trend for lower CFU counts in all the 
different compartments (implant, soft tissue and bone) tested. This was especially evident within 
soft tissue. Nevertheless, no statistically significant differences were observed. Thus, it seems that 
the previous exposure to S. epidermidis systemically had a very limited effect in our model system. 
In terms of immune responses between saline and Epi 103.1 pre-exposed animals, only minor 
differences were observed. This suggests that the infection process was the major driver behind 
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immune responses generation, and not the pre-exposure. For cytokine secretion, S. epidermidis Epi 
103.1 pre-exposure seemed to induce a more IFN-γ-skewed response (higher levels of IFN-γ in 
bone homogenates and after spleen re-stimulation). This was not dependent on gender or implant 
type, and thus we believe it is a mild effect of different immunological status in both groups. No 
significant differences were observed in popliteal lymph node populations. Nevertheless, few 
animals from the operated groups (both saline and Epi 103.1 pre-exposed) had higher cytokine 
responses compared to control animals. As we did not stimulate lymph nodes with Epi 103.1, we 
might be missing differences that could arise due to antigen-specific responses (as was observed in 
the splenocytes re-stimulation).  
Humoral responses were evaluated with an ELISA, using S. epidermidis 103.1 lysate to coat the 
plates. While inoculated animals tend to show higher levels of IgM and IgG, no differences were 
observed between saline and Epi 103.1 pre-exposed groups. Detectable levels of antibodies against 
S. epidermidis in our control animals (especially for IgM) suggest that cross-reactivity can explain 
part of the results observed. In the future, it would be interesting to elucidate differential antigen 
recognition between controls and inoculated groups to identify major immunogenic proteins during 
the infection process. This has been often addressed in the context of S. aureus infection [420-425]. 
A few studies have reported that the Na+/H+ antiporter, Acetyl-CoA C-acetyltransferase, lipoate 
ligase, cysteine synthase or alanine dehydrogenase can be important S. epidermidis immunogenic 
proteins [254, 255].  
In future, longer-term exposure to live microbes, instead of UV-treated microbes, could be tested. 
Also, "cutaneous-only" exposure has been successfully performed recently [188, 189] and would be 
interesting to undergo this approach, although it can induce regulatory responses. Ideally, a better 
characterization of human immune responses towards commensal strains should be achieved in 
order to replicate such responses in preclinical models when aiming to simulate clinical scenarios. 
In addition, infection models with common mouse-skin colonizers (such as S. xylosus or S. cohnii, 
based on our isolates) could represent an alternative approach to understand the impact of 
commensal strains in further infections occurring in the host.  
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Conclusion 
In contrast to human skin, murine skin does not present S. epidermidis. Thus, it is expected that the 
animals are completely naïve to this bacteria. We aimed to amend this situation, which is never 
present in humans, to understand the impact of previous immunity, arising from transient contact 
with the bacteria, in a deep-tissue infection. Although our data is a preliminary approach, we 
observed that immune responses built up upon infection did not differ significantly between pre-
exposed and saline groups. This suggests that the infection process was the main trigger of immune 
responses and previous exposure just led to minimal differences. 
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Supplementary Figures: 
 
Figure 5-45 Distribution of staphylococcal isolates (n=15) by species obtained from 7 mice.  
 
Figure 5-46 Total cell counts in bone, spleen and lymph node. Mean and SD (n=6-17). 1-way ANOVA with Tukey's 
post hoc test. No significant differences observed. 
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Figure 5-47 Cytokine and chemokine levels in bone homogenates of C57BL/6N mice. Mean and SD (n=5-12). 
Kruskal-Wallis with Dunn's post hoc test. 
 
Figure 5-48 Cytokine and chemokine levels in bone homogenates of C57BL/6N mice (samples subdivided by Gender). 
CTRL: mean of control values ± SD. Mean and SD (n=5-12). 2-way ANOVA with Sidak's post hoc test. 
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Figure 5-49 Cytokine and chemokine levels in bone homogenates of C57BL/6N mice (samples subdivided by Implant 
type). CTRL: mean of control values ± SD. Mean and SD (n=5-12). 2-way ANOVA with Sidak's post hoc test. 
 
Figure 5-50 Data from a pilot study were animals were injected subcutaneously with 2x10
6
 CFU of UV-inactivated 
S. epidermidis Epi 103.1, alone or in combination with Freund's adjuvant (complete in the first injection, incomplete in 
the second). A) anti-S. epidermidis antibodies in serum (dilution 1:20) from control mice and pre-exposed mice. Mean 
values and SD (n=2-4) B) Cytokine levels in splenocytes of C57BL/6N mice from control mice and pre-exposed mice 
after 72 hours stimulation with Epi 103.1 (10 bacteria: 1 cell). Mean values and SD (n=2-4). No statistical analysis 
performed. 
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6. General discussion 
6.1 Clinical and scientific rationale 
Fracture-related infection (FRI) is one of the major complications in orthopaedic trauma surgery. It 
can require prolonged antibiotic treatment, can delay healing, and may result in poor functional 
outcome for affected patients. S. epidermidis causes approximately 20-30% of orthopaedic device-
related infections (ODRI) [45, 49, 93] and the prevalence may even reach 50% in late-developing 
infections [94]. The predominance of this microorganism in late-developing infections may be 
linked to the sub-acute nature of S. epidermidis infections, which may first present many months 
after surgery and even then, with only subtle signs of infection. Importantly, clinical data has shown 
that S. epidermidis infection is associated with longer treatment and lower cure rates (75%) than 
equivalent infections caused by S. aureus (84%) [109], however, the scientific literature in the field 
is dominated by S. aureus.  
This thesis has focused on S. epidermidis FRI, with the aim of providing improved understanding of 
the development and progression of these infections under controlled experimental conditions. A 
first goal was to establish the first experimental model for S. epidermidis FRI. Furthermore, we 
aimed to investigate the role of features such as implant design, key receptors and cytokines in the 
progression of FRI and the role played by specific pre-existing immunity to S. epidermidis on the 
development of FRI. The following general summary will place the findings of this thesis into 
context from a general perspective, covering some discussion points that may not have already 
appeared in the preceding chapters. This section will also discuss the future studies that would be 
worthwhile to consider arising from the data generated in this thesis.  
6.2 Establishment of a Staphylococcus epidermidis fracture-related infection 
model 
One of the first aims of this thesis was to develop an in vivo model for S. epidermidis FRI, as there 
is a lack of such models in the literature [303, 340]. A model for S. aureus FRI was published 
within the context of this thesis [296], and the S. epidermidis model that was successfully 
established was based on that template. We also compared our S. epidermidis results with probably 
the most widely studied bacteria in the field, S. aureus as a means to compare and contrast the 
infections caused by these two pathogens. 
The model presented in this thesis is based on the MouseFix
TM
 system [329, 341], which is a range 
of commercially available implants and instruments designed to provide standardized fracture 
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fixation in mice. Historically, most preclinical studies have been performed in large animals, due to 
the possibility to use the implants and instruments used in human surgery, and the lack of such 
equipment for small animals. However, the development of the tools required to achieve stable 
fracture fixation in small animals has led to a significant increase in the use of rodents in bone 
research in the last 20 years [426, 427]. Although mice and rats lack a Haversian system [428], 
rodents offer numerous advantages over other animals that makes them attractive models for 
research. Rodents are easy to handle and to house, are often cheaper to obtain and maintain than 
other species and have shorter breeding cycles [426, 429]. This makes them especially suitable in 
exploratory studies where several time-points and/or conditions are to be tested and large numbers 
of animals are required. In addition, especially for mice, the most common strains are genetically 
well defined and they offer a large set of technical possibilities (from a broad range of antibodies to 
the possibility to use genetically modified animals). Amongst the available fixation systems for 
mice [430], we selected the MouseFix
TM
 system, which offers two fracture fixation plates for 
femoral fractures, and these two implants provide different mechanical support for healing: a rigid 
plate used to reproduce a stable fixation and a flexible plate to resemble an unstable fixation. The 
bone fracture (transverse osteotomy) is generated using a Gigli saw, ensuring that the defects are 
more consistent between animals and ensuring control over the size of the osteotomy gap. A 
transverse osteotomy obviously differs from a naturally occurring fracture, which may well involve 
oblique angles, uneven or jagged fracture ends and possibly may involve multiple fragments. A 
more naturally occurring fracture may be achieved in a mouse model by, for example, using the 3-
point bending system described in other models [431]. Such models are attractive for certain 
studies, but will inevitably result in greater variability in the precise fracture created and potentially 
increase the loss of animals who may not develop a fracture that is fixable using a plating system. 
For the purposes of developing a standardised, reproducible model, the use of an osteotomy 
therefore provided the most appropriate means to generate a fracture. 
When selecting the experimental mice for a bone healing study, several points such as gender, age 
and strain selection must also be carefully considered. We initially selected C57BL/6 for our studies 
as the MouseFix
TM
 flexible plate had been previously used in this mouse strain. This allowed us to 
compare our data with the previously published literature and ensure that the different implant types 
would result in a mechanics-based difference in vivo. As C57BL/6 mice are known to be Th1-
skewed (their T cells are more prone to produce Th1 cytokines such as IFN-γ, among other 
differences in their innate immune system [360, 432, 433]), we selected a second mouse inbred 
strain to provide a different background against which to compare our data. Therefore, we selected 
BALB/c mice as they are also widely used and their immune system is known to be Th2-
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skewed [360]. BALB/c mice have been used less frequently in bone healing studies than C57BL/6 
mice, and we have encountered certain difficulties in using this strain. For reasons that remain 
unknown to date, the healing of the osteotomy appeared inconsistent in BALB/c mice in our hands. 
We initially thought that this phenomenon may be due to the on-going infection, however, non-
inoculated animals also displayed a similar healing pattern. Based on these observations, the 
selection of BALB/c mice for FRI studies should be made with caution in the future. With regards 
to the age of the mice, we have been working with mice more than 20 weeks old, as they are 
considered to be skeletally mature at this age. Although our main goal was to characterize immune 
responses towards infection, which may not be as affected by age as skeletal development, we think 
that the use of adult animals was more appropriate in the context of a study involving bone healing. 
It has been documented that young, adult and old mice differ with respect to bone healing, being 
delayed in middle-age but specially in old mice [434, 435]. Since bone healing and fracture 
mechanics are central factors in FRI, young animals did not seem an appropriate option, despite the 
time savings this would offer. An additional consideration in animal selection for these studies was 
the use of specific pathogen free (SPF) mice. Recent publications have highlighted the relevance of 
adaptive immunity in bone healing [28, 362] and it has been observed that different housing 
conditions (SPF vs. non-SPF) lead to differences in bone healing, potentially as a result of greater 
adaptive immune responses in non-SPF mice [369]. In further support of this theory, a paper by 
Beura et al. proposed that non-SPF housing that exposes animals to a more diverse microbial 
environment, leads to the generation of effector and memory T cells, which more closely resemble 
those of a human adult [436]. While it seems that the use of non-SPF mice might therefore be the 
better option, there are certain disadvantages and difficulties. Firstly, standardization might be more 
difficult, especially between animal facilities, as the environment complexity would be increased. 
Secondly, it remains unclear exactly which environmental conditions are key in achieving these 
characteristics. In addition, the use of non-SPF mice may encounter regulatory difficulties in some 
facilities where the use of SFP mice is preferred to avoid certain diseases outbreak. The final 
consideration in animal selection in these studies was gender. Females were used throughout the 
study, although in the latter stages males were also included, following the National Institute of 
Health recommendations [437]. Males displayed a more aggressive behaviour, requiring single-
housing at times, and were more challenging to handle. We did not observe major differences in 
terms of bacteria clearance and CFU counts between the genders within the same group, although 
there were slightly different trends in some immune responses (e.g. cytokine production by 
splenocytes after antigen stimulation was higher in males). In future, it will likely become more 
commonplace to include both genders in animal studies; however, our data suggests that this may 
require an increase in total group sizes to account for greater variability between the genders.  
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With regards to the tested pathogen in these studies, we selected S. epidermidis as it is increasingly 
recognised as a prominent pathogen for all device related infections. Despite this, the literature on 
S. epidermidis FRI is limited [47]. We selected a clinical isolate rather than a laboratory strain for 
the model, which ensures clinical relevance. Laboratory strains of S. epidermidis are available, 
although as mentioned above, none had been included in an experimental FRI model prior to the 
start of this thesis. This isolate has since been submitted for whole genome sequencing and the 
culture has been deposited with the Swiss culture collection and will be available to other 
researchers in the field in the near future. The number of bacteria inoculated in this model is another 
crucial feature for discussion. Our infection model is based on a medium-low inoculum (10
4
 CFU), 
which we believe more closely resembles what may actually colonise a wound intraoperatively than 
the higher inocula models described for other pathogens. Whilst high inocula may be more 
representative of open fractures, this is not likely to occur in all patients. Furthermore, a high 
inoculum is likely to result in a more significant acute infection which may trigger different 
immune responses, as observed in some preclinical studies evaluating the effect of infectious dose 
[348]. In our model, a S. epidermidis medium/low inoculum leads to a low-grade infection, similar 
to clinical manifestation of these bacteria. In addition, this dose allowed some animals to 
spontaneously clear infection. This indicates that this dose is on the threshold of what is possible for 
the mice to clear, and represents an ideal starting point for this study. This is because any slight 
modifications in the local biology (e.g. fracture healing and/or immune response due to changes in 
stability) may dictate whether the mice gets an infection or is able to clear the inoculum. In other 
respects, the low-grade infection that develops in this model actually represents a challenge as 
differences between groups are often minor. For example, results with S. epidermidis were 
strikingly different when compared with S. aureus. For S. aureus, greater clinical signs (such as 
higher weight loss) and greater tissue inflammation were observed, which often yields datasets with 
more pronounced differences, rather than the less virulent S. epidermidis. Of course, the increased 
inflammatory potential of S. aureus also leads to more tissue damage and high levels of osteolysis, 
thus reducing the time of the study for ethical reasons, and also removes the possibility to study the 
effect of mechanical differences. In general, the fact that S. epidermidis inoculation with low 
numbers of bacteria leads to an infection with few clinical or immunological signs, more closely 
recapitulate the challenges faced by these infections in real life. 
6.3 Role of stability in infection 
After successfully establishing the S. epidermidis FRI model, we subsequently used the model to 
investigate the role of fracture stability in infection progression. Clinically, it is believed that 
unstable fractures have a higher infection risk, however, this evidence is not based on large scale 
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clinical studies, with the only supportive data coming from poorly standardized models of S. aureus 
infection. As described above, a few studies in the past have addressed the role of stability in 
infections [332-334], however most of those studies presented major drawbacks, such as the lack of 
a reliable fixation system to determine stability or comparing fixed fractures versus non-fixed ones. 
Our study provides the first standardized model that allows controlled conditions. In this first study 
(Results section 5.1), we evaluated the infection progression in the two different mechanical 
environments. We demonstrated that fracture stability was associated with a higher S. epidermidis 
infection clearance in C57BL/6N mice, and we observed the same effect in two independent 
experiments (Results section 5.1 and 5.2). For BALB/c mice, we observed that infection persisted 
for a longer time (with no clearance up to day 14), and no differences between stable and unstable 
groups were observed. These results highlight the relevance of host background and suggest that 
biomechanics are not the single critical feature in infection risk. Other studies with S. epidermidis 
foreign-body infection models have also found that BALB/c mice result in higher CFU counts 
and/or bigger abscesses compared to C57BL/6 equivalents [354, 355]. A possible reason for these 
observations, from an immunological perspective, is the fact that C57BL/6 mice are Th1-skewed 
and, from our data, Th1/Th17 responses may be important for bacteria clearance, as will be 
discussed below. 
We aimed to repeat the study in S. aureus; however, we encountered some important limitations 
that precluded a reliable outcome. Severe osteolysis was observed around the screws of S. aureus 
infected animals, which rendered even the rigid plate unable to provide stability. The osteolysis is 
considered due to the significant tissue inflammation, the capacity of S. aureus to induce 
osteoclastogenesis [285-288] and its negative impact on osteoblast viability [278, 438, 439]. It 
remains to be determined therefore, whether stability can influence the progression of S. aureus 
infection. In order to provide a reliable test, alternative technologies would be required to guarantee 
stability despite ongoing osteolysis.  
In future approaches, it would also be interesting to study if changes in mechanical stability within 
the experimental period (e.g. from flexible fixation to rigid fixation or vice versa) has an impact on 
the infection progression. Such data would be of high clinical relevance as it would provide 
evidence for the relative merits of the many different fixation options available to the modern 
trauma surgeon offering different mechanical fixation.  
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6.4 Immune responses associated with bone healing in differing mechanical 
environments 
We used our model to study immune responses associated with fracture healing in different 
mechanical contexts. Flexible fixation (unstable construct) consistently resulted in higher levels of 
inflammation when compared to rigid fixation (more stable construct). This was found to be true for 
both mouse backgrounds and was observed at protein (e.g. IL-6 or G-CSF secretion) and mRNA 
expression levels (e.g. Il6, Ccl2, Nos2) at most time-points. Higher levels of inflammatory markers 
have also been found in the bone marrow of patients at higher risk of developing delayed bone 
healing or non-union (e.g. patients with autoimmune diseases, cancer) [382]. In combination, this 
suggests that excessive inflammation can negatively influence the healing process.  
In addition, we also observed differences in inflammation between groups in the presence of 
infection. We observed that the combination of S. epidermidis infection and unstable fracture results 
in a significantly higher level of inflammation compared to the non-inoculated mice with flexible 
fixation. It could be hypothesized that excessive inflammation can impair immune responses 
towards bacteria. A possible mechanism could be through the licensing of mesenchymal stem cells 
(MSC) into an immunosuppressive phenotype, which only occur when MSC are exposed to 
sufficiently high levels of pro-inflammatory cytokines such as TNF-α or IFN-γ. Proposed mediators 
of this immunosuppressive role are nitric oxide, prostaglandin E2 or TGF-β, as well as cell-cell 
interaction [440, 441]. Among the immunosuppressive actions that MSC can exert, one can find: 
production of IL-10 by numerous cell types, reduction of antigen presentation by dendritic cells, 
lower proliferation of T cells or induction of Treg and B regulatory cells [441-443]. Although some 
of the markers associated with MSC immunosuppression function were increased in mice with a 
flexible implant (e.g. Tgfb2 or Nos2), we did not observe obvious signs of immunosuppression, 
such as higher levels of IL-10 or lower proliferation of lymphocytes (although reduced proportions 
of CD8+ T cells in S. epidermidis inoculated flexible group and S. aureus inoculated groups could 
be associated to a reduced proliferation of this subset).In addition, some of the genes highly up-
regulated in animals with a flexible implant and/or inoculated with S. epidermidis (e.g.Nos2 or 
Arg1) are also associated with myeloid-derived suppressor cells (MDSC).Classically, MDSCs are 
defined as a heterogeneous population of immature monocytes and granulocytes with 
immunoregulatory properties [444]. They accumulate during different pathologies that are 
accompanied by inflammation [445-447]. MDSCs have been shown to contribute to S. aureus 
persistence in a murine model of orthopaedic-device associated infection, through the production of 
IL-10[300, 448, 449]. The role of MSCs and MDSCs would be an interesting field to explore. Both 
cell types present similar immunosuppression mechanisms [447], which would be interesting to 
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explore in future (for example by using IL-10 KO mice). Finally, tissue damage or hypoxia, which 
based on mRNA expression were increased in animals with a flexible implant (e.g. higher levels of 
Il33 or Hif1a), may also contribute to the differences observed. 
Due to the link between instability and higher inflammation, the model presented here could be 
used in future to observe the effect of anti-inflammatory drugs in bone healing and/or infection 
outcome. While inflammation is needed to initiate the healing cascade [450, 451], data suggests that 
excessive inflammation may have detrimental effects on bone healing [375, 377, 382]. Of note, in 
our model animals already receive acetaminophen (paracetamol) for 5 days in the drinking water; 
however this was equivalent for all groups. In addition, in a previous publication with rats, no delay 
in bone healing was observed after treating animals with acetaminophen for 10 days [452]. In 
humans, the prolonged use of non-steroidal anti-inflammatory drugs (NSAIDs) and COX-2 specific 
inhibitors has often been associated with delayed bone healing [453, 454] while the effect of short 
term usage is less clear [325, 455]. In preclinical studies, contradictory findings have also been 
reported [456]. Interestingly, Goodman et al. compared a short period (2 weeks) of COX-2 selective 
NSAID consumption versus long term consumption (6 weeks) in rabbits and observed that only the 
long term consumption impaired bone healing [457]. In general, there is still a need to understand 
the ideal inflammation timing and intensity for bone healing, which could be addressed in out 
model. Moreover, our data might suggest that excessive inflammation can be linked to lower 
bacterial clearance, which would be an interesting research question to pursue in future. 
Another point to be discussed in the context of our studies is the role of IL-17A. IL-17A producing 
lymphocytes have been proposed to contribute to bone healing [32, 389]. In our experiments, IL-
17A producing lymphocytes levels and Il17a mRNA expression were very low in the non-
inoculated mice, suggesting no significant involvement for this cytokine in bone healing. However, 
we only studied animals from day 3, whereas many cytokines are secreted during the first 24 hours 
[18, 458], and so, a role for IL-17A in the immediate post-fracture period would still be possible. 
However, we performed histology in non-inoculated IL-17A KO mice and we did not observe 
major differences in terms of bone healing when comparing to WT. In both strains, osteotomies 
were closed at day 14, although techniques allowing quantification of bone formation (such as 
micro CT) should be used to confirm this histological observation. The exact role of IL-17A in 
bone healing is a matter of controversy also in the published literature: while some studies have 
shown a positive effect of this cytokine in supporting bone healing, contrasting data has shown that 
blocking of IL-17A in osteoporotic bone actually improved healing [459]. Further studies are 
required to more clearly define the role of IL-17A in bone healing, which could be pursued with the 
MouseFix
TM
 system. 
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Finally, it would be interesting to combine mouse models with co-morbid conditions (such as 
obesity, diabetes, nicotine intake) in this FRI model, in order to evaluate if host condition and 
fracture instability may have a synergistic effect. This could elucidate if instability may lead to a 
worse prognosis in certain groups of patients, which are already at higher risk of infection [319, 
460].  
6.5 Immune responses associated with infection 
Throughout our study, we observed that IL-17A was often up-regulated due to S. epidermidis 
infection (at mRNA and protein level). IL-17A is a cytokine from the IL-17 family, alongside IL-
17B, IL-17C, IL-17D and IL-17F [396]. IL-17A, as a homodimer or as a heterodimer with IL-17F, 
signals through the IL-17A receptor. IL-17A is produced by Th17 lymphocytes, but also by γδ T 
cells, NK cells or neutrophils. In our model, upon infection, the main producers of IL-17A were 
found to be Th17 and γδ T cells. Among its main functions, IL-17A will recruit neutrophils and will 
induce the secretion of pro-inflammatory cytokines, orchestrating immune responses particularly in 
tissues with high bacterial exposure [461]. Upregulation of IL-17A has also been observed in a S. 
aureus FRI [296] and there is data suggesting that Th17 responses are important for S. aureus 
clearance in infection models of peritonitis or soft tissue infection [388, 392, 393, 462]. Much less 
is known regarding the role of IL-17A in S. epidermidis infections. In these studies, we have 
provided the first evidence that IL-17A contributes to the clearance of S. epidermidis infection, with 
higher percentage of culture negative animals in wild-type (WT) than IL-17A knock-out (KO) 
groups at all time-points studied. However, the lack of complete reversal in infection rate suggests 
that other mechanisms also contribute to infection resolution. A possible explanation may be that 
IL-17F would have compensated for the lack of IL-17A, suggesting that the use of an IL-17A/IL-
17F double KO should be considered in future studies. Such double KO models have shown to 
result in greater differences (e.g. lower clearance in KO vs. the WT) than single KO in S. aureus 
nasal colonization models [394]. We were not able to detect IL-17F in the infected bone tissues, 
even in the KO mice, which suggest that in our system IL-17F may not play an important role. IL-
22, which is also often secreted by IL-17A secreting cells, was also not detected. Interestingly, IFN-
γ (Th1 responses) was significantly increased in KO mice compared to non-inoculated controls, 
suggesting that could compensate for IL-17A lack. In addition, IFN-γ administration has been 
shown by others to reduce bacterial load in a S. epidermidis foreign-body infection model [230]. 
Overall, it seems therefore that both Th17 and Th1 responses are required for infection clearance, 
although this should be confirmed in future studies by, for example, the use of double KO (e.g. IL-
17A and IFN-γ KO) or blocking antibodies. Additionally, the therapeutic potential of cytokines, 
like IL-17A or IFN-γ, would also be of great interest to address. For example, IFN-γ has been 
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shown to increase S. epidermidis clearance in a subcutaneous DRI model [230]. However, due to 
the osteolytic potential of these cytokines, their therapeutic use in bone infections should be 
considered carefully.  
The IL-17A KO study was only performed with rigid fixation. It remains an open question if bigger 
differences would be observed between WT and KO using the flexible implant, as a different 
inflammatory environment may influence the relative effect of IL-17A.In addition, it would be of 
interest to see if these observations can be also translated in humans. If the specific increased 
presence of IL-17A in bone marrow or infected tissues would hold true in patients, it could be used 
as a complementary tool, for example, to diagnose patients from whom bacteria cannot be isolated 
and have no obvious clinical signs (e.g. subclinical type of infections as often caused by 
S. epidermidis). Culture techniques are still the gold standard for diagnosis of trauma or arthroplasty 
infections. However, these techniques are time consuming (with some specimens taking several 
days to grow) and sometimes yield negative results due to non-cultivable bacteria, previous 
antibiotic therapy or samples collected where bacteria are not located. The detection of IL17A 
expression, together with other markers, may serve as an additional diagnostic tool that could be 
tested in humans. A similar proposal has already been used recently, to intraoperatively diagnose 
prosthetic joint infection patients, using an array of 12 genes [463]. The test, which included several 
immune markers such as TLRs or IFN-γ, was proven specific and quick to intraoperatively 
diagnose PJI patients, allowing the surgeon to take relevant decision regarding surgery and 
treatment. IL-17A was not included in this panel, but would be an interesting candidate to 
supplement the chosen genes. In addition, S. epidermidis is a usual contaminant of clinical samples 
due to its widespread presence, for this reason, at least 2culture positive biopsies are required for a 
more certain diagnostic [98]. Thus, molecular techniques addressing host parameters may 
complement tissue culture techniques in cases where contamination is suspected. 
6.6 Role of Histamine 2 Receptor 
In our initial studies investigating immune responses in the S. epidermidis FRI model, increased 
histamine 2 receptor (H2R) mRNA expression was observed in S. epidermidis inoculated mice 
compared to non-inoculated. The role of H2R in infection is controversial. Cimetidine (a H2R 
antagonist) treatment reduced mortality in diabetic mice in a sepsis model (induced by cecum 
ligation and puncture) and histamine administration lead to a lower survival rate [401]. Contrasting 
with this, the same antagonist led to an increased mortality in a Yersinia enterocolitica infection 
model [402] and lead to higher morbidity in a peritonitis model [403]. Finally, the use of 
antihistamines (specifically H2R agonists) has been linked to an increased risk of Clostridium 
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infections or infection complications in severely injured patients [464, 465]. In the FRI model 
developed in this work, different immune responses were observed between WT and KO mouse 
strains, with higher pro-inflammatory cytokine levels (e.g. TNF-α) or anti-inflammatory cytokines 
(e.g. IL-10) and higher antibody levels in the H2R KO groups. This was not exclusively associated 
with the presence of bacteria, as this was also observed for non-inoculated mice. However, these 
differences did not lead to differences in terms of bacterial clearance. The earlier studies described 
in this thesis revealed that BALB/c mice display a slower clearance of infection, and so later time-
points may provide further insight as to the exact role of H2R. As it stands, our data suggest that 
H2R does not play a role in bacteria clearance in this model of FRI. 
6.7 Impact of previous immunity in infection resolution 
Arising from its status as a commensal microorganism, S. epidermidis is expected to elicit adaptive 
immune responses in humans from early in life. This has been proposed to be largely triggered by a 
pattern of transient self-resolving infections due to micro-invasions, rather than resulting from local 
responses due to colonization [246], but the latter cannot be excluded as shown in skin-colonization 
mouse models [188, 189]. These life-long interactions will lead to the generation of an antibody 
repertoire and a set of memory T and B cells that may be expected to confer partial protection from 
infection by S. epidermidis. Antibodies recognizing S. epidermidis proteins are present in healthy 
individuals, and in higher titres in infected patients [251, 255].  
We induced adaptive immunity against S. epidermidis in mice, to study whether it influenced 
infection in our FRI model. In terms of clearance, we did not observe significant differences 
between saline and S. epidermidis pre-exposed mice, although there was a trend for lower CFU 
counts in the pre-exposed group. Of note, we did not observe as much clearance in WT C57BL/6 
mice as in previously performed studies at the same time-point (Results section 5.1 and 5.2). The 
only significant difference was the subcutaneous injections and blood collection performed before 
surgery. In theory, this may also have influenced the results by increasing stress levels in animals. Is 
important to note that we used inactivated bacteria instead of live bacteria, which would have been 
a more potent stimulus. Non-viable bacteria were used due to ethical requirements as the animals 
had to undergo a surgical procedure after exposure and the combination of both procedures with 
live bacteria was considered too burdensome. The method used to prepare non-viable bacteria can 
also influence the type of immune responses induced, potentially by affecting protein structures and 
thus the recognition by pattern recognition receptors [466]. Thus, we preferred UV-inactivation in 
comparison to heat-inactivation, although we did not address the differences that may arise between 
this or other methods. Another point of discussion would be the administration route. As described 
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before, S. epidermidis immunity in humans is thought to arise from micro-invasions which most 
likely happen in the skin and superficial tissues, and that is why we chose to inject bacteria 
subcutaneously. Intradermal administration would be also an interesting approach, as will deliver 
bacteria to a site rich in antigen presenting cells (e.g. Langerhans cells) [467]. In future, longer-term 
exposure should be considered, ideally from early stages in life, in young mice [188]. In addition, 
live microbes, instead of UV-treated microbes, would be desirable as metabolically active bacteria 
may trigger different responses in the host. Finally, topical application has been shown useful to 
study the effect of S. epidermidis when colonizing the skin, in health or in diseases like atopic 
dermatitis [189, 468], and would be another interesting approach to understand how previous 
colonization may influence the results of our pre-clinical models when aiming to simulate clinical 
scenarios.  
Finally, we have searched for the presence of S. epidermidis in mouse skin by means of culturing 
techniques using staphylococcal selective medium. However, it is known that such techniques tend 
to over-represent the most prevalent strains and/or strains with the faster growth rate. A more 
comprehensive analysis of murine skin with more specimens and combining different techniques 
such as 16s sequencing would be needed in other to achieve a better characterization of mouse 
microbiota. In addition, infection models with common mouse-skin colonizers (such as S. xylosus 
or S. cohnii based on our isolates) could represent an alternative approach to understand the impact 
of commensal strains in further infections occurring in the host. 
Interestingly, as discussed above, it has been described that non-SPF mice can display slower 
fracture healing. This is believed to be due to the negative effect that some components of adaptive 
immunity (described at least for CD8+ T cells) have in bone healing. We did not observe 
differences in our pre-exposed animals compared to saline; although we did not perform 
measurements (such as micro CT or high resolution radiographs) to quantitatively evaluate bone 
healing. That would be something interesting to assess in addition to infection responses, and a 
study for which the model used in the present study would be particularly suitable.  
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6.8 Conclusion 
In summary, this thesis presents a S. epidermidis fracture-related infection model, which results in a 
subclinical type of infection. Although this often leads to small differences (as observed when 
comparing cytokine secretion or mRNA expression in non-inoculated versus S. epidermidis 
inoculated mice), this matches the real-life clinical presentation of S. epidermidis infections. In any 
case, the model has been proven useful to evaluate the role of different parameters in infection 
clearance. Specifically, the role of fracture fixation, IL-17A, H2R and previous exposure to bacteria 
were addressed in our model. The data presented has provided some of the first data on FRI with 
this pathogen, and has opened up a wide range of experimental possibilities for future studies, as 
described above. The understanding of S. epidermidis FRI arising from this thesis has both clarified 
the clinical reality, providing some answers to long-held clinical beliefs, and further challenged our 
understanding of how infection can complicate the healing of fracture bones fixed with modern 
fracture fixation devices.  
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Danke viel mal 
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